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CHAPTER I 
INTRODUCTION 
General Introduction, Background And Purpose 
The simultaneous isolation of pilocarpine in l875 by Hardy 
(97) and by Gerrard (87,88,89,90) from the leaflets of pilo-
carpus jaborandi and Pilocarpus microphy11us Stapf was followed 
shortly by a description of its pharmacological properties. 
pilocarpine was shown to produce effects which resembled those 
produced by stimulation of parasympathetic nerves. It is there-
fore one of the oldest, if not perhaps the oldest, parasympa-
thomimetic drug in use today. 
It is generally accepted' that a drug produces an effect as 
a result of the interaction of the drug molecule with certain 
specific areas or enzymes of certain cells in the effector organs 
or tissues, and it is further believed that these active areas 
or receptors are protein in nature. No one has as yet isolated 
a 'receptor', and our knowledge of some of the characteristics 
of the receptor sites has been derived from an understanding of 
the physico-chemical characteristics of the drug or chemical 
molecules which produce a biological response. It has also been 
, 
postulated (186) that a molecular complementariness between the 
structure of the reacting molecule and that of the receptor is 
responsible for biological specificity. It should be mentioned, 
1 
2 
however, that this specificity on the part of the drug molecule 
or the protein surface may only be relative. For example, 
Beckett (24) has indicated that the shape of the drug molecule 
itself may be altered in the environment of the protein surface. 
Evidence that some enzymes and receptor surfaces may be suf-
ficiently flexible so that the surfaces may change their spatial 
characteristics upon the steric or electronic demands of differ-
ent substrates is also available (146). These factors may be 
further complicated by the fact that the biological effects of 
molecules with different sizes and shapes may be the result of 
differences in metabolism or distribution rather than differ-
ences in fit at a hypothetical receptor surface (23). 
Some of the first attempts at correlating the pharmaco-
logic action of parasympathomimetic drugs with functional 
('prosthetic') groups was made by Pfeiffer (194). After in-
spection of numerous compounds, he proposed that parasympa-
thetic stimulant action in a molecule depended on adjacent 
ether and ketone oxygens at a distance of about 5 to 7 i, re-
spectively, from one or more methyl groups attached to a 
nitrogen atom. The compounds measured in his study included 
not only acetylcholine and some choline esters but also pilo-
," carpine, arecoline, neostigmine and physostigmine. Ing (120) 
subsequently argued that although many parasympathomimetic 
drugs possessed carbonyl and ether oxygen atoms, as well as a 
methylated nitrogenl their presence did not necessarily insure 
parasympathomimetic stimUlant action. Raventos (207)1 for onel 
had previously demonstrated that alkyl quaternary ammonium 
salts had an acetylcholine-like action on frog heart. Maximum 
activity was reached with the n-amyl trimethylammonium member 
of the series. Based in part on this finding and other inves-
tigations conducted on the size of the cationic moiety (1161 
2311 256) in drugs of the type RN(CH3 )31 Ing noted that the 
most active parasympathomimetic compounds are those in which 
R is a five-atom chainl and further l that it was not necessary 
that R include oxygen functions. He feltl thereforel that the 
"five-atom rule" was in better agreement with the available 
.' experimental evidence than was the "prosthetic group" or 
"two-atom" rule advanced by Pfeiffer. Although the five-
atom rule can be successfully applied to many compoundsl it . 
breaks down when applied to 4-acetoxybutyn 2-yltrimethylammo-
nium iodidel a very active parasympathomimetic agent reported 
3 
by Jacob et al (121). The rule also fails to hold when applied 
to tremorinel oxotremorine (47) and 3-acetoxyquinuclidine (170)1 
tertiary amine compounds displaying muscarinic activity. The 
preceding examples seem to emphasize the conclusions reached by 
Belleau (29) regarding the muscarinic receptor when he said 
that the muscarinic receptorl like that of the acetylcholin-
esterase receptorl while displaying a high degree of absolute 
stereospecificity has a lim1ted structural specificity toward 
agents which are capable of stimulating it. 
It is perhaps natural to attempt to deduce relationships 
between chemical structure and pharmacologic activity by com-
paring the properties of acetylcholine with those of other 
compounds related to it. Attempts to correlate the action of 
pilocarpine on the basis of its structure have not always been 
presented in an acceptable fashion. Because of the seeming dis-
similarity of its structure to that of acetylcholine, pilo-
carpine has been proclaimed an enigma among cholinergic ~gents. 
cutting (57) has described pilocarpine as a tertiary amine 
resembling histamine more than acetylcholine. The structural 
resemblance of pilocarpine to·histamine has also been mentioned 
by Koelle (142) writing in The Pharmacological Basis of Thera-
peutics. Pilocarpine and histamine both have imidazole rings 
as part of their structure and to infer more than this, in the 
writer's opinion, is fallacious. Marshall (169) demonstrated 
in 1904 that the activity of pilocarpine was dependent upon the 
presence of the lactone ring. When the lactone ring was opened 
by the formation of a pilocarpate (salt of pilocarpic acid) 
and the solution was injected into a rabbit, all pilocarpine 
activity, determined on the basis of a circulatory response, was 
lost, whereas the vasodepressor response to an unreacted portion 
of the pilocarpine solution was present. 
5 
The similarity in structure between pilocarpine and acetyl-
choline is shown in Fig. 1. Acetylcholine (upper photo) is 
shown in its fully extended form. The distances between the 
carbonyl oxygen and the ester oxygen of acetylcholine and pilo-
carpine (lower photo), as measured on the models, were the same, 
2.79 i. The ester oxygen to carboxyl (carbonyl) carbon atom dis-
tance was 1.28 i in both molecular models and compares favorably 
with the 1.32 i distance reported by Canepa, Pauling and 
Sorum (43) from X-ray diffraction data obtained on crystalline 
acetylcholine bromide. The interatomic distance between the 
nitrogen atom to ester oxygen atom was 3.84 i in the acetyl-
choline model. The same distance (unsubstituted N) in the 
pilocarpine model was 3.92 i.' This distance in acetylcholine 
(molecule not fully extended) was reported by Canepa et al (43) 
to be 3.29 i. In a fairly recent review (1961), Waser con-
cluded that the two groups should be. separated by a distance 
of about 4 i for maximum activity (255). Although the 
molecules may assume different conformations in the in vivo 
--
environment, a strong similaritr in molecular structure can be 
demonstrated between models of acetylcholine and pilocarpine. 
A few of the studies (47,86,211,220) undertaken on 
various drug compounds have implied that at physiological pH 
many drugs or receptors may be protonated, i.e., may exist in 
the form of a cation. If this were the case with pilocarpine, 
one of the more apparent, inexplicable discrepancies that 
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Fig. 1 - Framework molecular models showing mutual relationship 
of atoms in the acetylcholine molecule (upper photo) and in 
the pilocarpine molecule (lower photo). Models constructed 
on the relative scale of 1 ~=l inch. 0 atom, red: N 
atom(s), blue: C atoms, black: H atoms, narrow band on 
white tubing. 
7 
exists between its chemical structure and action and that of 
most other parasympathomimetic agents would be dispelled. How-
ever, since many of the other cholinomimetic agents exist as 
quaternary compounds before their introduction into a physio-
logical system, .it appeared. that the preparation and inves-
tigation of quaternary ammonium salts of pilocarpine would be 
of pharmacological interest. Our purpose was to prepare a 
series of quaternary derivatives of pilocarpine in order to 
simulate in some degree the functional group common to other 
parasympathomimetic agents. Once the compounds had been pre-
pared, they would be subjected to as many appropriate screening 
tests as time would allow. 
One of the simplest ways to investigate the pharmacology 
of a series is to alter the size of an alkyl and/or aralkyl 
group. An.investigation of this type has some practical advan-
tages. Generally, it might be expected that the physical and 
chemical changes which are brought about as one ascends a series 
might not be too great. Also, the probability that a highly ac-
tive compound would be passed over can be minimized. Of perhaps 
greater importance is the likelihood that a study of a homol-
ogous series may reveal mechanisms of drug action which could 
not be revealed by a study of derivatives which differed greatly 
from one another in their basic 'structure. 
• 
Imidazole 
1. General Description of Imidazole and Some of its 
Chemical Characteristics - A place of particular 
importance is attached to substances which have as their parent 
compound a ring system known as the imidazole nucleus. Repre-
sentatives of this five-membered heterocycle are found in the 
natural, products of both plant and animal origin and also con-
stitute an important area in the field of organic medicinal 
products. Imidazole was first prepared by Debus (62) from 
glyoxal (O:CH.CH:O) and ammonia, and to indicate its source, he 
called it glyoxaline. Glyoxaline, as well as iminazole and 
l,3-diazole, are names still encountered in the literature. The 
commonly accepted name, imidazole, was given to the compound by 
Hantzsch (96). He classed as azoles the five-membered polyhe-
teroatomic ring systems containing at least one tertiary nitrogen 
atom. The term imidazole implies a five-membered heterocyclic 
ring system containing an imino (=NH) group in addition to a 
tertiary nitrogen, just as the names oxazole and thiazole des-
ignate five-membered rings containing an oxygen or sulfur atom 
in addition to a tertiary nitrogen. In these azoles, the hetero-
atoms are oriented in the 1,3- positions with respect to one 
another. The numbering of the imidazole ring is shown on the 
following page. 
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In principle, it should be possible to prepare isomeric 
4- and 5- substituted imidazoles. However, no such pairs have 
been separated because of rapid tautomeric shifts of H from one 
N to the other. Consequently, the 4- and 5- positions in imid-
azole are to be regarded for practical purposes as indistin-
guishable. The ambiguity is often indicated in naming these 
compounds by including the alternative positions of substi-
tuents in parentheses, as in 4(5)-methyl imidazole. However, 
when the H on the N is replaced by a less mobile group, for 
example an alkyl group, then the isomeric 4- and 5- substituted 
compounds can be obtained (213). 
The structure generally written for imidazole would seem 
to indicate that one heteroatom resembles the nitrogen in 
pyridine while the other resembles that in pyrrole. Imidazole 
is a base of moderate strength, having a pKa of 7.16. It is, 
however, a stronger base than pyridine and a stronger acid than 
pyrrole. This has been explained by the fact that the imido 
group increases the availability of the "lone-pair" of electrons 
on the tertiary nitrogen and hence increases the basicity rela-
tive to pyridine. On the other hand, the tertiary nitrogen 
attracts electrons and hence increases the tendency for the 
imido hydrogen to separate as a proton, thus increasing its 
acidity (15). 
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By virtue of the double bonds and its varying degrees of 
resemblance to benzene in some of its chemical and physical 
properties, the heterocycle has definite aromatic character-
istics. This ring system is stable to acids and bases and 
generally resists reduction (hydrogenation). Imidazole itself 
is stable to chromium trioxide; but is attacked by potassium 
permanganate and by hydrogen peroxide. Furthermore, imidazoles 
undergo typical aromatic substitution reactions such as 
halogenation, nitration and sulfonation. Alkylation of imid-
azole yields l-alkylimidazoles. The N-alkyl derivatives readily 
add alkyl halides, forming imidazolium salts (15,106,166,221). 
The imidazolium salts will be discussed at greater length in a 
subsequent section. In common with other aromatic compounds, 
no single satisfactory valence-bond structure can be drawn for 
this molecule, but imidazole must be considered as a resonance 
hybrid of a number of contributing structures. The ultraviolet 
absorption spectra of the azoles provide some evidence for the 
existence of these electronic configurations, but additional 
work has yet to be done (15). 
Imidazole is the gateway to'a discussion of heterocyclic 
compounds whose physiological activities and pharmacologic 
actions vary with modifications in the imidazole nucleus. Some 
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of the more important and interesting compounds which are repre-
sentative of these modifications will be briefly discussed in 
the sections to follow. 
2. Imidazole Derivatives - This discussion of imidazole 
derivatives will be concerned with those natural and synthetic 
compounds which, for the most part, possess marked physiological 
and pharmacological activity. A review of some of the biolo-
gically important imidazoles has been made by Fox (81). In 
addition, information concerning some of the more important 
imidazole derivatives appears in the works already cited 
(15,106,166,221), as well as in the texts by Burger (38) and by 
Jenkins, Hartung, Hamlin and Data (124). 
Imidazole itself has little action and is relatively non-
toxic (12). No one will dispute the importance of proteins in 
the viability and maintenance of structures in both the plant 
and animal kingdoms. L-histidine, an essential amino acid, has 
been shown to be a constituent of most proteins. The amino acid 
was originally isolated in 1896 by Kossel (147) from the prot-
amine, sturine. Structurally, histidine is ~-(4-imidazoyl) 
alanine, the imidazole nucleus with an alpha-aminopropionic acid 
side chain. It has been said that the imidazole content of 
protein is due chiefly to histidine, and it has been proposed 
that the uncoupled imidazole radical contributes to the basic 
property of many proteins (81). Two dipeptides which have been 
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found to be normal constituents of mammalian muscle are car-
nosine, ~-alanyl-L-histidine, and anserine, whi.ch is fo-alanyl-
l_methylhistidine. Since anserine is a methyl derivative of 
carnosine, it is probably formed from the latter by a trans-
methylation reaction (257). A review on the chemistry and 
physiology of carnosine and anserine has been published by du 
Vigneaud and Behrens (253). Gamma-aminobutyric acid (GABA) is 
one of the more active amino acids which can substitute for 
~-alanine. The peptide which results from the combination of 
GABA and histidine, gamma-aminobutyrylhistidine, has been named 
homocarnosine. Homocarnosine formed from GABA can be found in 
the brain, but has unknown metabolic significance (259). 
Probably the best known and perhaps one of the most active 
of the imidazoles is histamine, 4(5)-(~-aminoethyl) imidazole. 
Before it was recognized as a naturally occurring substance, 
the base was synthesized by Windaus and Vogt (262) as part of 
a program involving the synthesis of imidazoles. Histamine was 
first identified in extracts of ergot simultaneously in 1910 by 
Barger and Dale (17) and by Kutscher (153). In this same year, 
Ackermann (1) showed that histamine was produced as a result of 
the enzymic decarboxylation of histidine. Several years later, 
tracer studies confirmed that histamine could be formed from 
histidine. Since its isolation from plant material, the pres-
ence of histamine has been demonstrated in many animal tissues 
1J 
and body organs. 
Additional compounds related to histidine are ergothioneine 
(alsO called thioneine) and hercynine. Ergothioneine, so named 
because it was first isolated from an extract of ergot (234), 
has also been shown to be a normal constitutent of mammalian 
blood (119). Structurally, the compound has been shown to be 
the betaine of thiohistidine. 
Its physiological significance is as yet not known. The com-
pound was shown to be one of the nonsugar reducing substances 
in blood (30), and it has been theorized that its value may be 
related to this fact. Desulfurization (replacement of SH by H) 
of ergothioneine yields the betaine of histidine, hercynine 
(16). This compound has been found in extracts from certain 
fungi (mushrooms), especially Agaricus muscarius Pers. and A. 
campestris L., Agaricaceae (8l.152.154). The biological or 
physiological importance of hercynine is unknown at present. 
A choline ester of imidazole of possible physiological sig-
nificance is murexine, or as it is also known, urocanylcholine. 
This substance, which was obtained from the hypobranchial glands 
of Murex trunculus and other snails of the Muricidae, was 
isolated and identified by Erspamer and co-workers (7l,72,73) 
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as 4-imidazoleacrylycholine. Murexine has also been isolated 
from mammalian brain, and this has raised some speculation as to 
its possible function (94). 
Another important group of substances which contain the 
imidazole nucleus are the alkaloids isolated from the leaflets 
of various species of pilocarpus, especially from Pilocarpus 
iaboranmHolmes and Pilocarpus microphyllu~ Stapf. The most 
important of these alkaloids is pilocarpine. A more extensive 
discussion of these alkaloids will be presented in a later 
section. For the present, it may be said that structurally the 
alkaloids consist of the imidazole nucleus linked to a gamma-
butyric acid lactone. 
3. Partially Reduced and Reduced Imidazoles - The degree 
of saturation of an imidazole is designated by changing the end-
ing -ole into -oline or by using the prefix dihydro- for the 
partially reduced heterocycle. The fully reduced imidazole is 
designated by changing the -ole ending into -olidine or by at-
taching the prefix tetrahydro- to imidazole. Theoretically, 
three isomeric imidazolines are possible, depending on the 
position of the double bond in the ring heterocycle. These are 
the 2-imidazolines (4,S-dihydroimidazoles), the 3-imidazolines 
(2,5-dihydroimidazoles), and the 4-imidazolines (l,2-dihydro-
i', imidazoles) • 
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2-Imidazoline 3-Imidazoline 4-Imida~oline 
The imidazolines are monoacidic bases and form monohydrogen 
halide salts. The ring system is only moderately stable, the 
2-imidazolines, for example, hydrolyze when heated with con-
centrated hydrochloric acid or with concentrated alkali. 
Reduction of imidazolines is difficult, but dehydrogenation to 
imidazoles, though not readily accomplished, has been reported 
(15,166). Representatives of all three classes have been de-
scribed. However, those which have received a great deal of 
attention and are the most common are the 2-alkyl- and 2-aralkyl 
SUbstituted 2-imidazolines (78,107). Many of these compounds 
exhibit surface-active properties, and because of this they have 
received wide application in a number of fields as bacterio-
statics, fungicides, emulsifiers, textile aids (dye inter-
mediates, softening agents for textiles), flotation agents, and 
asphalt additives (108,221). The high degree of pharmacologic 
action has led to the synthesis of many analogues of the 2-
substituted-2-imidazolines. Their chief value is found in their 
effects on the circulatory system. One cannot make broad 
generalizations about their~activity as cardiovascular drugs for 
one compound may be a potent vasoconstrictor whereas its nearest 
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congener is a vasodilator. Hartman and Isler (102) were the 
first to investigate the pharmacology of a series of 2-substi-
tuted imidazolines. A review of some of these compounds and a 
~orrelation between structure and aqtivity was presented by 
scholZ (224). Some of the more familiar 2-imidazolines which 
have been employed in medicine will be briefly discussed. The 
discussion will highlight not only some of the imidazole-derived 
structures which have been explored and utilized, but also some 
of the difficulty involved when attempts to correlate structure 
and activity are made. 
Tolazoline hydrochloride, 2-benzylimidazoline, one of the 
simpler members of the series, is a vasodilator and a vasodepres-
sor substance. The introduction of methoxyl groups into the ben-
zene ring, or the inclusion of an imino group between the benzene 
ring and the methylene group in tolazoline, yields phedrazine 
[2-(3,4,S-trimethoxybenzyl) -imidazoline] and octrivin [2-(ani-
linomethyl)-2-imidazoline] respectively, both active vasocon-
strictor substances. The replacement of the phenyl group in 
tolazoline by an alpha-naphthyl radical, as in [2-(1-naphthyl-
methyl)-imidazoline], naphazoline hydrochloride, also alters the 
activity from that of a vasodilator to a hypertensive vasocon-
strictor. The corresponding 1,2,3,4-tetrahydronaphthyl deriva-
tive, [2-(1,2,3,4-tetrahydro-l-naphthyl)-2-imidazoline hydro-
chloride], tetrahydrozoline hydrochloride, has similar 
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vasoconstrictor properties (15, 18, 38, 224). The naphthyl de-
.. rivatives are employed locally as nasal decongestants. The tet-
rahydro derivative has also enjoyed some popularity in ophthalmo-
logic practice as a vasoconstrictor in the treatment of conjunc-
tivitis (173). The last of the so-called cardiovascular drugs of 
the 2-imidazoline series is phentolamine, 2-[N-(p-tolyl)-N-(m-
hydroxyphenylaminomethyl)]-imidazoline (102). This compound, 
like tolazoline, is a hypotensive agent. In addition to its di-
rect cardiac and smooth muscle effects, phentolamine has been 
shown to have a mode~ateblocking effect on adrenergic receptors 
(212, 236). Not all of the 2-imidazolines which are of pharmaco-
logic or medicinal interest are cardiovascular drugs, one such 
exception being antazoline. This compound is 2-(N-phenyl~N-ben­
zylaminomethyl)-2-imidazoline. Though slightly weaker than other 
agents in its class, antazoline has been successfully employed 
as an antihistamine (124). 
The nomenclature of the fully reduced imidazoles follows 
from the system previously described, these compounds being 
called imidazolidines (tetrahydroimidazoles). The imidazolidines 
are generally prepared by condensing an aldehyde with "an ethylen-
ediamine in which at least one of the amino groups is secondary 
,(209). Cyclization occurs with the formation of a 1, 2 disubsti-
tuted imidazolidine. 
The 
CH~NH2 I 
CH 2 
"NHR 
imidazolidines 
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do not possess the stability of the other im-
idazole derivatives discussed so far, but are readily hydrolyzed 
by acids to the aldehyde and the diamine of synthesis. The com-
pounds are, however, more stable toward alkali (79) •. Oxo deriv-
atives of imidazolidine appear to be relatively more important 
pharmacologically than this parent ring system in so far as there 
are many examples of natural and synthetic compounds which con-
tain oxygen, and few, if any, examples of useful unmodified imid-
azolidines. 
4. Oxygen Derivatives of Partially Reduced and Reduced 
Imidazoles - The system of nomenclature used to describe 
the degree of saturation in the dihydro- and tetrahydroimidazoles 
(imidazolines and imidazolidines) is applied in a similar way to 
the oxygen compounds. The ketodihydroimidazoles and ketotetrahy-
droimidazoles are known as the imidazolones (ketoimidazolines) 
and the imidazolidones (ketoimidazolidines) (106). Oxygen com-
pounds of major pharmacologic interest are found in the latter 
class, which as previously mentioned are derivatives of the fully 
reduced imidazole ring. Three classes of imidazolidones (ketoim-
idazolidines) are known, depe~ding on the number of oxygen atoms 
which are contained in the molecule. 
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The monooxo derivatives (ketoimidazolidines) are called 
imidazolidones and are commonly known as ethyleneureas. The 
dioxo derivatives (diketoimidazolidines) are given the name 
imidazolidinediones, but are more familiarly known as 
"hydantoins." Not quite as well known, the trioxo derivatives 
(triketoimidazolidines) are also called imidazolidinetriones. 
These compounds are more generally identified as oxalylureas, 
with the parent trione known as parabanic acid (106,166,221)'. 
An important monooxo derivative of imidazolidine, a 2-
imidazolidone, is the vitamin biotin (vitamin H, coenzyme R). 
The substance is an essential growth factor for a number of 
yeasts, bacteria and for some animals (254). Biotin is widely 
distributed in both the plant and animal kingdoms, but the best 
sources are egg yolk, yeast, liver, fruits and vegetables. In 
animal and yeast products, biotin occurs mainly in a bound form. 
One such complex, biocytin, has been isolated from yeast and 
characterized as c-N-biotinyl-L-lysine (266). After considerab 
degradation studies the main structural features of biotin were 
formulated by du Vigneaud and his co-workers (252), and the 
structure was confirmed with the successful synthesis by Harris 
and his associates (99). Desthiobiotin, oxybiotin, biotin sul-
foxide and other numerous analogs of biotin have either been 
isolated and/or synthesized. They have shown variable growth-
promoting activities, depending upon the microorganisms involved 
(166,254) • 
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It is believed that biotin is required for biological carbon 
fixation in the animal organism. It has also been sug-
gested that biotin participates in various enzymatic reactions, 
such as decarboxylation, deamination and in dehydrogenation reac-
tions in the role of a hydrogen-transport agent (162). 
Another monooxygen derivative, an imidazo1idone with the 
keto group located at C-4 rather. than.C-2, has been introduced 
as an anticonvulsant in the treatment of epilepsy. This compound 
given the name G1ior, is S,S-diphenyltetrahydroimidazol-4-one or 
5~-dipheny1imidazo1id-4-one. 
(C6HS)1:C c=o 
I I 
HN'C~NH 
2 
The compound is not a hydantoin, but rather interestingly bears 
the same relationship to diphenylhydantoin as the drug primidone 
does to phenobarbital, i.e., a methylene group is substituted 
for a keto group of the parent compound in each instance. G1ior 
has been used with some success in cases of grand and petit mal 
which had become refractory to other drug therapy. The drug has 
also demonstrated a beneficial effect when used to control psy-
chomotor seizures (34,176). 
The 2,4-imidazo1idinediones (hydantoins), as previously 
mentioned, are important derivatives which have been very exten-
sively investigated. It has been said that the name "hydantoin" 
stems from the fact that the parent substance (hydantoin) was 
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first obtained by reduction of allantoin (15). Allantoin 
(s_ureidohydantoin) was first discovered in the allantoic fluid 
o.f the cow and is also a common constituent of the urine in most 
The compound is a degradation product of uric acid and 
can be prepared from this source by oxidation with potassium 
permanganate (167). In the dog (with the exception of the Dal-
is oxidized to allantoin by the enzyme uricase 
and is excreted in this form (100). Interest in allantoin was 
stimulated by the discovery that it was released in considerable 
amounts, and presumably was the effective agent, in the maggot 
therapy of indolent ulcers and suppurating wounds. Allantoin, 
topically applied in the form of an ointment or a wet dressing, 
was found to promote healing of wounds and ulcers by stimulating 
cell proliferation and tissue growth (167). 
One of the earliest hydantoins introduced into medicine was 
nirvanol (5-ethyl-5-phenylhydantoin). This compound was similar 
to phenobarbital in that it possessed sedative and hypnotic 
qualities. It was also prescribed for a time in the treatment 
of chorea in children. Its use was short-lived, however, because 
toxic reactions caused the drug to be withdrawn (124). A sys-
tematic study of the hydantoins made by Merritt and Putman in 
1938 (174) showed that 5,5-diphenyl substituted hydantoin had 
the greatest anticonvulsant activity combined with the lowest 
depressant effect of the many drugs they investigated. The un-
substituted hydantoin ring in itself has no anticonvulsant 
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activity. The position of diphenylhydantoin in the treatment of 
'grand mal epilepsy has not been seriously challenged in spite of 
the myriad of compounds which have been synthesized and tried at 
one time or another. Numerous hydantoins have been made and are 
still being synthesized (49,182). A complete resum~ of this 
program is beyond the scope of this presentation in view of the 
fact that no position in the hydantoin ring has remained invio-
late to substitution by a variety of groups. Position 5 has 
carried not only the diminutive methyl group, but larger alkyl. 
and alkoxy groups, numerous heterocycles and the huge, bulky 
phenanthrene nucleus (Bagrasin, 5-(3-Phenanthryl)-5-methylhydan-
toin). In addition to the 5,5-disubstitution, hydantoins have 
been synthesized with additional substitution in the 1- or 3-
positions (for example, methetoin, 5-ethyl-l-methyl-5-phenyl-
hydantoin, and mephenytoin, 5-ethyl-3-methyl-5-phenylhydantoin). 
Even the 2,4-diketo groups which have been strongly associated 
as an integral part of the hydantoin nucleus have not been sac-
rosanct, having been replaced by sulfur atoms, with the forma-
tion of what has been termed 2-thio and 2,4-dithiohydantoins. 
The substituted thiohydantoins have been less intensively 
studied than their oxygen analogues, but they have been pro-
posed for the treatment of epilepsy (230). 
Irninohydantoins as a class are represented by a physiologi-
cally important member, creatinine (1-methyl-2-iminohydantoin). 
The compound could have also been classfied as a 4-imidazolidone 
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with an imino group in position 2 of the heterocyclic ring, rath-
er than a 2-substituted hydantoin. In any event, creatinine is 
a naturally occurring substance and is commonly regarded as the 
anhydride of creatine. The latter is present in the muscles of 
vertebrates, where it plays an important role in muscular acti-
vity. It is present in combination with phosphoric acid as 
phosphocreatine. Creatine undergoes ready conversion to creati-
nine under physiological conditions and is then excreted in the 
urine (258). 
Imidazole compounds which are composed of aromatic rings 
condensed or fused with the heterocycle, for example, benzimida-
zoles, naphthimidazoles, purines, etc., although important in 
many respects, have not been 'included in this discussion. It 
was felt, therefore, that a review of these imidazole deriva-
tives was beyond the needs of this dissertation. 
5. Quaternary Imidazole Salts - Replacement of the imino 
hydrogen of imidazole was first performed by Wyss (267). He 
prepared N-ethylimidazolium bromide and N-benzylimidazolium 
chloride by the treatment of imidazole with ethyl bromide and 
benzyl chloride respectively. The corresponding free alkylimi-
dazole could be liberated from these salts by treatment with 
silver oxide. Further studies have demonstrated that imidazoles 
containing a free imino group readily undergo N-alkylation under 
a variety of conditions. The removal of the imino hydrogen or 
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the addition of a proton to the pyridine nitrogen leads to the 
formation of the positively charged imidazolium ion (106, 225). 
The N-alkyl- and arylimidazoles are basic substances, since they 
have lost the acidic properties associated with the imino hydro-
gen. 
Benzimidazole, a compound in which a benzene ring is fused 
to the 4,5-positions of imidazole, has also been shown to un-
dergo alkylation to form a benzimidazolium salt. Alkylation of 
benzimidazole proceeds in successive stages to form l-alkylben-
zirnidazole and a 1,3-dialkylbenzimidazolium compound (80). It 
has also been shown that a disubstituted 1,3-alkylbenzimidazol-
iurn salt results when methyl iodide is allowed to react with a 
monosubstituted alkylbenzimidazole (13). 
Alkylation experiments conducted on the partially reduced 
imidazoles, the 2-imidazolines, have been reported (140, 155, 
225). In this instance, the products obtained were the 1,3-
dialkyl-2-imidazolinium salts. 
The ability of the monoalkylbenzimidazoles to add another 
molecule of alkyl halide to form dialkylbenzimidazoliurn salts 
has been mentioned. The N-monoalkylimidazoles readily add alkyl 
halides to form dialkylimidazoliurn salts. Two possible ways in 
which this addition may occur can be visualized. Either the 
alkyl halide adds to the nonalkylated nitrogen with the forma-
tion of a 1,3-dialkylimidazolium salt (I), or it may combine 
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with the substituted nitrogen, thus forming a l,l-dialkylimida-
zolium salt (II). 
(II) 
+ 
HC:---N 
+ 
II II 
HC, CH R 
/ R/N(RI .bH2 OH-R I_X ~-~---.. + + 
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Heating one mole of such salts with sodium or potassium hydrox-
ide solution brought about complete fission of the imidazole 
ring with the formation of two moles of primary amine, and for-
mic acid. This was shown by Pinner and Schwarz (201). This be-
havior of the quaternary salts shows that they are 1,3-dialkya~",,-. 
idazolium salts and not l,l-dialkylimidazolium salts. A 1,1-
dialkylimidazolium salt would not be expected to yield two moles 
of primary alkylamine on decomposition with alkali. Instead, 
one would expect one mole of ammonia, one of a dialkylamine and 
formic acid (201). 
pyman (205) also showed that the positive charge was not 
fixed at one of the nitrogen atoms. He found that the isomeric 
2' 
1,4- and 1,S-dimethylimidazoles gave the same cation with methyl 
iodide. 
HfI- _ j-CH3 
CHrC'N,CH 
CH-C N-CH 
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C. Pilocarpine And The. Pilocarpus Alkaloids 
1. Introduction - It was long known by the natives of 
South America that chewing the leaves of Pilocarpus plants 
caused salivation. Using an extract of the leaves, Dr~ Coutinho, 
a Brazilian physician, showed that the drug also caused marked 
diaphoresis. In 1874, the first amount of drug was sent to 
Europe from Pernambuco by Dr. Coutinho (6). This first 
jaborandi of commerce was shown by Holmes (111,112,113,114) to 
be Pilocarpus jaborandi. Since 1896 the main source of the drug 
has been the leaflets of Pilocarpus microphyllus Stapf. The 
name jaborandi has been applied to the several closely related 
species of South American shrubs of the Rue -family~ 
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The presence of alkaloids in jaborandi was first reported 
by M. Byasson (42), and the principle alkaloid, pilocarpine, 
was isolated independently by Hardy (97) and by Gerrard (87,88, 
89,90). In following years other well-defined alkaloids have 
been isolated from jaborandi and their structures fully eluci-
dated. Four of these alkaloids and their structures are pilo-
carpine, CllH1602N2' its stereoisomer isopilocarpine, pilocar-
pidine, C10H1402N2' and pilosine, C16H1803N2. 
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According to Battersby and Openshaw {22), the alkaloid 
pilocarpidine was first isolated by E. Merck from the mother 
liquor remaining after the isolation of pilocarpine from P. jab-
orandi. This material was also isolated and investigated by 
Harnack. Jowett (125) confirmed the findings of Merck and 
Harnack, but showed that pilocarpidine was not present in the 
leaves of P. microphyllus. The physiological action of pilo-
carpidine is said to be qualitatively similar to, but much 
weaker than, that of pilocarpine. 
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pilosine, a minor alkaloid, was obtained by pyman (206) and 
almost simultaneously by Leger and Roques from mother liquor re-
maining after the isolation of pilocarpine and isopilocarpine 
from ~. microphyllus. Dehydration of the alkaloid with hot 
acetic anhydride results in the formation if anhydropilosine, 
C16H1602N2. When treated with boiling 20% potassium hydroxide, 
pilosine is degraded to benzaldehyde and a new base, pilosinine, 
C9H1202N2. As pilosine is not readily isomerized, it was felt 
that it is related stereochemically to isopilocarpine rather 
than to pilocarpine. In physiological activity, pilosine and 
anhydropilosine possess a weak pilocarpine-like effect; the base 
pilosinine has a somewhat stronger action, but the activity 
still is less than that of pilocarpine (206). 
H 2' 
I 
Pilosine 
Pilosinine Anhydropilosine 
2. Configuration, Physical and Chemical Properties of Pilo-
carpine and its Salts - Although the first complete ac-
count of pilocarpine and its salts was given by Petit and Polo-
nov sky (187,188,189,190,191), knowledge of their constitution is 
due primarily to the works of Jowett (125,128,130,131,132,133, 
135,136) and of Pinner and his co-workers ·(195,196,197,198,199, 
200,201). Pilocarpine is the lactone of pilocarpic acid, 
H H 
I I C2HSY--C-CH2-C N-CH3 
0=9 H-~-H \I I 
OH OH H-C"N~CH 
Jowett (127) has reviewed the work of Hardy and Calmels and Petit 
and Polonovsky in his work and further describes the preparation 
of the sodium, barium, copper and silver salts of pilocarpine.· 
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pilocarpic acid is not stable and attempts to isolate it result 
in the regeneration of pilocarpine. 
pilocarpine is best obtained by adding an excess of ammo-
nia to an aqueous solution of its salts, followed by extraction 
with chloroform. Evaporation of the chloroform yields a color-
less, viscous oil. Pilocarpine has also been obtained (200) as 
a low melting, hygroscopic solid with a melting point of 340 e. 
The oily base is soluble in water, alcohol, or chloroform, but 
almost insoluble in ether or light petroleum. The boiling point 
of pilocarpine is reported as 2600 e. under 5 mm. pressure, but 
during this treatment or during vacuum distillation it is par-
tially isomerized to its stereoisomer, isopilocarpine. 
The specific rotation of pilocarpine (water solution) was 
reported by Petit and Polonovsky (192) to be +1060 at laoe. The 
specific rotation of pilocarpine in a range of concentrations 
o was reported by Jowett to be +100.5. Jowett believed the dis-
crepancy was due to the fact that pilocarpine base retained the 
last traces of solvent very firmly, and, therefore,these other 
workers may not have known the exact concentration of pilocar-
pine in their solution. He, however, fails to record the tem-
peratures at which his rotations were obtained. The specific 
rotation of pilocarpine is lowered by the addition of alkali, 
due to the opening of the lactone ring. The rotation of an 
aqueous pilocarpine solution also falls in the absence of alkali 
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after standing for three weeks (126). 
pilocarpine base, in alcoholic solution, shows an absorp-
tion maximum of low intensity of 2630 ~ (204). The infrared 
absorption spectra of pilocarpine and its hydrochloride have 
been previously examined and reported (183) and are also re-
ported in this dissertation (See Spectra Rand Q). 
Isopi10carpine is very similar to pilocarpine in its solu-
bility. The specific rotation of isopi10carpine was reported 
by Petit and Po10novsky (192) to be +500 and reported by Jowett 
to be +42.80 (125). Isopi1ocarpine boils at 2610 C. under 10 mm. 
pressure. It can be distilled in a vacuum without decomposi-
tion. The conversion of pilocarpine to isopi10carpine is shown 
to occur by many au~hors under a variety of conditions. Petit 
and Po10novsky describe this change when pilocarpine base was 
heated with aqueous sodium hydroxide {193} or with sodium eth-
oxide (192), or when the hydrochloride was heated at 200o C. 
{193}. These observations were confirmed by Jowett. However, 
he objected to their calling this base Ipi10carpidine" (which 
was shown by Harnack and Merck to be a different base) and pre-
ferred to call it isopi1ocarpine. He also showed that isopi10-
carpine could be obtained by heating an alcoholic solution of 
pilocarpine with alcoholic sodium hydroxide. A quantitative 
yield of isopi10carpine was obtained when pilocarpine was heated 
. 0 1n a sealed tube at 180 C. for four hours. Isopi10carpine could 
? 
<~ 
I~·. ~. , 
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alsO be obtained by distillation of pilocarpine; this, however, 
usually resulted in a mixture of pilocarpine and isopilocarpine. 
work conducted by Langenbeck (157) gave clear evidence that 
these two alkaloids are stereoisomers, and that the isomerism 
is due to a stereochemical difference in the lactonic portion of 
the molecule. Furthermore, the isolation of methylamides from 
both alkaloids confirms the 1:5 orientation of substituents in 
the imidazole nucleus. 
A proposed method for the synthesis of pilocarpine and a 
general survey of their synthetic investigations was reported by 
N.A. and W.A. Preobrashenski and A.M. Poljakova in the Bulletin 
of the Academy of -Science, U.R.S.S., 983 (1936). In this arti-
cle, they apparently suggest the cis-trans relationship of pilo-
carpine and isopilocarpine, and it is this publication Which has 
given rise to some confusion, probably in the area of transla-
tion. When one reads the review of Battersby and Openshaw (22), 
reference is made to the Russian work with the statement that 
pilocarpine possesses the cis-configuration, isopilocarpine 
having the corresponding trans-configuration. In Henry's text 
on plant alkaloids (104), reference is made to the same Russian 
work, but he states that isopilocarpine is t~ be regarded as the 
cis-form and pilocarpine as the trans-form. The monograph on 
pilocarpine in the Encyclopedia of Chemical Technology (141) 
states that pilocarpine is trans, while isopilocarpine is cis, 
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thUS reporting the same as Henry's text. A.N. Dey (63) has de-
scribed an independent synthesis of the alkaloids. At one point 
in his synthesis, two racemic forms of glutaric acid were sepa-
rated by virtue of their different ease of anhydride formation. 
On treatment with hydrobromic acid, the cis form gave rise to 
d1-homopi1opic acid while the trans form of the acid gave rise 
to d1-homoisopi1opic acid. Additional synthesis via the forma-
tion of homopi1opy1 and homoisopi1opy1 methyl ketone ultimately 
yielded d1-pi1ocarpidine and d1-isopi1ocarpidine, which were 
then methylated. Resolution of the resulting d1-pi1ocarpine was 
achieved through the tartrates, and the optically active forms 
could be isomerized to give d- and 1-isopi1ocarpine. On the 
basis of the rotations of the' various products and the products 
formed, Dey's synthesis would suggest that pilocarpine is the 
cis-form while isopi1ocarpine is the trans-form. 
Analysis of the numerous salts of pilocarpine and isopi1o-
carpine indicate that the alkaloids are monoacidic bases. These 
salts, e.g., the nitrate, hydrochloride, hydrobromide, etc., are 
easi~y formed and crystallize well. The salts of the alkaloids 
are all dextrorotatory. Pilocarpine and isopi1ocarpine give 
precipitates with auric and platinic halides and with picric 
acid. Many precipitation reactions have been adapted for the 
identification and detection of these alkaloids and are summar-
~ ized in an article by Battersby and Openshaw (21). 
, 
~ ~ 
~ 
~ 
~ 
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Among the color reactions of pilocarpine, the most charac-
teristic are Helch's test (103) and Ekkert's test (69). In the 
experimental section of this dissertation, Helch's test was em-
ployed to check for the completeness of extraction of pilocar-
pine from solution. In this test, the pilocarpine solution is 
treated with a small crystal of potassium dichromate and 1 - 2 
mls. of chloroform, followed by 1 ml. of 3% hydrogen peroxide. 
The mixture is shaken for 1 - 5 minutes. The chloroform layer 
becomes blue. The absence of any color, when this test was ap-
plied to 5 - 10 mls. of the solution remaining after the extrac-
tion of pilocarpine, indicated that extraction had been complete. 
structural investigations have demonstrated the presence of 
a lactone grouping, isolated 'in the form of isopilopic acid, 
H H 
I I 
c2Hsi-rOOH 
0=\ /CH2 
o 
Isopilopic Acid 
obtained by Jowett (129) by the oxidation of isopilocarpine 
nitrate by permanganate. This acid was named "pi'lopic" acid by 
Jowett, but since it was obtained from isopilocarpine and is 
stereochemically related to it, the name has been changed to 
isopilopic acid. Pilopic acid is the name assigned to the C7 
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acid related stereochemically to pilocarpine. The lactonic na-
ture of isopilopic acid was established largely by the action 
of hot and cold aqueous alkali. On titration in the cold, it 
behaves as a monobasic acid, but it reacts with two molecular 
portions of hot aqueous alkali indicating that it retains the 
lactonic structure of the alkaloids. In the oxidation of iso-
pilocarpine, another acid was also obtained. This acid has the 
formula CaH1204 and is called homoisopilopic acid. 
H H 
I I 
C2H5~2--COOH 
o=c CH 
"0/ 2 
This acid could also be obtained from pilocarpine. Like its 
lower homolog, homoisopilopic acid is shown to possess a lactone 
grouping by its behavior toward alkali. Jowett concluded that 
isopilopic acid is a further oxidation product of homoisopilopic 
acid and that the latter must contain the group -CH2-C02H. 
other oxidizing agents, such as 30% hydrogen peroxide, oxi-
dize pilocarpine with the formation of ammonia, methylamine, 
carbon dioxide and crude. homoisopilopic acid (19a). 
The presence of an imidazole nucleus in the alkaloids pilo-
carpine and isopilocarpine was shown by alkaline fusion. Both 
alkaloids are stable when heated with aqueous potassium hydro~ 
ide. . Though isomerization of pilocarpine to isopilocarpine 
may occur, there is no degradation of the imidazole nucleus. 
When isopilocarpine nitrate is fused with excess potassium 
hydroxide, ammonia, methylamine and butyric acid are formed 
(125) • 
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The distillation of isopilocarpine with soda lime by Jowett 
(134) gave three bases in addition to ammonia and methylamine. 
These bases were identified by subsequent treatment as l-methyl-
imidazole, a dimethylimidazole, shown by Burtles, Pyman and 
Roylance (40) to be 1:5-dimethylimidazole, and N-amyl-l-methyl- . 
imidazole. The investigation~ not only established the presence 
of imidazole in the jaborandi alkaloids, but established the 
structure of isopilocarpine. 
One final point which deserves inclusion in this discussion 
of pilocarpine alkaloids deals with a substance known as neopilo-
carpine. In an attempt to shown the relationship of pilocarpi-
dine to pilocarpine, Burtles, pyman and Roylance (40) methylated 
pilocarpidine. In addition to the expected product, the presence 
of another compound was observed. This compound was given the 
name neopilocarpine. Where pilocarpine has a 1:5 configuration 
or orientation between the imidazole nucleus and the rest of the 
molecule, neopilocarpine was shown to have a 1:4 orientation. 
The significance of this is that the orientation between the 
SUbstituted imidazole and the rest of the molecule in the syn-
thesized quaternary pilocarpine compounds could be either 1:5 
,"" 
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or 1:4 depending on whether or not you accept the methyl nitroge 
of pilocarpine in these compounds as position 1 or 3. An inves-
tigation into the pharmacology of neopilocarpine was performed 
for Burtles, et al by J. H. Burn. Burn reported that neopilo-
carpine had a weak stimulating effect on isolated intestinal 
muscle, but no perceptible trace of true pilocarpine action. 
3. Pharmacology of Pilocarpine - It has been mentioned 
previously that some of the earliest observations made on the 
effects of pilocarpine were a result of its prominent salivatory 
and diaphoretic actions. By 1875, Langley (158) and Murrell 
(179) had described the effects of pilocarpine on the heart and 
submaxillary glands, as well as the antagonism which existed 
between pilocarpine and atrop'ine. 'Physiological' investigations 
on pilocarpine, isopilocarpine and pilocarpidine were made by 
Marshall (169) in conjunction with the chemical investigations 
of the pilocarpine alkaloids undertaken by Jowett (125,128,130, 
131,133,135). Marshall reported that effects of the alkaloids 
on the circulatory system, pupillary and salivary glands were 
essential~y similar, the difference being simply quantitative. 
Rather interestingly, he relates, "This was evident in all the 
experiments made--on frogs, rats, rabbits, and myself" (169). 
By 1921, the autonomic nervous system had been well de-
scribed, and it was accepted that it contained two major divi-
sions. The proof that transmission was accomplished by a 
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chemical mediator or transmitter was classically demonstrated 
by otto Loewi in 1921. When it was shown that acetylcholine was 
not only the transmitter substance at the postganglionic para-
Sympathetic nerve endings but was also involved in transmission 
at autonomic ganglia and the neuromuscular junction, Dale (58) 
Suggested the terminology which classified nerves on a physio-
logical rather than on an anatomic basis. His terms "choliner-
gic" and "adrenergic" were readily adopted and are in use today. 
Dale originally applied these terms to nerve fibers, but today 
they have been commonly extended to describe various autonomic 
drugs, types of effector cells and their responses. 
Although the results of earlier studies indicated that pi 
carpine essentially affected the postganglionic cholinergic re-
ceptors and revealed a fairly strong muscarinic action, evidence 
also led to the conclusion that the drug affected other sites as 
well. An examination of the studies conducted on pilocarpine 
reveal that it presents an unusual pattern of action in many 
organs and tissues. It may be, as inferred in the introduction 
to this dissertation, that the multiplicity of action could sug-
'gest common features either among the various receptors con-
cerned or in the relative efficiency of the substrate molecule 
to produce a conformational perturbation (28) in the receptor 
protein. The exact mechanism of action of pilocarpine is un-
known. However, the following actions are among those which 
• 
" have been demonstrated or postulated for pilocarpine: (1) a 
direct effect on muscarinic receptors, (2) an indirect effect on 
adrenergic receptors, (3) an atropinic or antispasmodic activ-
ity, (4) stimulation of non-nicotinic receptors in autonomic 
ganglia, (5) blockade of autonomic ganglion cells, (6) central 
excitatory effects as well as (7) central depressant effects, 
(8) a blockade of spinal inhibitory pathways, (9) a release of 
acetylcholine from cholinergic nerve endings, and (10) an effect 
at the neuromuscular junction. 
Effects on exocrine glands - In general, pilocarpine stimu-
lates exocrine glands and smooth muscle innervated by postgan-
glionic cholinergic nerves. It has been stated (143) that the 
administration of 10 - 15 mg. of pilocarpine will produce a 
marked diaphoresis with the secretion of as much as 2 to 3 
liters of sweat. The composition of the secretion includes not 
only the electrolytes of the extracellular fluid, but also urea 
nitrogen. The response of the sweat glands to pilocarpine was 
postulated by Wilson (261) to be due to a direct action of pilo-
carpine upon the glands. Following intradermal injection, the 
sweating response to acetylcholine was increased after physo-
stigmine, whereas the response to pilocarpine, before or after 
physostigmine, was unchanged. This would perhaps indicate that 
pilocarpine does not stimulate nerve endings to release acetyl-
choline. The sweating responses to both acetylcholine and 
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pilocarpine were abolished by atropine. Diaphoretic doses of 
pilocarpine may also produce unpleasant side-effects such as 
nausea, vomiting, weakness and occasionally collapse (143). 
It is well known and can be readily demonstrated that copi-
ous salivation follows the administration of pilocarpine. This 
aspect of the activity of pilocarpine has been the subject of 
many investigations. The salivary glands are innervated by both 
divisions of the autonomic nervous system. Stimulation of para-
sympathetic fibers produces a saliva which is serous and some-
what poor in organic constituents (mucin, amylase), while stimu-
lation of sympathetic fibers yields a more mucous saliva with a 
fairly high concentration of organic matter. Even though pilo-
carpine increases the blood flow through the submaxillary gland, 
the salivary flow which is produced for a given blood flow is 
still greater than that which is obtained when the chorda tym-
pani is stimulated electrically (260). Dreisbach (64,65) demon-
strated that the rate of transfer of Ca45 from the blood to the 
submaxillary glands of rats was increased by pilocarpine. When 
the increased rate of transfer of Ca45 was also shown by in ~~~ 
~xperiments, he suggested that part of the effect of pilocarpine 
could be attributed to direct effects on tissue, rather than on 
the effects of an increased blood flow or changes in vascular 
permeability alone. 
The levels of the protein components of pilocarpine-evoked 
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salivas (parotid gland) differed from those which were obtained 
from the gland in response to stimulation of the parasympathetic 
nerve. The fact that the levels of protein approximated those 
which are observed when sympathomimetic stimulation of the gland 
was employed suggested to' Schneyer (222) that pilocarpine may be 
acting on noncholinergic sites as well as cholinergic sites. 
Amylase levels of pilocarpine-evoked saliva were reduced to th~ 
produced by auriculo-temporal nerve stimUlation following the 
administration of propranolol, a beta-receptor blocking agent. 
Phenoxybenzamine, on the other hand, caused increases in the 
amylase levels of pilocarpine-evoked saliva. Since neither 
blocker had any effect on the amylase levels of the nerve-
stimulated saliva, it indicated that pilocarpine, while having 
some effects which are parasympathomimetic, had additional ef-
fects which involved the stimUlation of adrenergic receptor 
sites (222). In a subsequent study on rats, Schneyer and Hall 
(223) demonstrated that the sympathetic-like character of pilo-
carpine-evoked saliva was due to an indirect effect on adrener-
gic receptors mediated through the superior cervical ganglion, 
rather than a direct effect of pilocarpine on adrenergic recep-
tor sites in the gland. Removal of the superior cervical gan-
glion altered amylase levels in pilocarpine-evoked salivas to 
values characteristic of auriculo-temporal stimUlation. These 
investigators also showed that severance of preganglionic fibers 
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to the ganglion caused no change in amylase levels when pilo-
carpine was given to evoke secretion. 
smith, Ilievski and Hadidian (228) reported that pilocar-
pine hydrochloride administered to dogs in doses of 0.7 mg/kg 
stimulated the flow of prostatic fluid. The secretion could be 
completely blocked by pretreatment with atropine. Large doses 
of hexamethonium produced only partial block. On the basis of 
these results, they concluded that a portion of the pilocarpine-
induced prostatic secretion appeared to result from activation 
of the preganglionic fibers supplying the sympathetic choliner-
gic fibers which are known to innervate the gland. 
In studying the effect of pilocarpine on the secretory ac-
tivity of the stomach in "pouch" - dogs, Hollander (109) and 
Hollander and Stein (110) reported that adequate doses of the 
drug stimulated the flow of hydrochloric acid and water in con-
centrations and amounts which were comparable with the amounts 
evoked by histamine. Even though there was considerable secre-
tion of gastric mucus, the investigators discounted the fact 
that the secretory activity was induced by direct action. They 
felt, rather, that a considerable part of the mucus was squeezed 
out from the surface epithelial cells by the muscular activity 
induced by pilocarpine. 
Trier (242) obtained peroral jejunal biopsies from fasting 
human subjects before and at various intervals after the 
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'administration of pilocarpine. Within 15 minutes after the 
"intravenous administration of 5 to 14 mg. pilocarpine, abundant 
secretory activity was demonstrated by undifferentiated crypt 
cells of the small intestine. The nature and the role of the 
secretion was not discussed, but the results again illustrate 
the stimulatory effect that pilocarpine has on cells of the in-
testinal tract. Pilocarpine stimulates the secretory activity 
of the bronchial glands. Coupled with the constriction ofbron-
chio1ar smooth muscle, the enhanced secretion may be sufficient 
to produce a pulmonary edema. 
Effects on the eye and other smooth muscle - When instilled 
into the eye, pilocarpine stimulates the sphincter muscles. 
The contraction of these muscles produces a constriction of the 
pupil. Contraction of the ciliary muscles decreases the tension 
on suspensory ligaments, and the lens rounds up for near vision. 
In constricting the pupil, pilocarpine widens the anterior cham-
ber angle which facilitates drainage through the canal of 
Sch1emn, and thus reduces intraocular pressure. 
In general, the smooth muscle of the intestinal tract re-
'sponds to pilocarpine by contraction. Stimulation of smooth 
muscle of the intestinal tract also produces increases in tone 
and motility. As previously mentioned, pilocarpine caused a 
constriction of bronchiolar smooth muscle. Curry and Leard (56) 
showed that the vital capacity of some normal patients was 
-
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reduced by 1 to 4 mg. doses of pilocarpine. In contrast, all 
asthmatic patients in this study uniformly suffered reductions 
in vital capacity. This was serious enough in a few to suggest 
that pilocarpine may precipitate an asthmatic attack. In a 
study of the exchange of several ions in guinea pig ileum, 
Chujyo and Holland (48) found that pilocarpine caused a tempo-
rary increase in potassium efflux, a temporary decrease in po-
tassium influx, but had little or no effect on the sodium or 
chloride during the initial period of contact. The drug in-
creased the rate of calcium exchange, presumably by releasing 
calcium from a bound form in the tissue. Since the importance 
of calcium in the excitation, excitation-coupling mechanism had 
been demonstrated for some smooth muscle, and its role had been 
suggested in skeletal and cardiac muscle, these investigators 
suggested that pilocarpine's effect on calcium exchange may be 
intimately linked to the mechanism of drug-induced contraction. 
A spasmolytic action of pilocarpine on smooth muscle was 
reported by Dzoljic and Atanackovic (67). They showed that 
pilocarpine produced a transitory relaxation in the contrac-
tions of arecoline and carbachol elicited in isolated rat in-
testine. The contractions produced by the initial application 
of pilocarpine, however, were not relaxed by arecoline or car-
bachol. In addition, the contractions produced by acetylcho-
line, histamine or barium chloride were not relaxed when pilo-
carpine was added to the bath. These investigators suggest that 
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the spasmolytic action of pilocarpine depends on: (a) the dose 
of pilocarpine, (b) the dose of the spasmogen and (c) the time 
~hich elapses between the administration of the two sUbstances. 
What should undoubtedly be added, and which was indicated in 
their experiments, is that the • spasmolytic' activity also de-
pends upon the drug sequence. 
Based on studies (244,24S) of its dose-response curves, 
pilocarpine was found to be a partial agonist, i.e., the maxi-
mal height of the dose-response curve of pilocarpine on the in-
testine was about 70 per cent of that of acetylcholine or 
thonium, both "pure" agonists. Pilocarpine has an intermediate 
intrinsic activity value (O.B) and is an example of a natural 
dualistic drug. The concept of dualism implies that at the same 
receptor system, pilocarpine would act both as a parasympatho-
mimetic and as a parasympatholytic. This would mean that pilo-
carpine would act synergistically· with low doses of a pure ago-
nist (ACh) , but would act as a competitive-antagonist with high 
doses of the agonist. The mode of action of pilocarpine, how-
ever, is still more complex, since in high doses a papaverine-
'like action was shown in the intestine, i.e., pilocarpine also 
had affinity toward noncompetitive receptors as well. When all 
these factors are considered together, pilocarpine would be an 
example of a drug with multiple modes of action. In low doses, 
pilocarpine would behave as an agonist and a competitive-
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antagonist. In high doses, it would be a noncompetitive antago-
nist. (Additional references explaining the theory and defining 
terms in the above approach to the pharmacodynamic study of a 
biologically active compound are 7,8,9,10,11,246,247,251). 
Effects on cardiovascular system - The reactions of the 
cardiovascular system to pilocarpine are anomalous. While it 
might be expected that stimulation of postganglionic cholinergic 
fibers to the heart would produce a slowing of the heart, a de-
creased cardiac rate does not always occur. A variable response 
to the subcutaneous administration of pilocarpine was obtained 
in different human subjects. In a few cases, initial slowing 
was followed by an increased cardiac rate, while in other sub-
jects, cardiac acceleration was the only observable effect (261). 
The peripheral vasodilatation, when it occurs, is usually less 
than that produced by acetylcholine. In dogs, the vasodepressor 
response is not always striking, and the drug may produce a 
vasopressor effect. In a study on the hemodynamic effects of 
pilocarpine, Koppanyi (145) reported that pressor effects in dogs 
up to 100 mm. mercury (following initial vasodepression) were 
elicited by intravenous injections of pilocarpine in doses rang-
ing from 0.1 to 1.0 mg. The magnitude of the rise, but not the 
fall, was proportional to the size of the dose. Doses less than 
0.1 mg. usually produced vasodepressor effects only. Nicotine 
(1.0 to 6.0 mg.) increased the pressor effects from effective 
47 
doses of pilocarpine and converted the pure vasodilator re-
sponse of smaller doses (0.025 to 1.0 mg.) into marked pressor 
effectS. COcaine reduced the height of the pilocarpine pressor 
effect, and atropine in doses from 0.1 to 5.0 mg. abolished it 
completely. Koppanyi states that the pilocarpine pressor ef-
~ect must be wholly different from that of acetylcholine, be-
cause the acetylcholine pressor effect is (a) not abolished by 
atropine, (b) is reversed by nicotine, and (c) is potentiated 
by cocaine. The exact opposite holds for the pilocarpine pres-
sor effect. In the investigation of certain aspects of the 
vasopressor action of pilocarpine, Root (216) found that the 
continuous infusion of tetraethylammonium ion into cats con-
verted the usual depressor response of intravenous pilocarpine 
to a marked pressor response. Atropine inhibited the response 
completely. The adrenergic blocking agents, ergotoxine and di-
benamine, were effective in reducing, completely blocking, or 
in some cases, reversing the pressor response to pilocarpine. 
This pressor response was unaffected by adrenalectomy or kidney 
ligation. From the group of substances which blocked the re-
sponse, Root postulated that the pressor response was secondary 
to a release of epinephrine from sympathetic nerves and chromaf-
fin tissue other than the adrenal gland. She indicated that lo-
cating the site of action of pilocarpine at sympathetic ganglia 
could be supported by the findings of Marrazzi (168) and of 
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Marrazzi, by recording the postganglionic action 
potentials, found that pilocarpine increased the ganglionic re-
sponses to natural or test stimuli. He proposed the word Itcho-
linotropic" for this action of the parasympathomimetic drugs, 
a descriptive sense indicated that the action of the 
drug was exerted on cholinergic systems, but not necessarily 
through direct reaction with acetylcholine. Ambache, using the 
nictitating membrane as an indicator of superior cervical gan-
glion activity, showed that pilocarpine perfused through the 
ganglion could produce a contraction of the membrane. 
Trendelenburg (238) investigated some of the factors which 
might be involved in the secondary blood pressure rise after the 
administration of pilocarpine by observing the effects of co-
caine, nicotine and hexamethonium on the rise. He found, like 
KOppanyi, that cocaine reduced the blood pressure rise after 
the injection of pilocarpine. Since cocaine was previously 
shown (237) to block the actions on the superior cervical gan-
glion, it suggested that the secondary pilocarpine rise was 
mainly due to an action on ganglia. The observation that co-
caine did not completely abolish the rise in pressure further 
suggested that liberation of catecholamines from the adrenal 
medulla contributed to a small extent to the rise. This was 
proven when cocaine completely blocked the response after adre-
nalectomy. Hexamethonium was found to potentiate the pressor 
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~esponse to pilocarpine. Nicotine was administered in increased 
until it failed to elicit any pressor rise. In this in-
complete blockade of the ganglia by paralyzing doses of 
also abolished the secondary rise of pilocarpine. The 
of the secondary rise in blood pressure caused by pilo-
carpine was extended by Trendelenburg (241) in another series of 
experiments by studying the effect of various substances known 
to interfere with: (a) the ganglionic actions of pilocarpine 
(e.g., nicotine; tetramethylammonium, TMA), (b) the release of 
catecholamines from postganglionic nerve endings (choline 2:6-
xylyl ether bromide, TM 10, morphine and methadone), and (c) the 
storage of catecholamines (reserpine). The response of ganglion 
cells to nicotine is composed of several phases. The initial 
stimulatory phase is followed by a blockade of transmission as-
sociated with ganglionic depolarization. This is followed by a 
later period of blockade which is thought to be a competitive-
type blockade. The response of the ganglion cells to pilocar-
pine is abolished only during the first phase, while the re-
sponse to pilocarpine is generally increased during the second 
competitive phase. In order to block the responses of pilocar-
pine, repeat doses of nicotine had to be given (ganglion paraly-
sis). Trendelenburg indicated that TMA causes ganglionic block 
by pure depolarization. After treatment with TMA (repeated until 
no further pressor response was obtained), the pressor response 
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pilocarpine was fully abolished. The pressor rise to pilo-
carpine was abolished by TM 10 in both normal and adrenalecto-
Both morphine and methadone reduced the secondary 
pilocarpine, with methadone being the more effective 
The pressor rise to pilocarpine was also abolished fol-
the depletion of peripheral norepinephrine by reserpine. 
by the process of exclusion, ganglionic stimulation 
seemed to be the most probable mechanism for the secondary pres-
sor response to pilocarpine. The previous observations that 
competitive blockade of the ganglia by either hexamethonium or 
tetraethylammonium ion failed to abolish the secondary rise in 
was not contradictory, because pilocarpine has been 
to be a "non-nicotinic" "ganglion-stimulating substance 
(237, 240). The pilocarpine response was antagonized by depolar-
izing blocking agents, but was fully effective during the phase 
competitive block of these agents. 
Effect on autonomic ganglia - The ability of pilocarpine to 
autonomic ganglia has already been mentioned in connec-
the effects produced by the compound on the exocrine 
glands and the cardiovascular system. It appears that ganglionic 
stimulation is an important component of many of pilocarpine's 
effects, and therefore plays a significant role in the drug's 
over-all pattern of response. As early as 1912, Dale and Laidlaw 
(59) demonstrated that pilocarpine increased the rate of 
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enaline secretion from the adrenals. These investigators also 
indicated that pilocarpine had a stimulant action on sympathetic 
gangliOn cells, but that this action was probably overshadowed 
bY the outpouring of adrenaline. Feldberg, Minz and Tsudzimura 
(76) postulated that the effect was a peripheral one that had a 
"muscarine" component" because it was abolished by small doses 
of atropine. The finding by Marrazzi (168) that pilocarpine in-
creased the postganglionic action potentials from the superior 
cervical ganglion and that of Ambache (4) which demonstrated 
that drugs may exert an action on an end organ,indirectly by 
affecting its innervation has already been mentioned. Even 
this "nicotinic" action of pilocarpine was demonstrated" 
thought by some (25) to be relatively unimportant" because 
atropine, which did not combat the nicotinic effects of other 
cholinergic agents, would completely antagonize this effect of 
In a series of experiments performed on the superior cervi-
ganglion, Burn and Trendelenburg, and Trendelenburg, have 
contributed materially to our knowledge of the action of pilo-
They showed that the stimulating effect of pilocarpine 
on the nictitating membrane was not due essentially to the pres-
enCe of the adrenal glands, but that the response was indirectly 
mediated (39). Pilocarpine had no direct effect on the contrac-
tion of the nictitating membrane" but the contraction was due to 
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stimulation of the superior cervical ganglion. The effect of 
pilocarpine was not abolished by hexamethonium which abolished 
the effects of preganglionic stimulation; however, the effect 
was antagonized by atropine (237). Pilocarpine potentiated the 
response of the nictitating membrane to submaximal pregangli-
onic stimulation (239). Pilocarpine stimulated the sympathetic 
ganglion cells of the cat by a mode of action different from 
that of acetylcholine and other nicotine-like substances. Pilo-
carpine is therefore a "non-nicotinic" ganglion stimulating 
agent; its effects are abolished by depolarization of the gan-
glion cells, but not by competitive blockade of the acetylcho-
line receptors (240). 
The alterations in the responses to acetylcholine (ACh) 
and methacholine (MCh) following repetitive preganglionic stimu-
lation, the administration of anticholinesterase agents 
(antiChE) and the injection of pilocarpine were recently re-
ported by Takeshige and Volle (233). In analyzing the ganglion 
potentials, they found that the initial period of depolariza-
tion produced by acetylcholine (the D potential) was depressed 
after preganglionic stimulation, antiChE, and pilocarpine at a 
time when the early postganglionic response (ER) to ACh was en-
hanced. Small doses of atropine prevented the depression of the 
D potential, but had no effect on the ER to ACh. The ganglionic 
hyperpolarization (H potential) evoked by ACh or MCh was 
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enhanced in ganglia to the three test procedures. On the other 
hand, the late occurring depolarization (LD potential) evoked 
by ACh or MCh was depressed. The response to pilocarpine alone 
consisted of a long-lasting monophasic wave of ganglion negati-
vity. In confirmation of the work of others (145, 168, 237, 
240), small doses of atropine prevented the ganglionic response 
to pilocarpine when administered before pilocarpine and antag-
onized the response when given afterwards. The findings demon-
strated a good relationship between depolarization of atropine-
sensitive cholinoceptive sites and the enhancement of postgan-
glionic action potentials. 
The stimulant effects of 4~(m-chlorophenylcarbamoyloxy)-2-
butynyltrimethylammonium chlo"ride (McN-A-343) on autonomic gan-
glia were first reported by Roszkowski (219). On the basis of 
its autonomic effects and on the influence of drugs on the com-
pound, he concluded that the site of action was at a receptor 
which was distinct from the acetylcholine receptor in the gan-
glia. In an extension of this work, Murayama and Unna (178) 
studied the action of McN-A-343 on the superior cervical gan-
glion and inferior mesenteric ganglion in cats in comparison 
with (DMPP), l,l-dimethyl-4-phenylpiperazinium iodide (46) and 
pilocarpine. McN-A-343 caused contraqtion in both normal and 
decentralized preparations; it had no direct action on the post-
ganglionic effector organ. Its ganglionic stimulant action was 
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blocked by tetramethylammonium ion (TMA), cocaine, morphine 
and especially by atropine, but not by tetraethylammonium (TEA), 
hexamethonium or nicotine. McN-A-343 caused a marked increase 
in the discharges of the inferior mesenteric ganglion. Its 
action in this instance also was blocked by atropine, but not 
by hexamethonium. The action of McN-A-343 on sympathetic gan-
glia corresponded to that of a non-nicotinic ganglion stimulant. 
Its spectrum of action resembled pilocarpine in many but not 
all respects, and vice versa. Pilocarpine differed from 
McN-A-343 in that prior administration of nicotine abolished 
its effect, but the effect of McN-A-343 was not abolished. Like 
pilocarpine, McN-A-343 caused profuse salivation. It was, how-
ever, ineffective in causing miosis on instillation of a solu-
tion into the conjunctival sac of rabbits, probably because its 
quaternary configuration impeded penetration of the corneal 
epithelium. A preganglionic site of action of McN-A-343 was 
excluded by the results of ablation on decentralized prepara-
tions of the superior cervical ganglion. Its site of action 
seemed to be the same as that of atropine, possibly the LN re-
ceptor postulated by Eccles and Libet (68) or the LD potential 
described by Takeshige and Volle (233). 
Ginsborg (9l) examined the effects of pilocarpine, McN-A-
343 and methacholine chloride on individual sympathetic ganglion 
cells of the frog. Individual cells were impaled with 
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microelectrodes and stimulated both ortho- and antidromically. 
Pilocarpine and McN-A-343 both depressed synaptic transmission. 
They did not depolarize or stimulate. Methacholine also de-
pressed synaptic transmission, but in addition, it depolarized 
and stimulated the cells. The depolarization was transient but 
the depression of transmission persisted in the presence of the 
drug. The stimulant action of methacholine was blocked by both 
hexamethonium and atropine. Ginsborg indicated that with re-
gard to transmission" in frog sympathetic ganglia, two classes 
of substances with postsynaptic actions may be distinguished. 
The first class, which included d-tubocurarine, hexa- and deca-
methonium, atropine, McN-A-343 and pilocarpine, were capable of 
blocking transmission and reducing the sensitivity of cells to 
acetylcholine-like substances without causing changes in resting 
potential or the antidromic potential. The second class, which' 
contained acetylcholine~ carbachol, methacholine, nicotine and 
tetramethylammonium, were capable of producing an initial phase 
of depolarization, stimulation and blockade of synaptic trans-
mission. These results were different from those experiments 
made on mammalian ganglia. In the mammal the situation appears 
more complicated, since in addition to nicotinic receptors, 
additional receptors which are stimulated by pilocarpine and 
McN-A-343 appear to be present. Ginsborg emphasized that the 
results obtained in the two animal preparations might be 
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reconciled by the supposition that the non-nicotinic receptor 
is absent from frog ganglion cells and that the discrepancies 
are not necessarily all due to species differences. Esplin and 
Zablocka (74) also mentioned that they had evidence of a block-
ing action of pilocarpine on autonomic ganglia (unpublished). 
Effects on central nervous system - Monnier and Romanowski 
(177) studied the action of pilocarpine on both the spontaneous 
and evoked brain activities in the rabbit. Intracarotid injec-
tion of pilocarpine (0.07 - 0.33 mg/kg) produced an arousal 
syndrome characterized by desynchronization in the cortex with 
synchronization in the hippocampus, caudate nucleus, thalamus 
and midbrain reticular formation. The alerting response to 
sensory and reticular formation stimulation was increased after 
pilocarpine. The cortical potentials evoked by stimulation of 
the ventrolateral thalamus were found to be unaltered or slight-
ly decreased, and there was a decrease in the cortical response 
to recruitment evoked by stimulation of the medial thalamus. 
By contrast, pilocarpine augmented the responses elicited in 
the cortex by stimulation of the hippocampus. Atropine sup-
pressed the alerting syndrome in the EEG, with the exception 
that the hippocampal potentials appeared to be unaffected. 
Atropinic blockade of the arousal response and the EEG activa-
tion evoked by cholinergic agents was also demonstrated by 
Rinaldi and Himwich (210). 
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The stimulatory activity of pilocarpine on cholinoceptive 
cells in the cerebral cortex of rabbits and monkeys was re-
ported by Krnjevic and Phillis (150). Pilocarpine was applied 
to single neurones by iontophoresis, and recordings of the ex-
tracellular spikes were made simultaneously. They found that 
the action of pilocarpine was slower in onset than acetylcho-
line, but when the full effect was obtained, the fast rate of 
discharge persisted for several minutes. The stimulatory ef-
fect could be blocked by atropine. Evidence also showed that 
the cholinoceptive neurones had well defined muscarinic charac-
teristics and thus differed from Renshaw cells which possess 
acetylcholine receptors that are predominantly nicotinic in 
nature. It was concluded that pilocarpine stimulated cortical 
neurones which possessed a muscarinic type of action. 
In a study designed to elucidate the central emetic action 
of pilocarpine in the cat, Borison et al (33) found that de-
cerebration at midcollicular levels prevented the emetic re-
sponse to intravenously administered pilocarpine. Following a 
variety of cerebral ablations, it was found that vomiting in 
response to pilocarpine was prevented in those cats in which the 
orbital cortex of the frontal lobe had been destroyed. The ab-
lation of the medullary emetic chemoreceptor trigger zone fol-
lowing cerebral intraventricular injection of pilocarpine was 
reported in a later study (32). It was shown that although the 
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incidence of vomiting was reduced, trigger-zone ablation did 
not regularly abolish the vomiting response to pilocarpine. In 
addition, the doses of pilocarpine required to provoke vomiting 
by the intraventricular route were of the same order of magni-
tude as those which were administered intravenously to produce 
emesis. Since the findings of this study were in general agree-
ment with the earlier work, it was postulated that the emetic 
action of pilocarpine in cats was due to stimulation of the 
basal cortex of the frontal lobe, possibly aided by an action 
on the chemoreceptor trigger zone in the area postrema of the 
medulla oblongata. 
pilocarpine appears to have depressant as well as excita-
tory actions on the central nervous system. Zablocka and Esplin 
(268) showed that pilocarpine had an anticonvulsant effect 
against maximal electroshock seizures (MES) in rats. The anti-
convulsant effect of pilocarpine could be overcome by longer 
duration of stimulation and suggested that pilocarpine was act-
ing to limit the spread of seizure discharge in the brain. The 
presumption was supported by the fact that diphenylhydantoin, 
which reduces seizure spread, was similarly less effective 
against seizures elicited with longer duration of stimulation. 
Pilocarpine markedly reduced electroshock seizure threshold 
(EST) in both mice and rats. Atropine antagonized the actions 
of pilocarpine on both MES and EST. It was further suggested 
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by these investigators that the depressant and excitatory ef-
fects were due to direct actions of the drug, because changes 
in blood pH, plasma CO2 and plasma electrolytes after pilocar-
pine were slight and not sufficient to account for the effects 
observed. Large doses of pilocarpine produced clonic convul-
sions in rats {36, 268}, which is consistent with the reduction 
in the electroshock seizure threshold. 
Behavioral changes - Marked changes in behavior are pro-
duced by pilocarpine in both rats and cats. The psychotic-like 
behavior produced in rats by pilocarpine {36} is discussed at 
greater length under the toxicity heading in this section. 
Borison {32} reported after injection of pilocarpine into the 
cerebral ventricles, that many cats displayed a rage reaction 
which involved piloerection, pupillary dilatation and growling. 
The animals also assumed a defensive posture. Zablocka and 
Esplin (269) reported somewhat similar responses in cats follow-
ing the intraperitoneal administration of pilocarpine. After 
doses of 10 - 20 mg/kg, the animals became restless and irrit-
able, and with larger doses, they became defensive and sometimes 
aggressive. The behavioral changes became particularly apparent 
When the animals were provoked by touching or loud noises and 
appeared to be of maximum intensity with doses in the range of 
40 - 80 mg/kg. The aggressive behavior was directed toward the 
source of the provoking stimulus. Under the influence of 
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pilocarpine, cats which were normally docile could not be 
handled. It was suggested that the behavioral syndrome bore 
somewhat of a resemblance to the mania seen in cats after the 
administration of morphine. Atropine prevented or terminated 
the whole behavioral reaction. 
Effects on neuromuscular transmission - Large doses of 
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pilocarpine (400 mg/kg) have been shown to produce signs of 
muscular weakness in cats. Studies on the gastrocnemius muscle 
_ sciatic nerve preparation in unanesthetized, spinal cats 
demonstrated that pilocarpine in doses of 320 mg/kgproduced 
virtually a complete paralysis of neuromuscular transmission. 
Direct stimulation of the paralyzed muscle still provoked a con-
traction. Partial restoration of transmission was produced by 
physostigmine. It was also indicated that gallamine triethio-
dide and pilocarpine displayed a high degree of synergism with 
respect to the neuromuscular paralysis. The paralysis produced 
on skeletal muscle by pilocarpine was enhanced rather than an-
tagonized by atropine (269). 
Blockade of spinal inhibition - Zablocka and Esplin (268) 
demonstrated that pilocarpine slightly lowered the seizure 
threshold for pentylenetetrazol and very markedly reduced the 
threshold for strychnine convulsions in rats. This effect of 
pilocarpine was not blocked by atropine. In subsequent studies 
(74, 269) conducted on spinal cats, pilocarpine produced tonic 
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e~tensor convulsions. The convulsions were similar to those 
seen with strychnine and could be provoked by tactile or audi-
tory stimulation. It was indicated that subconvulsant doses of 
strychnine and pilocarpine summated to produce the effect. As 
in the previously reported experiments, the extensor convul-
sions were not blocked by atropine. The results of the experi-
ments also indicated that the principal effects of pilocarpine 
were qualitatively similar to strychnine. There was an increase 
in the monosynaptic response through extensor pathways and an 
increase in polysynaptic activity. The convulsions and the 
spontaneous ventral root discharges were attributed to a reduc-
tion in background inhibition. In the case of recurrent inhibi-
tion mediated by the Renshaw cells, both pilocarpine and strych-
nine blocked the inhibitory effect of activity in the system in 
doses which did not block the Renshaw cell discharges. 
Evidence for the release of acetylcholine by pilocarpine -
Experiments described by MCCashland (171) suggested to him that 
pilocarpine's mechanism of action involved stimulation of ace-
tylcholine production by cholinergic nerves. A turtle was 
killed by crushing its brain. The heart was exposed and per-
fused with Ringer's solution containing physostigmine salicy-
late. The right vagus was exposed for stimulation. The per-
fusate was collected after vagal stimulation or after the ap-
plication of pilocarpine to the heart and tested for the 
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presence of acetylcholine on the heart of the clam (Venus ~­
cenaria). The perfusate collected after vagal stimulation of 
-
the heart caused a temporary inhibition of the Venus heart. 
The perfusate collected from a normally beating and untreated 
heart had no such effect. Thirty seconds after the application 
of a 1 per cent solution of pilocarpine hydrochloride to the 
region of the sinus, the perfusate was collected and tested. 
The results obtained were similar to those obtained after vagal 
stimulation, i.e., temporary inhibition of the Venus heart. 
When pilocarpine, in the amount applied to the turtle heart, was 
added to the Venus heart, no effect on the heart beat was ob-
served. He concluded, therefore, that inhibition of the heart 
was not due to a direct pilocarpine action. Rapid breakdown of 
material collected in the perfusates was indicated by the fact 
that successive applications to the clam heart at 5 minute in-
tervals had less and less effect. McCashland suggested that 
pilocarpine stimulated cholinergic nerve endings in the heart 
to produce their specific secretion. This substance had the 
same effect as the acetylcholine formed upon vagal stimulation. 
Toxicology - Pilocarpine, in toxic quantities, produces 
signs and symptoms referable to an exacerbation of the various 
parasympathomimetic effects of the drug. The fatal dose of 
pilocarpine is not known, but it has been stated (144) that 100 
mg. may be viewed as a dangerous amount. Death is thought to 
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be due either to pulmonary edema or to central respiratory 
failure. The antidote for pilocarpine intoxication is atropine, 
along with other measures of a supportive nature such as fluid 
therapy to restore water and electrolyte balance and the main-
tenance of an adequate respiratory exchange. 
A recent report of systemic pilocarpine toxicity resulting 
from overdosage has been presented by Epstein and Kaufman (70). 
pilocarpine had been repeatedly instilled into the eye of a 
hospitalized patient because of an acute angle closure secondary 
to dilatation in an eye with an intumescent lens. The patient 
complained of nausea and began to sweat. Diaphoresis became 
more marked and was accompanied by retching, salivation and 
tremors of the arms, legs and thoracic muscles. The blood pres-
sure fell, and the pulse was weak and irregular. Shock therapy 
consisting of intravenous fluids and pressor amines was insti-
tuted. Atropine, which could have substantiated the diagnosis, 
had not been administered. 
A rather interesting toxic syndrome, occurring in the rat, 
was reported by Boyd and Fulford (36). Following the injection 
of pilocarpine hydrochloride, rats displayed two types of acute 
toxicity syndromes, an immediate muscarinic convulsive reaction 
and a delayed psychotic-like reaction. The LD50 of the immedi-
ate reaction was 642 mg/kg and the mean time to death was 34 
minutes. The LD50 of the delayed reaction was 430 mg/kg with a 
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mean time to death of 4.4 days. The cause of death in the 
immediate reaction was attributed to post-convulsive respiratory 
paralysis following marked parasympathomimetic activity. This 
was accompanied by hypothermia and vascular congestion of the 
brain, heart, lungs and kidneys. The animals surviving immedi-
ate death remained apathetic and stuporous for the remainder of 
the day. The muscarinic and convulsive signs were replaced by 
either a depressant or excitant type of neuropsychosis charac-
terized by disorientation and cateleptiform trances ("praying 
kangeroo trance"). Animals with the depressant type of psycho-
sis tended to die in hypothermic stupor with capillary vasodila-
tation and hemorrhagic or toxemic changes in many organs. The 
animals who displayed the excitant type of reaction tended to 
survive with degrees of psychotic-like behavior persisting for 
a month. 
Fate and excretion - Pilocarpine is readily absorbed from 
the gastrointestinal tract. Biochemical data are meager on the 
metabolism and fate of pilocarpine in the body. The work of 
Nakanishi and Sumiya (lSO) demonstrated that rabbit lymph in 
vitro could destroy pilocarpine. Using rat serum, Lavallee and 
Rosenkrantz (159) found that there was a serum system that was 
capable of transforming pilocarpine to form{s) which were not 
detectable by the imidazole or lactone reactions. Transforma-
tion of pilocarpine added to the serum occurred within 10 
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minutes and was approximately completed in 1 hour. It was fur-
ther reported that dog serum converted 31%, monkey 60%, human 
68% and rabbit 100% of the added pilocarpine during a 60 minute 
in vitro incubation. Various inhibitors were tested for their 
----
ability to prevent the transformation of pilocarpine by rat 
serum. Good inhibitory activity Was revealed by EDTA (ethyl-
enediarninetetraacetate) and PMBA (p-chloromercuribenzoic acid). 
It was also demonstrated that the serum transformation system 
was dependent on dialyzable components. 
It is believed that pilocarpine is excreted in the urine 
in both free and combined forms with perhaps the largest frac-
tion in a combined form. 
4. Uses of Pilocarpine - Because of its prominent effect 
on the sweat glands, pilocarpine was at one time employed in 
the elimination of edema fluid, toxic substances and nonprotein, 
nitrogeneous waste products in conditions of renal shutdown. 
Although fairly large volumes of fluid can be lost following 
the administration of pilocarpine to the patient with renal or 
cardiorenal disease, the threat of pulmonary edema, fluid and 
electrolyte imbalance often times countermanded its use. As a 
result of the newer, safer methods used in the treatment of 
renal failure, the practice of promoting diaphoresis with pilo-
carpine has become a thing of the past. pilocarpine has been 
employed in the investigation of disturbances in the sweating 
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mechanism as a result of peripheral nerve lesions. In this in-
stance, it has some diagnostic value in demonstrating the nature 
of the peripheral nerve lesion (122, 163, 164, 165, 181, 261). 
patient complaints of uncomfortable dryness of the mouth and 
pharynx following the therapeutic use of phenothiazines or some 
of the imipramine-type antidepressants have reportedly been 
alleviated by the administration of pilocarpine (215). Pilo-
carpine has also been employed along with ganglionic blocking 
agents to minimize some of their undesirable side-effects, es-
pecially the xerostomia which attends their use (83, 95). Reid 
(208) recommended the use of pilocarpine in the treatment of 
pruritis. It was thought that relief obtained in this instance 
may be related to sweating or to slight changes in cutaneous 
circulation. 
The most important use of pilocarpine is in the field of 
ophthalmology. Administered locally as 0.5 - 4% solutions of 
the nitrate or hydrochloride salt, pilocarpine produces miosis 
with spasm of accommodation (fixation of lens for near vision). 
There is a brief transitory rise in intraocular pressure fol-
lowed by a more persistent fall. The miosis which is produced 
may last from several hours to as long as a day. Fixation of 
the lens for near vision is said to disappear in about 2 hours. 
The miotic action of pilocarpine is also employed to antagonize 
the mydriatic and cycloplegic effects of atropine following 
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ophthalmOlOgic examination. Potts (202) has stated, "Despite 
attempts of two textbooks to declare it obsolete, pilocarpine 
is the single most important drug in the present day treatment 
of glaucoma. II Sugar (232) has stated that glaucoma does not 
apply to a particular ocular disease state, but rather to a 
whole group of diseases. The diseases have in cornmon an abnor-
mal elevation of intraocular pressure coupled with functional 
or anatomical changes resulting from that abnormal pressure. 
In a general sense, glaucoma may be defined as an elevation of 
intraocular pressure beyond the limits of an established norm, 
or the state which exists when the function of the eye has been 
damaged by such an increase in pressure. Two types of glaucoma 
are recognized clinically, a narrow angle glaucoma, in which 
the access of aqueous humor to outflow channels is blocked by 
outer portions of a dilated or semidilated iris, and a wide 
angle glaucoma, where no blockage exists and the resistance to 
the outflow of the aqueous humor appears to be caused by nar-
rowing within the outflow channels. Pilocarpine is effective 
in the treatment of wide angle glaucoma, causing a marked re-
duction in intraocular pressure as a result of the increased 
drainage or outflow of aqueous humor (202). 
Huggins (118) had previously suggested that since the 
adult prostate was not self-sustaining, its secretion might 
easily be adapted to serve as a quantitative indicator of the 
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activity of many hormones, especially as they affect androgen 
production. Perhaps with this as a basis, Rosenkrantz and Mason 
(217, 218) devised a unique bioassay procedure for the biologi-
cal evaluation of estrogenic compounds. An established dose 
level of pilocarpine hydrochloride was administered to unanes-
thetized, castrated, testosterone-treated dogs with surgically 
produced prostatic fistulas. A dose of O.7mg/kg resulted in 
the stimulation of prostatic secretion with hourly volumes of 
10 - 30 mls. of fluid. When various natural or synthetic estro-
gens or estrogenic steroids were administered to the dogs prior 
to the administration of the pilocarpine, a biopotency of the 
test estrogens could be obtained. This was reflected by a 
change in the volume of prostatic fluid secreted, which could 
be correlated with the antiandrogenicity properties of the hor-
mone. The investigators have proposed that the test, in addi-
tion to providing clues to the various mechanisms whereby the 
gland was stimulated or inhibited, could also be important in 
the screening of compounds which might be successful in the 
treatment of prostatic cancer • 
CHAPTER II 
EXPERIMENTAL - CHEMISTRY 
Introduction 
1. The Quaternization Reaction - When a tertiary amine is 
allowed to react with an alkyl or aryl halide, the product 
formed is a quaternary ammonium salt. The general reaction for 
the formation of a quaternary ammonium salt may be represented 
as follows: 
where R' = an alkyl or aryl group 
The reaction is regarded as a substitution reaction, with the 
new incoming group, the tertiary amine, substituting for or tak-
ing the place of the old (leaving) group X. The end result of 
the reaction is the formation of a carbon-nitrogen bond. Since 
the attacking nitrogen atom possesses an unshared pair of elec-
trons which it donates in the formation of the carbon-nitrogen 
bond, the reaction is said to involve a nucleophile, and has 
therefore been characterized as a nucleophilic substitution 
reaction. In general, the reactions are ionic or involve polar 
molecules, and as a result, the quaternary ammonium salts which 
are formed are very polar compounds. 
In the alkylation of an amine, the reactivity of a given 
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alkyl derivative, R'-X, is, determined in part by the nature of 
the leaving group, X. It has been shown that there is a reason-
able correlation between the reactivity of an alkyl halide 
(R'-X) and the acid strength of its halogen acid (H-X) , with the 
X groupS that correspond to the strongest acid being the best 
leaving groups. Since hydrofluoric acid is a relatively weak 
acid and hydroiodic acid is a very strong acid, the usual order 
of reactivity of alkyl halides is R-I >R-Br >R-Cl >R-F (213). 
Alkyl and aryl iodides were used in the quaternization of pilo-
carpine whenever possible. 
2. Quaternary Salts of Pilocarpine Alkaloids - Alkylation 
experiments on pilocarpine and isopilocarpine with methyl and 
ethyl iodides have previously been reported (45, 98, 125). 
These experiments were conducted in an attempt to elucidate the 
• • • I 
structure and functional groups of the p1locarp1ne alkalo1ds. 
They did confirm the tertiary nature of the nitrogen atoms, the 
products formed with either alkaloid being quaternary salts. 
More recent studies on the alkylation of pilocarpine have demon-
strated the existence of a crystalline form of the methiodide 
(265). The formation of quaternary salts by Langenbeck (157) in 
1924 was used to prove the stereoisomerism that exists between 
pilocarpine and isopilocarpine. The formation of quaternary 
salts of pilocarpidine by Burtles, Pyman and Roylance (40) and 
by Spath and Kunz (229) was used to show the relationship of 
N 
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pilocarpidine to pilocarpine. Spath and Kunz further demon-
strated that a similar relationship exists between the alkaloids 
isopilocarpidine and isopilocarpine, methylation of isopilo-
carpidine yielding the methiodide of isopilocarpine. 
In a review of the literature, there were no reports of any 
further investigations conducted on the quaternary salts in them-
selves. The current study was initiated to further assess these 
compounds and to investigate some of their pharmacologic activ-
ity. The molecular structure of methyl pilocarpinium iodide, 
the first and simplest member of the series, is depicted in 
Fig. 2. 
B. Synthesis Of Quaternary Pilocarpine (Pilocarpinium) Com-
pounds 
1. Preparation of Pilocarpine Base for all Alkylation 
Reactions - In order to obtain pilocarpine as the free 
amine base, weighed samples of the commercially available U.S.P. 
hydrochloride salt were treated in the following manner. A 
weighed sample of pilocarpine hydrochloride U.S.P., Merck or 
Mallinckrodt, calculated on the amount of the alkaloidal base 
needed for a particular synthesis, was transferred to a 125 ml. 
Squibb separatory funnel. The salt was dissolved in 20 mls. 
distilled water, and the solution was made alkaline (pH @ 8.0, 
pHydrion test paper) by the addition of 15 mls. dilute ammonia 
T.S. The alkaline solution was extracted with six portions of 
) J 
J 
Fig. 2 - Framework molecular model showing mutual relationship 
of atoms in a molecule of methyl pilocarpinium iodide. 
Model constructed on the relative scale of I ~=l inch. 
o atom, red; N atoms, blue; C atoms, black; H atoms, nar-
row band on white tubing. Discontinuous (blue-banded) 
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bonds imply some binding between nitrogen atoms and carbon 
over and above that ofordinary carbon-nitrogen single bonds. 
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reagent grade chloroform, i.e., 20, 15, 15, 10, 10 and 10 ml. 
portions respectively. The individual chloroform extracts were 
collected in a second 250 ml. Squibb separatory funnel. The com-
bined chloroform extracts contained in the second separatory fun-
nel were then washed with a 20 and a 15 ml. portion of distilled 
water. A 5 ml. fraction of the original solution was checked 
for the completeness of extraction of pilocarpine by employing 
the Helch test (See dissertation, page 34). The test was nega-
tive in all instances when performed on the original extracted 
I 
solution. Five ml. portions of the distilled water washings 
were checked for the presence of pilocarpine, also by means of 
the Helch test. In a few instances, a faint positive test was 
obtained in the second water wash. The washed chloroform extract 
was treated with anhydrous sodium sulfate and then filtered 
through Whatman #42 paper into a 200 ml. round-bottomed, 3-necked 
flask. The chloroform was evaporated by heating the flask with 
a Glas-col mantle set to low heat. During the evaporation 
period, the contents of the flask were continually stirred by 
means of a magnetic stirring device. Most of the chloroform 
evaporated at a temperature of 68 to 700 C. The maximum tempera-
ture reached during the evaporation period was about 750 • Evap-
oration was continued until a colorless, mobile oil, having only 
a faint to slight trace of chloroform odor, remained. The pilo-
carpine base so obtained was used in the preparation of the 
> 
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compounds which are about to be described. 
2. Preparation of 62- (hydroxymethyl)-Ot-ethyl-l, 3-dimethyl-
• 
5-imidazole butyric acid lactone iodide (Methyl Pilo-
carpinium Iodide or Pilocarpine Methiodide) - A 14.0 
gram sample of pilocarpine hydrochloride, Merck, representing 
11.9 gros. (0.06 mole) pilocarpine base, was transferred to a 125 
ml. separatory funnel and extracted in the manner just described. 
The 3-necked, 200 ml., round-bottomed flask containing the pilo-
carpine base was connected to a reflux condenser, and while stir-
ring, an excess (10 mls.) of methyl iodide was added through one 
of the side arms. The reaction was almost immediate and accom-
panied by the generation of heat. Within a short period of time, 
the reaction subsided and the mixture acquired a light yellow 
color. Thirty mls. absolute ethanol were added through the con-
denser, and the contents were continuously stirred while the 
flask was warmed by means of the mantle. The mixture was re-
fluxed for 6 hours, with the temperature being maintained at an 
almost constant 790 throughout this period. The alcohol solution 
was decolorized as much as possible by the addition of 1 gm. of 
Norit A (activated charcoal) and filtered into a 250 ml. Erlen-
meyer flask. Anhydrous ether was added just to the point of a 
first permanent turbidity, a few seed crystals reserved from a 
previous synthesis (265) were added, and the solution was placed 
in a refrigerator (approximately 40 ). Within a short period of 
-15 
time (about an hour), clear, small, cubical crystals had formed 
on the bottom and sides of the flask. When the crystals were 
scraped from the sides and loosened from the bottom of the flask, 
additional crystal growth was initiated. Additional anhydrous 
ether was added to the clearing solution, the flask was stop-
pered and returned to the refrigerator overnight. In the morn-
ing, crystallization appeared to be complete (no further turbid-
ity upon the addition of more ether). The crystalline material 
was collected on a Buchner funnel, rinsed with a few small por-
tions of anhydrous ether, then transferred to a desiccator to 
dry and to loose the last traces of residual ether odor. The 
weight of product obtained after drying was 17.4 gms. (87% 
yield). 
The product was recrystallized by dissolving it in about 
125 mls. of absolute ethanol and warming the flask slightly to 
effect solution. The alcohol solution was filtered through 
Whatman #1 paper into a 500 mI. Erlenmeyer flask. Anhydrous 
ether was added to the filtrate in divided portions almost to 
the point of incipient clouding. The solution was seeded with a 
few crystals of the methiodide and set aside. Once crystalliza-
tion was initiated, the solution was stirred with a polyethylene 
rod to hasten crystallization and to form a finer crystalline 
material. After about 16 hours, the supernatant was checked for 
completeness of precipitation by the addition of a small portion 
-of anhydrous ether. The crystals were collected on a Buchner 
funnel by means of the vacuum produced by a water aspirator. 
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The white crystals were dried overnight in a desiccator. These 
crystals had a melting pointl of 124.5 - 126.00 (Lit. m.p. 122.5 
_ 1250 (265». A dried sample was sent out for microanalysis. 2 
Anal. - for methyl pilocarpinium iodide (C12H19N202I): 
calcd.: C 41.16; H 5.47; N 8.00; I 36.23; O(by difference)9.l4 
Found: C 41.50; H 5.06; N 8.29; I 36.55; O(by difference)8.60 
3. Preparation of Ethyl Pilocarpinium Iodide (Pilocarpine 
Ethiodide) - A 13.44 gm. sample of pilocarpine hydro-
i 
chloride, representing 11.4 gms. (0.05 mole) pilocarpine base, 
was extracted as previously described. An excess (10 mls.) of 
l-Iodoethane (ethyl iodide) was added to the oil remaining in 
the flask after evaporation of the chloroform. The flask was 
stoppered, stirred continuously by means of a magnetic stirring 
bar for an hour, then allowed to remain at room temperature over-
night. In the morning, the flask contained an upper, thicker, 
oily liquid layer, light yellow in color, and a clear, lower 
liquid layer which presumably consisted of the excess alkylating 
agent and perhaps residual chloroform. A small portion of the 
lAll melting points were obtained on a Fisher-Johns hot 
stage melting point apparatus. 
2All analyses were performed by Micro-Tech Labs., Skokie, 
Illinois. 
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thicker liquid was transferred to a 10 ml. beaker and 1 ml. dis-
tilled water added to it. Most of the material went into solu-
tion, with the exception of a few globules of a clear, colorless, 
immiscible liquid which were deposited on the bottom of the 
beaker. The light yellowish, aqueous solution was decanted into 
a glass crucible and the liquid evaporated in an oven maintained 
at 1000 . After evaporation of the water, a light yellow, oily 
substance remained. The crucible was then placed in a vacuum 
desiccator. By the following morning, most of the material con-
tained in the crucible had crystallized. Scratching the residual 
oil on the sides of the crucible with a glass rod converted it to 
a whitish powder. This material was reserved as a seed source. 
The flask containing the bulk of the product was unstoppered 
and heated in a Glas-col mantle to drive off the excess alkylat-
ing agent. After about 20 minutes, the temperature of the con-
tents had reached 750 • Heating was discontinued, and the con-
tents were stirred for an additional 30 minutes. After this 
interval, a fairly thick yellowish oil remained. The oil was 
seeded with some of the crystalline material which had been ob-
tained above, the flask was then stoppered and allowed to stand 
at room temperature.· After some 16 to 18 hours, the flask was 
filled with yellowish-white, mushy crystals. The crystalline 
product, dissolved in 15 mls. absolute methanol, was filtered 
into a 250 ml. Erlenmeyer flask. The flask and filter were 
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rinsed with an additional 15 ml. portion of methanol, and anhy-
drous ether was added in divided portions almost to the point of 
a permanent turbidity. The solution was seeded to initiate 
crystallization and set aside. The solution began to clear, with 
the deposition of fine droplets of oil along with the formation 
of crystals. After the addition of more ether the flask was 
swirled and the oil which had been deposited became crystalline. 
The pale yellowish-white crystals were separated from the liquid 
by filtration through a Buchner funnel and placed in a desicca-
tor. The yield of product was 17 gms. (85%). When recrystal-
lized two more times in a similar manner, but employing absolute 
ethanol and anhydrous ether as the solvent and precipitating 
agent, the ethiodide was obtained as a white crystalline material 
which melted at 114.5 - 116.00 (Lit. m.p. 1140 (125». 
Anal. - for ethyl pilocarpinium iodide (C13H21N202I): 
Calcd.: C 42.87; H 5.81; N 7.69; I 34.84; O(by difference) 8.78 
Found: C 42.76; H S~80; N 7.69; I 34.76; O(by difference) 8.99 
4. Preparation of n-Propyl Pilocarpinium Iodide - Pilo-
carpine base (approx. 10.9 gms. (0.05 mole», extracted from 
12.92 gms. pilocarpine hydrochloride and contained in a round-
bottomed flask connected to a reflux condenser, was reacted with 
an excess (10 mls.) l-Iodopropane (n-propyl iodide). Reaction 
was initiated by warming the flask with a Glas-col heating man-
tle. Within half an hour the temperature of the reaction mixture 
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reached 79. The heat was reduced and maintained at about 
700 for an interval of 3 hours with continuous stirring. At the 
end of this period heating was discontinued, and the mixture was 
allowed to stand overnight at room temperature. By morning the 
material was composed of 2 layers, a lower, somewhat clear layer 
which was assumed to be unreacted alkylating agent, and an upper, 
slightly yellowish, thicker layer. The flask was placed in a 
refrigerator. After an hour, the chilled product had acquired a 
gel-like consistency, and the separated clear liquid which still 
had a watery consistency could be decanted from the product. 
crystallization of the product could not be induced, so a small 
portion was removed and dissolved in I - 2 mls. distilled water. 
The aqueous phase was decanted from the few oily droplets which 
were not water soluble into a glass crucible. After evaporation 
of the water, the remaining oily material was redissolved in I -
2 mls. absolute methanol. The methanol was evaporated almost to 
dryness on an electric hot plate. The crucible, now containing 
the residue in a thin film on its sides, was placed in a vacuum 
desiccator. 
The bulk of the product was dissolved in 50 mls. absolute 
ethanol, and the solution was transferred to a 250 mI. separatory 
funnel. Anhydrous ether was added to the alcohol in divided por-
tions, swirling the flask after each addition. Ether was con-
tinuously added in this manner until a persistent turbidity 
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developed in the solution. The funnel was stoppered and set 
aside. After a short time, the solution began to clear, with 
the concomitant deposition of a light yellow, oily precipitate. 
The precipitated oil was drawn off into a 150 ml. beaker. Addi-
tional portions of anhydrous ether were added to the separatory 
funnel from time to time to insure complete precipitation of the 
product. Each subsequent fraction of oil was collected and com-
bined with the rest of the product in the beru<er. Allowing the 
beaker to stand uncovered on the laboratory bench permitted the 
slight traces of ether contained in the product to evaporate 
spontaneously. 
By the following morning, the material contained in the 
glass crucible which had been placed in the vacuum desiccator was 
crystallized sufficiently to serve as a seed source. The addi-
tion of some of these crystals to the oily product in the 150 ml. 
beaker induced crystallization in the oil. During one of the 
recrystallizations which followed, absolute methanol was employed 
as a solvent for the product. After addition of ether, the prod-
uct could only be recovered as an oil in spite of repeated seed-
ing with crystal nuclei. It would appear that methanol solvates 
or complexes with the iodide salt and the product will not crys-
tallize with the adhering alcohol. Additional evidence for meth-
anol bonding or solvation of the product was demonstrated on 
another occasion. In this instance, n-amyl alcohol was added to 
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a beaker containing the oily product which had been recovered 
from an anhydrous methanol-ether solvent mixture. This beaker 
had stood uncovered for a few days, but had formed only a few 
Crystals and contained an oily liquid which could not be induced 
to crystallize further. When n-amyl alcohol was added to this 
product, a fine, yellowish-white crystalline material was depos-
ited almost immediately. It would appear that the amyl alcohol 
extracted the methanol which had been bound to the product, and 
since the quaternary salt was probably only slightly soluble in 
amyl alcohol, it crystallized from solution. Recrystallization 
was attempted using amyl alcohol followed by anhydrous ether in 
a manner similar to that already described. This solvent mixture 
did result in the production of a crystalline product, but the 
crystals retained a fair amount of the yellowish color of iodine. 
A second crystallization from this solvent system did not improve 
the appearance of the crystals; they still retained a light yel-
lowish color. This behavior was different from that experienced 
in other experiments, where repeated recrystallization usually 
resulted in a product with an improved physical appearance. On 
this basis amyl alcohol was rejected as a solvent, and the propyl 
compound was finally recrystallized from an absolute ethanol-
anhydrous ether solvent system. There was a tendency for some of 
the product to be precipitated as an oil along with the formed 
crystals, but the oil was readily converted into a crystalline 
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solid upon standing. The product collected the following day on 
a Buchner funnel consisted of whitish granular crystals which had 
a faint yellowish cast. After drying, the crystals had a melting 
o point of 92.5 - 94.0 . Weight of the final product was 9.09 gms. 
(45% yield), with perhaps substantial loss of product sustained 
as a result of the repeated crystallization procedure. 
The propyl derivative was resynthesized some five months 
later, using the method of ether addition employed in the pre-
paration of the allyl compound (see dissertation, page 86) with 
the following variation. In addition to the ether triturations 
as performed with the allyl compound (which did not evoke crys-
tallization of the propyl derivative), a final 25 mI. portion of 
anhydrous ether was poured into the reaction flask. The mixture 
was seeded, stoppered and set aside. Soon afterwards, the thick-
ened oily material was converted into a yellowish-white solid. 
This procedure gave a 92.5% yield (18.5 gms.) of crude product. 
Recrystallization of the crude material from the absolute alcohol 
-anhydrous ether solvent described above resulted in a final 
yield of 17.7 gms. (88.6%). 
Anal. - for n-propyl pilocarpinium iodide (C14H23N202I): 
Calcd.: C 44.46; H 6.13; N 7.41; I 33.55; O(by difference) 8.46 
Found: C 44.19; H 6.02; N 7.32; I 33.48; O(by difference) 8.99 
5. Preparation of Isopropyl Pilocarpinium Iodide - An ex-
Cess (11.0 mls.) of 2-Iodopropane (isopropyl iodide) was added 
• 
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through the side arm of a 3-necked flask containing the pilocar-
pine base (approx. 11.05 gms.,O.05 mole) extracted from 12.99 
gms. of pilocarpine hydrochloride, U.S.P. The flask was connect-
ed to a reflux condenser, and heat was supplied by means of a 
Glas-col heating mantle. The mixture was continuously stirred by 
a magnetic bar. The reactants began to cloud up and become more 
viscouS after about one-half hour. At this point the temperature 
of the reaction mixture was 500 • At the end of an hour the flask 
was completely filled with a whitish, crystalline mass. The 
crystalline mass scraped from the flask weighed 18.44 gms. (92% 
yield). A portion of the crystals were reserved as a source of 
seed crystals. The bulk of the material was dissolved in 100 mls. 
absolute ethanol by gentle warming of the solution on a hot plate. 
The solution Was filtered through Whatman #1 paper, the filtrate 
being collected in a 500 mI. Erlenmeyer flask. The flask and 
filter were rinsed with an additional 10 mI. portion of warm eth-
anol. Anhydrous ether was added in divided portions to the alco-
hol solution until the persistence of a turbidity. The flask was 
seeded with some of the crystals which were reserved for this 
purpose, stoppered and set aside at room temperature. After 16 
to 18 hours, the crystalline product which had formed was col-
lected on a Buchner funnel. The crystals were washed with sever-
al small portions of anhydrous ether. When the ether washings 
came in contact with the filtrate, additional crystallization 
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initiated. These crystals were recovered and combined with 
first crop of crystals that were collected. The pooled mate-
'al when recrystallized from absolute ethano~anhydrous ether, r~ , 
yielded 15.6 gms. of white, light, needlelike crystals. Melting 
point of the product after overnight drying in a desiccator was 
o 158.0 - 159.5 • 
Anal. - for isopropyl pilocarpinium iodide (C14H23N202I) : 
Calcd. : C 44.46; H 6.13; N 7.41; I 33.55; ° (by difference) 8.46 
Found: C 44.04; H 6.21; N 7.75; I 33.59; ° (by difference) 8.41 
6. PreEaration of Allyl PilocarEinium Iodide 
a. Preparation of 3-Iodo-l-propene by halogen exchange: 
The increased nucleophilic activity of alkyl iodides over other 
alkyl halides was previously discussed. Since the negatively 
charged iodide ion is a good nucleophile, an iodide salt will 
enter into a nucleophilic substitution reaction (51). Although 
most allylic halides are highly reactive alkylating agents and 
could be expected to react readily with the imidazole nitrogen 
in pilocarpine, we chose to convert 3-Bromo-l-propene to 3-Iodo-
l-propene so that the quaternary derivative which was to be syn-
thesized would be obtained as an iodide rather than a bromide 
salt. The reaction for the exchange is: 
(acetone) 
CH2=CH-CH2Br + NaI • CH2=CH-CH2I + NaBr 
Sodium iodide, 44.97 gms. (0.3 mole) dissolved in 260 mls. 
acetone, was added to 36.30 gms. (0.3 mole) freshly distilled 
b 
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allyl bromide contained in a 500 ml. Erlenmeyer flask. After 16 
hours the solution was filtered to remove the precipitated sodium 
bromide, and the filtrate was transferred to a distillation ap-
paratus. Distillation of the filtrate gave an acetone fraction 
(boiling range 54.5 - 57.00 ) which was discarded and a higher 
boiling (97.0 - 99.00 ) reddish fraction which was collected 
(Allyl iodide Lit. b.p. 103.10 (105». Continued heating of the 
small volume of liquid remaining in the distilling flask did not 
yield any fraction which boiled over 990 • 
b. Preparation of allyl pilocarpinium iodide: Six mls. 
(a calculated 20% excess) of 3-Iodo-l-propene was added to the 
base which was obtained by the extraction of a 12.99 gm. sample 
of pilocarpine hydrochloride (representing 11.05 gms. (0.05 mole) 
pilocarpine). The base, a slightly yellowish thick oil, was con-
tained in a 200 ml., round-bottomed flask and had been obtained 
in the manner previously described. Upon the addition of the 
allyl iodide, there was an almost immediate exothermic reaction. 
The material in the flask acquired a dark iodine color and thick-
ened to such an extent that attempts at magnetic stirring were 
ineffective and virtually impossible. ~Vhen the contents of the 
flask had cooled down, another milliliter of allyl iodide was 
added to the flask, the flask was stoppered and allowed to re-
main overnight at room temperature. In the morning, the product 
consisted of a thickened, dark reddish-brown mass with no visible 
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excess alkylating agent and no apparent crystallization. 
Before attempting purification and crystallization by any of 
the methods used in the previous experiments, a 25 mI. portion 
of anhydrous ether added to the flask was triturated with the 
product to aid in the removal of the excess allyl iodide. This 
portion of ether Was decanted from the product and replaced with 
another 25 mI. portion. During trituration of the product with 
this second portion of ether, the material began to crystallize, 
forming a yellowish-brown, granular solid. The solid was al-
lowed to settle, and the supernatant ether was discarded. After 
two more ether washings, which were effective in removing much 
of the color, the product was collected on a Buchner funnel. The 
dark yellowish powder which was collected weighed 18.8 gros., a 
94% yield. A portion of the material was reserved as a seed 
source. 
Dissolution of the product was effected by warming it with 
75 - 80 mls. absolute ethanol on a hot plate. The warm solution 
was filtered into a 500 mI. Erlenmeyer flask, and anhydrous 
ether Was added in divided portions until the persistence of a 
slight turbidity. The flask was seeded with a few crystals re-
served for this purpose, and almost immediately crystallization 
was initiated. Additional ether was added to the clearing super-
natant, the flask was stoppered and placed in a refrigerator. 
The following morning the crystalline product was separated 
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from the solution by vacuum filtration. Recrystallization from 
the same solvent mixture yielded 17.5 gms. of a faintly yellow-
ish-white, granular, crystalline powder which had a melting 
o point of 109.0 - 110.0 . 
Anal. - for allyl pilocarpinium iodide (C14H2lN202I): 
Calcd .: C 44.69; H 5.63; N 7.44; I 33.73; O(by difference) 8.50 
Found: C 44.58; H 5.68; N 7.50; I 33.63; O(by difference) 8.61 
7. Preparation of n-Butyl Pilocarpinium Iodide - A 12.5 gm. 
sample of pilocarpine hydrochloride, representing 10.6 gms. 
(0.05 mole) pilocarpine base, was extracted in the manner previ-
ously described. An excess (10 mls.) of l-Iodobutane (n-butyl 
iodide) was added to the pilocarpine which was contained in a 
round-bottomed flask. There Was no heat generated after this 
addition (no immediate reaction) as with some of the lower mem-
bers in this series, so the flask was attached to a reflux con-
denser. The flask was gradually heated by a Glas-col mantle to 
initiate the reaction. At about 500 the mixture was beginning 
to acquire a light yellow color. The reactants were heated un-
til a temperature of 60 - 650 was reached, at which time the 
mantle was adjusted so that this temperature could be maintained. 
The mixture was continuously stirred throughout this period. 
Heating was discontinued after 4 hours, but the mixture was 
stirred until it had cooled down to room temperature. At this 
point the stirring was discontinued, and the mixture was allowed 
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to remain undisturbed overnight at room temperature. By morning 
the product had appreciably thickened, forming a yellowish "gel-
like" product. The excess alkylating agent had separated as a 
clear, colorless liquid which was decanted from the product. 
The "gel" could not be induced to crystallize. The contents of 
the flask were dissolved in 60 mls. absolute ethanol by gentle 
warming on a hot plate, and then the solution was transferred to 
a 250 ml. separatory funnel. Anhydrous ether was added in di-
vided portions until a permanent turbidity persisted in the solu-
tion. with the development of turbidity, there was an almost 
simultaneous separation of a yellowish oil in fine drops which 
collected in the bottom of the separatory funnel. The separated 
oil was collected in a beaker. As the solution cleared, more 
anhydrous ether was added to the point of incipient clouding. 
The solution continued to develop more turbidity on standing, 
followed in a little while by the deposit of additional droplets 
of oil. The oily droplets were scraped from the sides of the 
funnel, and as they collected in the bottom of the vessel, they 
were drawn off into the beaker. Once again, ether was added to 
the clear liquid just to the point of a permanent turbidity. 
After several hours, white needlelike crystals formed in the 
separatory funnel. When the crystals were freed from the sides 
by a rubber policeman, additional crystallization was initiated. 
Some of these crystals were removed from the solution and were 
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used to seed the product collected in the beaker. The crystal-
line product Was separated from the solution by filtration. In 
the meantime, crystals had begun to form in the beaker. Several 
hours later, the material in the beaker had formed a mushy, yel-
lowish-white, crystalline mass which had a fairly strong odor 
characteristic of the alkylating agent and alcohol. The mass 
was triturated with 20 mls. anhydrous ether and transferred to 
a Buchner funnel. The collecting beaker and crystals were 
rinsed with several smaller portions of ether. The product was 
spread on filter paper to air-dry and to lose the residual ether 
odor. When dry, both batches which consisted of light yellowish-
white crystals were combined. The yield of product was 17.1 gros. 
(85.5%). Two recrystallizations from an absolute ethanol-anhy-
drous ether solvent system in a manner similar to that already 
described gave a white, crystalline powder having only a very 
faint yellowish cast. The melting point of the quaternary salt 
was 108.0 - 109.50 (Lit. m.p. 106 - 1080 (264». 
Anal. - for n-butyl pilocarpinium iodide (C15H25N202I): 
Calcd.: C 45.93; H 6.42; N 7.14; I 32.35; O(by difference) 8.16 
Found: C 45.82; H 6.60; N 7.25; I 32.57; O(by difference) 7.76 
8. Preparation of ~-(hydroxymethyl-~-ethyl-l-methyl-3-(2-
butyl)-5-imidazole butyric acid lactone iodide (sec-
Butyl Pilocarpinium Iodide - A 12.5 gro. sample of pilo-
carpine hydrochloride, representing 10.6 gms. (0.05 mole) 
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pilocarpine base, was transferred to a separatory funnel and 
dissolved in 20 mls. distilled water. The solution was made 
alkaline by the addition of 15 mls. ammonia T.S. and extracted 
in the manner previously described. Ten mls. (an excess) of 
2_Iodobutane (sec-butyl iodide) was added to the flask contain-
ing the pilocarpine base. The mixture was continuously stirred 
and heated under a reflux condenser for a period of about 3 
hours. The maximum temperature attained during this period was 
850 , which occurred in a short interval following the initiation 
of the reaction. For the most part, the reaction was conducted 
at a temperature of 70 - 750 • Heating was discontinued at the 
end of 3 hours. The flask was stoppered and allowed to remain 
at room temperature overnight. In the morning, the excess alky-
lating agent which had separated was decanted from the product. 
The product was dissolved in 70 mls. absolute ethanol by warming 
slightly, and the solution was transferred to a 250 mI. separa-
tory funnel. Anhydrous ether was added to the alcohol solution 
in divided portions until the first appearance of a permanent 
turbidity. From this point on, the sec-butyl derivative reacted 
in a manner very similar to that described for the n-butyl deri-
vative. The turbidity in the solution cleared, with the com-
pound being deposited as an oil. When the oil was drawn off and 
more ether was added, the solution became cloudy again and de-
posited a second fraction of oil. By employing IIfractional 
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precipitation", a point was reached where the amount of product 
precipitated with each subsequent ether addition was diminished, 
but a sufficient amount of product was still present to produce 
a slight turbidity in the solution. Conditions for crystalliza-
tion were apparently optimal, because as this solution was al-
lowed to stand, crystals formed spontaneously. The crystals 
were separated from the solution by filtration. These crystals 
were used as a seed source for inducing crystallization either 
in the oily product or in the recrystallization steps which 
followed. The sec-butyl derivative, after three recrystalliza-
tions from an absolute ethanol-anhydrous ether solvent system 
(fully explained in prior experiments), had a melting point of 
o 120.0 - 122.5 9 The product was composed of light, white, 
needlelike crystals. 
Anal. 
-
for sec-butyl pilocarpinium iodide (C15H25N202I): 
Calcd. : C 45.93: H 6.42: N 7.14: I 32.35: ° (by difference) 8.16 
Found: C 46.41: H 6.35: N 7.39: I 32.60: ° (by difference) 7.25 
The initial synthesis was invariably more involved as evi-
denced by the number of purification steps and improvisations 
that had to be employed in order to obtain a solid product. 
However, once a solid product was obtained, subsequent batches 
could be crystallized with less difficulty. A case in point is 
the following description of a follow-up synthesis of the sec-
butyl derivative. Extraction of the hydrochloride salt and the 
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reaction conditions were essentially the same as those followed 
in the initial synthesis. After the excess alkylating agent was 
decanted from the product, the thickened oily "gel" was tritu-
rated with several successive portions of anhydrous ether. The 
spent ether was discarded after each trituration. With the ad-
dition of a third portion of ether, some crystals from the ini-
tial synthesis were also added and both were triturated with the 
product. This time the ether was not poured away from the pro-
duct, but allowed to remain undisturbed in contact with it. 
Within a few hours the oily liquid product was converted to a 
crystalline solid. The product, collected and dried, weighed 
18.17 gms. (90.87% yield). The losses incurred in recrystalli-
zations were not so extensive, because with the acquisition of 
a purer "crude" product, fewer recrystallizations were necessary 
to obtain an acceptable product. The melting point of the pilo-
carpinium salt was 121.5 - 123.00 • 
9. Preparation of Isobutyl Pilocarpinium Iodide - The 
quaternization of pilocarpine with the alkylating agent l-Iodo-
2-methyl propane (isobutyl iodide) was attempted on four dif-
ferent occasions over a span of many months. A yellowish-white, 
fine crystalline powder having a melting range of 83.0 - 87.00 
could be isolated from the reaction mixture. Many attempts at 
purification from water or a varied mixture of different solvents 
have been unsuccessful. The products were either recovered as 
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oilS of varying consistencies or as a tacky, yellowish-white 
solid. One was encouraged to attempt repeated purification by 
the appearance of white, needlelike crystals in some of the re-
crystallization solvent mixtures. However, even when these crys-
tals were isolated and used to seed other flasks, they usually 
reacted with the solvents forming oily globules before crystal-
lization could be initiated. The synthesis of this derivative 
still presents a challenge which will be reserved for some fu-
ture date. 
10. Preparation of tert-Butyl Pilocarpinium Iodide - Eight 
mls. (an excess) of 2-Iodo-2-methyl propane (tert-butyl iodide), 
the final isomer remaining in the butyl series, was added to the 
pilocarpine base (10.61 gros. (0.05 mole» which had been ex-
tracted from 12.47 gros. pilocarpine hydrochloride. The reaction 
flask was connected to a reflux condenser and heated by means of 
a Glas-col mantle. Five minutes after the addition of the alkyl-
ating agent the reaction was initiated? with the temperature of 
the reactants rapidly rising to 550 • Within an hour the flask 
was half filled with a dark reddish-brown solid. The flask was 
cooled and the product washed with several successive portions 
of anhydrous ether. The washings not only removed the excess 
alkylating agent, but were also effective in removing much of 
the color contaminating the product. A final ether washing was 
Used to transfer the material to a Buchner funnel. A yield of 
b 
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15. 3 gms. (76.5%) of a yellowish-brown, fine granular powder was 
obtained. A small portion of the material was reserved as a seed 
source to be used in the following purification procedures, if 
necessary. The product was dissolved in 100 mls. absolute etha-
nol, warming slightly to effect solution. Activated charcoal 
(1 gm. Norit A) was added to the solution in an attempt to remove 
the dark reddish iodine color, and the mixture was filtered into 
a 500 ml. Erlenmeyer flask. As described previously, anhydrous 
ether was added to the alcohol solution in divided portions until 
the development of an initial persistent turbidity. The flask 
was seeded, stoppered and set aside. Ether was added from time 
to time as the solution cleared to insure complete precipitation 
of the solid product. The following morning a light yellowish 
granular powder was separated by vacuum filtration. After three 
recrystallizations, a faint yellowish tinged, white granular pow-
der was collected, which for all intents and purposes had a good 
physical appearance, but which displayed a poor melting behavior. 
The melting point of a sample, dried in an oven for 3 hours at 
1050 , started at 113.0 - 114.00 • The melt acquired a yellowish 
color at 124.0 - 126.00 , and it wasn't until 128.0 - 130.00 that 
the remaining powder on the slide melted and ran together. 
Two previously synthesized batches of the tertiary butyl 
derivative had reacted in a similar fashion. After the addition 
of the alkylating agent, a dark reddish-brown, granular material 
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rapidly formed. In one case the solid formed in 20 minutes, 
and in the other within 40 minutes. The reaction which was ef-
fected in the shorter time period gave only a 46.75% yield. In 
the purification steps which followed the synthesis of these two 
batches, there were times when the collected product appeared to 
be an admixture of yellowish-white, needlelike crystals and a 
finer, yellowish-white, granular salt. A mixture of products 
would certainly be one explanation for the wide range in melting 
temperature observed in these two syntheses and in the synthesis 
which was first described. 
Persistent attempts at purification finally resulted in ob-
taining a fine granular product, which in the now combined first 
two batches melted at 127.0 - 130.00 , and in the separate third 
batch melted at 128.5 - 130.00 • Because of its slightly sharper 
melting range, the third reaction product was sent away for 
microanalysis. 
Anal. - for tert-butyl pilocarpinium iodide (C15H25N202I): 
Calcd.: C 45.93; H 6.42; N 7.14; I 32.35; O(by difference) 8.16 
Found: C 39.82; H 5.47; N 8.04; I 37.82; O(by difference) 8.85 
The disparity between the calculated and determined micro-
analysis was greater than any other in the whole series of syn-
thesized quaternary derivatives. The melting point of the pic-
rate derivative of "tert-butyl pilocarpiniumll was 162.5 - 163.50 • 
Pilocarpine picrate which will be discussed in a later section 
• 
96 
had a melting point of 162.0 - 163.50 • The similarity in picrate 
melting points made one suspect that the product of this synthe-
sis was perhaps pilocarpine hydroiodide. The following compari-
son of the microanalytical results gives strong evidence that 
this may indeed be the case. 
Anal. - for pilocarpine hydroiodide (CllH16N202'HI): 
calcd.: C 39.30: H 5.10: N 8.33: I 37.75: O(by difference) 9.52 
Found: C 39.82: H 5.47: N 8.04: I 37.82: O(by difference) 8.85 
No further work was done with this compound. 
11. preparation of n-Arnyl Pilocarpinium Iodide - A calcu-
lated 20 per cent excess (12.0 gros., 0.06 mole) l-Iodopentane 
(n-amyl iodide) was added to a round-bottomed flask containing 
the pilocarpine (10.25 gms., 0.05 mole) extracted from a 12.04 
gm. sample of pilocarpine hydrochloride. The extraction of the 
salt and recovery of the base has been previously described. The 
reaction flask was connected to a reflux condenser, the mixture 
was warmed and stirred continuously for about 4 hours. Heating 
was discontinued, and the stoppered flask was allowed to remain 
at room temperature overnight. After 16 - 18 hours, the flask 
contained a light yellowish, semisolid oil and a clear liquid, 
presumably the unreacted excess alkylating agent. The clear liq-
uid was decanted from the flask and the product stirred with sev-
eral successive 25 ml. portions of anhydrous ether. The spent 
ether was decanted from the product. The product was dissolved 
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. 60 mls. absolute ethanol, transferred to a separatory funnel l.n 
and anhydrous ether was added in divided portions until incipient 
clouding. The product was recovered as an oil. All attempts to 
~ f Crystallize the product, including prolonged storage in a vacuum 
'" 
desiccator, were unsuccessful. The final product was a very vis-
cid, light amber-colored, semisolid oil. 
Anal. - for n-amyl pilocarpinium iodide (C16H27N202I): 
calcd.: C 47.30; H 6.70; N 6.89; I 31.23: O(by difference) 7.88 
Found: C 46.16: H 6.81: N 6.83: I 30.51; O(by difference) 9.69 
12. Preparation of @ - (hydroxymethyl) -~ethyl-l-methyl-3-
(3-methylbutyl)-5-imidazole butyric acid lactone 
iodide (Isoamyl Pilocarpinium Iodide) - Pilocarpine 
base (10.25 gms., 0.05 mole) was obtained by the extraction of 
12.04 gros. of the hydrochloride salt in the manner previously 
described. The thin, mobile oil remaining after the evaporation 
of the chloroform was reacted with an excess (10 mls.) of l-Iodo-
3-methyl butane (isoamyl iodide) in a 200 ml., round-bottomed 
flask. The reaction mixture was heated under a reflux condenser 
for about 4 hours at a temperature of 65 - 680 • The heating was 
discontinued, the flask stoppered and the reaction mixture al-
lowed to remain at room temperature for about 16 hours. The ex-
cess alkylating agent which had separated as a clear liquid from 
.the thickened "gel-like" product was decanted" and the product 
was dissolved in 75 mls. absolute ethanol. The alcohol solution 
• 
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was treated with 1 gm. Norit A (activated charcoal) and filtered 
into a separatory furinel. Anhydrous ether was added in divided 
portions to the alcohol solution until the first appearance of a 
permanent turbidity. By following what has previously been 
called "fractional precipitation" (see preparation of sec-butyl 
derivative), whitish, needlelike crystals were obtained. Innocu-
lation of the oily product with some of these crystals was suffi-
cient to induce crystallization. Collection, washing with ether 
and drying yielded 15.97 gms. (76.93%) of product. A final re-
crystallization from an absolute alcohol-anhydrous ether solvent 
mixture yielded white, needlelike crystals having a melting point 
of 105.0 - 107.00 (Lit. m.p. 102.5 - 1040 (264». 
Anal. - for isoamyl pilocarpinium iodide (C16H27N202I): 
Calcd.: C 47.30; H 6.70; N 6.89; I 31.23; O{by difference) 7.88 
Found: C 47.44; H 6.85; N 6.96: I 31.62: O(by difference) 7.13 
13. Preparation of /3- (hydroxymethyl) -~-ethyl-l-methyl-3-, 
(2-ethylacetoxy)-5-imidazole butyric acid lactone 
bromide (Acetoxyethyl Pilocarpinium Bromide) - A 13.39 
gm. sample of pilocarpine hydrochloride, representing 11.39 gms. 
(0.05 mole) pilocarpine base, was extracted as previously de-
scribed. The flask containing the base was set under a reflux 
condenser, and while stirring, an excess (12 mls.) of 2-Bromo-
ethyl acetate was added through one of the side necks of the 
flask. The reaction mixture was heated by means of a Glas-col 
mantle for 2 hours, after which time heating was discontinued and 
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the reaction allowed to remain overnight at room temperature. 
After 20 hours, 25 m1s. absolute methanol Was added to the flask, 
and the mixture was ref1uxed at 650 for 2 hours. The solution 
was clear and a light yellowish-brown in color. One gm. of Norit 
A was added to deco10rize the solution, and it was filtered into 
a 250 m1. separatory funnel. Anhydrous ether was added until the 
solution became permanently turbid. Almost simultaneously with 
the development of turbidity, an orange-colored layer separated, 
the volume of which approximated the volume of methanol that had 
been added to the reaction mixture. The orange-colored layer was 
drawn off into a 150 m1. beaker. Additional ether was added to 
the separatory funnel in order to insure complete precipitation 
of the product. The material deposited after this addition was 
collected in a second beaker. About 1 m1. of the product con-
tained in the second beaker was dissolved in 1 - 2 m1s. distilled 
water and transferred to a glass crucible. The water was evapo-
rated almost to dryness, and the oily residue which remained was 
spread in a thin film on the sides of the crucible. The crucible 
was placed in a desiccator which was then evacuated. After four 
days, the crucible showed a small bit of whitish powder around 
its top edge. Scratching the oil film on the sides of the cruci-
ble and distributing the whitish powder in the process converted 
all the residue in the crucible to a solid product. During the 
intervening period, the product which had been left uncovered in 
I"""'" 
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the two beakers had acquired a little more of an orange color in 
addition to becoming more viscous. The solution had also ac-
quired a slight "acetic" odor. Seeding the two beakers with the 
solid material resulted in the formation of an orange-white pow-
der admixed with a persistent thickened liquid phase which did 
not solidify. The liquid phase was greater in the first beaker, 
the first portion of product collected. About one-half ml. of 
the liquid from the first beaker was transferred to a test tube, 
5 mls. acetone was added and the solution stirred with a glass 
rod. The liquids appeared miscible, but within half a minute a 
whitish powder formed, which settled from solution. Dissolution 
of the powder was not possible either by warming or by the addi-
tion of another 5 mls. of acetone. The powder was separated by 
filtration and reserved as a possible seed source, since the 
original small bit of whitish powder was almost all used to seed 
the product in the two beakers and that which remained, being 
somewhat hygroscopic, had become tacky. 
The ability of acetone to aid in the precipitation of the 
quaternary salt is analogous to the situation which was experi-
enced in the preparation of the n-propyl derivative. It will be 
remembered that in this case, n-amyl alcohol was effective in 
breaking the solvate complex (the methanol which had bonded with 
the product). In the case of the acetoxy derivative, acetone 
presumably has a greater affinity for the bound alcohol than the 
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quaternary derivative, and since this quaternary is also rela-
tively insoluble in acetone, the sal~ is freed from the adhering 
or complexed solvent. 
Recrystallization of the acetoxyethyl derivative from an 
absolute ethanol-anhydrous ether solvent mixture was successful. 
When the just turbid solution was seeded with some of the white 
"acetone" powder, crystallization was induced. The flask was 
swirled to facilitate and induce further crystallization, then 
set aside for completeness of precipitation. The product was 
collected on a Buchner funnel, rinsed with several portions of 
ether, dried and weighed. The yield of product after the purifi-
cation steps was 12.19 gms. (61%). Two additional recrystalli-
zations gave fine, white, needlelike crystals having a melting 
point of 135.0 - 137.00 • 
Anal. - for acetoxyethyl pilocarpinium bromide (C15H23N204Br): 
calcd.: C 48.01; H 6.18; N 7.46; Br 21.29; O(by difference)17.0 
Found: C 47.68; H 6.50; N 8.15; Br 21.64: O(by difference)16. 
14. Preparation of Benzyl Pilocarpinium Iodide 
a. Preparation of benzyl iodide (~-Iodotoluene): Ben-
zyl iodide was prepared from benzyl chloride by halogen exchange. 
This may be illustrated as follows: 
(acetone) 
Sodium iodide, 16.5 gms. (0.11 mole), a calculated 10 per 
cent excess, was dissolved in 90 mls. acetone. The solution was 
.", 
.... 
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added to 8.8 m1s. (12.66 gms.,O.l mole) benzyl chloride contained 
in a 125 m1. Erlenmeyer flask. Almost immediately, there was 
precipitation of a whitish powder (NaC1), and the acetone ac-
quired a brownish-iodine color. After standing overnight at room 
temperature, the solution was filtered through a Buchner funnel. 
A small portion (about 5 mls.) of the acetone filtrate (dark red-
dish-brown in color) was added to a 125 ml. separatory funnel. 
Ice cold distilled water was added to the filtrate. This step 
performed a dual purpose. It not only precipitated the benzyl 
iodide from the acetone, but it also removed residual amounts of 
sodium chloride or sodium iodide which might have contaminated 
the product. The aqueous phase was decanted from the benzyl 
iodide, and a second portion of ice water was added to the prod-
uct. The second portion of ice water converted the liquid alky-
lating agent to a pinkish-white, crystalline solid. The crystals 
were collected on a chilled Buchner funnel and rapidly pressed 
between several thicknesses of filter paper to remove adhering 
water. The crystals were transferred to a covered beaker and 
stored in a refrigerator. Subsequent portions of the acetone 
filtrate were treated in a like manner until it had all been 
processed. The crystals were stored in the refrigerator for the 
short interval before they were to be used, since they would 
otherwise liquify at room temperature (Lit. m.p. 240 (82». 
b. Preparation of benzyl pilocarpinium iodide: An 
I 
I 
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11. 48 gm. sample of pilocarpine hydrochloride, representing 9.77 
gms. (0.047 mole) pilocarpine base, was extracted in the manner 
previOusly described. Calculating on the basis of a 25 per cent 
excess, 12.79 gms. (0.059 mole) of the benzyl iodide prepared 
above was added to the flask. Within minutes after the addition 
of the alkylating agent, a spontaneous exothermic reaction was 
initiated. After approximately half an hour, the reactants pro-
duced an amber-colored solid. ~1.hen the material in the flask had 
cooled sufficiently, the reaction flask was stoppered and allowed 
to remain overnight at room temperature. After 16 hours, the 
solid in the flask was broken up with a glass rod and triturated 
with a 25 mI. portion of anhydrous ether to remove the excess 
benzyl iodide. The ether was decanted from the resulting yellow-
ish-white, granular material. The product was triturated with 
two additional 25 mI. portions of ether in order to remove as 
much of the discoloration as possible before recrystallization. 
The product was transferred to a Buchner funnel, rinsed with sev-
eral small portions of anhydrous ether and dried in a desiccator. 
The reaction yielded 18.66 gms. (93.3%) of a yellow, granular 
material. The product was warmed with 100 mls. absolute metha-
nol to effect solution and filtered into an Erlenmeyer flask. 
Anhydrous ether was added to the methanol solution in divided 
portions until the solution had developed a slight turbidity. 
After standing for a short time, the solution began to clear with 
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the formation of crystals on the sides and bottom of the flask. 
After several hours the supernatant had cleared completely. The 
Crystals were scraped from the sides of the container, and addi-
tional amounts of ether were added to insure complete precipita-
tion of the product. The following morning, pale yellowish-white 
crystals were separated from the solution by filtration. The 
product was recrystallized twice more in an identical manner from 
I 
a solvent system of absolute methanol-anhydrous ether. The final 
product collected (16.94 gms.) consisted of light, white, needle-
like crystals which had a melting point of 151.5 - 153.00 • 
Anal. - for benzyl pilocarpinium iodide (C18H23N202I): 
Calcd.: C 50.72: H 5.44: N 6.57: I 29.77: O{by difference) 7.51 
Found: C 50.83: H 5.69; N 6.82: I 29.51: O{by difference) 7.15 
Another synthesis of the benzyl quaternary was undertaken. 
In this instance, the alkylating agent employed was benzyl chlo-
ride. As previously mentioned, one of the considerations in the 
alkylation of pilocarpine was to use the more reactive alkyl or 
aryl iodides. This choice was based on the fact that the reac-
tivity of the halide was determined by the nature of the leaving 
group. It was indicated that other factors also were involved 
in nucleophilic substitutions, and one of these is the electronic 
configuration of the substrate. All benzyl halides are very re-
active alkylating agents. One explanation for this is that an 
aryl group attached to the carbon atom undergoing substitution by 
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a nucleophile markedly increases its activity (51). The central 
carbon atom of benzyl chloride has some of the character of a 
carbonium ion. This will favor the withdrawal of the unshared 
pair of electrons from the unsubstituted nitrogen atom of pilo-
carpine and facilitate the reaction. 
An excess of benzyl chloride, 8 mls. (11.5 gms., 0.09 mole), 
was reacted with approximately 12.4 gms. (0.06 mole) pilocarpine 
using 25 mls. nitrobenzene as a solvent. The pilocarpine was 
obtained by the extraction of the hydrochloride salt as previous-
ly described. The reactants were continuously stirred and heated 
under a reflux condenser at about 500 • Heating was discontinued 
after 4 hours, and the mixture was allowed to stand overnight at 
room temperature. After 16 hours, the reaction mixture was tra~ 
ferred to a 250 ml. separatory funnel and extracted with several 
portions of anhydrous ether. The spent ether, containing the ex-
cess alkylating agent and nitrobenzene, was discarded. Various 
attempts at crystallization were unsuccessful, the product being 
obtained as a clear, colorless, oily liquid. The product was 
dissolved in acetone, and a halogen exchange was accomplished by 
adding 8.05 gms. (0.05 mole) sodium iodide which had been dis-
solved in 50 mls. acetone. After an hour, the acetone solution, 
now light yellow in color, was filtered to remove the precipi-
tated sodium chloride. Anhydrous ether was added to the filtrate 
in divided portions until the appearance of a persistent turbidit¥. 
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Within a short period of time, a yellowish-white, granular prod-
uct was deposited in the flask. Recrystallization of the materi-
al from an absolute methanol-anhydrous ether solvent system 
yielded a fine, white, crystalline product which, after drying, 
o had a melting point of 151.0 - 153.0. There was no depression 
of the melting point when admixed with benzyl pilocarpinium io-
dide obtained by direct synthesis. 
Thus, benzyl pilocarpinium iodide could be synthesized 
either directly by the alkylation of pilocarpine with benzyl io-
dide or indirectly by halogen exchange between the quaternary 
chloride and an iodide. Both methods yielded a product with an 
identical melting point. After admixture of the two products, 
the melting point was not depressed. 
15. Preparation of Phenylethyl Pilocarpinium Iodide - An 
11.10 gm. sample of pilocarpine hydrochloride, representing 9.45 
gms. (0.04 mole) pilocarpine base, was extracted as previously 
described. A 20 per cent excess (12.65 gros.) of 2-Iodoethyl 
benzene (~-Phenylethyl iodide) was added to the oil remaining in 
the flask after evaporation of the chloroform. The flask was set 
under a reflux condenser, warmed slightly to initiate reaction 
and the mixture continuously stirred. After an hour, the process 
of heating and stirring was discontinued, the flask was removed 
from the condenser, stoppered and set aside over the week end. 
At some time within 64 hours, a pale yellowish-white, waxy solid 
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was formed. The product was broken up with a glass rod and 
transferred to a 250 mI. beaker. The product was triturated 
twice with 50 mI. portions of anhydrous ether to remove the ex-
cess phenyl ethyl iodide. The quaternary compound, collected on 
a filter and dried, weighed 19.0 gms. (95% yield). The product 
was transferred to a 400 mI. beaker. One hundred mls. of abso-
lute methyl alcohol was added, and the mixture was heated to 
boiling (650 ). Additional amounts of warmed methyl alcohol were 
added to just completely dissolve the product (final volume 190 
mls.). The solution was filtered rapidly (water aspirator) 
through a warmed filter. Upon cooling, the solution began to 
deposit whitish, needlelike crystals. The flask was transferred 
to a refrigerator to insure complete precipitation of the prod-
uct. The following morning the product was collected on a Buch-
ner funnel. The phenylethyl derivative, when recrystallized from 
absolute methanol, yielded white, fluffy, needlelike crystals 
having a melting point of 168.0 - 170.00 • 
Anal. - for phenyl ethyl pilocarpinium iodide (C19H25N202I): 
Calcd.: C 51.83; H 5.72; N 6.36; I 28.82; O(by difference) 7.27 
Found: C 51.93; H 5.71; N 6.80; I 28.96; O(by difference) 6.60 
16. preparation of Phenoxyethyl Pilocarpinium Bromide - An 
11.95 gm. sample of pilocarpine hydrochloride, representing 10.17 
gms. (0.05 mole) pilocarpine base, was extracted as previously 
described. An excess, 13.76 gms. (0.07 mole), of ~-Bromophenetole 
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(PhenOxyethy1 bromide) was dissolved in 30 m1s. absolute metha-
nol and added to the flask containing the pilocarpine. The flask 
was set under a reflux condenser, and the mixture was stirred and 
heated at 500 for 8 hours. Heating was discontinued, and the re-
action mixture allowed to stand overnight at room temperature. 
After about 12 hours, the contents of the flask were transferred 
to a 250 m1. separatory funnel. Anhydrous ether was added to the 
funnel in divided portions until the solution became permanently 
turbid. After standing a short while, the solution began to 
clear with the deposit of a grayish-yellow oil. The oil was de-
canted into a beaker, and additional ether was added to the sepa-
ratory funnel until the solution clouded up again. The funnel 
was then placed in a refrigerator. After several hours, the 
additional oil which had been deposited was decanted into the 
beaker containing the first portion of product that had been col-
lected. Anhydrous ether, then added in excess to the separatory 
funnel, produced only faint clouding which did not result in 
crystallization even after prolonged periods of storage in a re-
frigerator or at room temperature. 
Twenty five mls. acetone was added to the oily product. It 
dissolved, forming a clear solution slightly gray in color. One 
gm. Norit A was added to the acetone solution, and it was fil-
tered into a separatory funnel. Anhydrous ether was added as 
before until the appearance of a permanent turbidity. Almost 
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simultaneously, a heavier colorless liquid separated, which was 
collected in a beaker. The volume which was collected approxi-
mated that which was originally filtered into the separatory fun-
nel. The solution was allowed to evaporate spontaneously at room 
temperature, and a tacky, oily liquid was recovered. Dissolution 
was attempted by the addition of 25 mls. ethyl acetate to the 
product. As it was stirred, a whitish powder was formed. A por-
tion of the powder was collected for use as a seed source. An 
additional 100 mls. of ethyl acetate was added, and the suspen-
sion was warmed to promote solution. During warming, the mate-
rial became tacky but did not appear to dissolve, so small 
amounts of absolute ethanol were added to effect solution. After 
the addition of 15 mls. of alcohol, the material dissolved in the 
ethyl acetate. The solution was transferred to a separatory fun-
nel, and anhydrous ether was added almost to the point of a per-
manent turbidity. The solution was seeded with some of the pow-
der, and within a short period of time, minute crystals began to 
form on the sides of the vessel. The funnel was placed in a re-
frigerator to hasten and promote further crystallization. The 
following morning, some 16 hours later, 9.29 gms. of grayish-
white crystals were recovered from the solution. This amounted 
to a 46.45 per cent yield of product. The phenetole derivative, 
recrystallized twice more from an ethyl acetate, absolute ethanol 
-anhydrous ether solvent mixture was obtained as a white 
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Crystalline product with a melting point of 83.0 - 85.00 • 
Anal. - for phenoxyethyl pilocarpinium bromide (C19H25N203Br): 
Calcd .: C 55.75; H 6.16; N 6.84; Br 19.52; O(by difference)11~3 
Found: 
17. 
C 54.00; H 6.38; N 6.48; Br 19.11; O(by difference)14.03 
Preparation of.<3 - (hydroxymethyl) -ct-ethyl-l-methyl-3-
I 
(4-methoxybenzyl)-5-imidazole butyric acid lactone 
iodide (p-Methoxybenzyl Pilocarpinium Iodide) 
a. preparation of p-methoxybenzyl iodide: The iodide 
was prepared in two steps from anisyl alcohol (p-methoxybenzyl 
alcohol). First, the chloride was prepared from the alcohol by 
the method of Grice and OWen (93). The chloride was then con-
verted to the iodide by a slight variation in the method of 
Gardner and Noyes (85). 
The steps in the production of p-methoxybenzyl iodide are: 
(1) CH30·C6H4·CH20H + SOC1 2 pyridine. CH O·C H 'CH Cl + SO + HCl benzene 3 6 4 2 2 
(anisyl alcohol) (p-methoxybenzyl chloride) 
acetone. CH30· C6H4 • CH21 + NaCl 
(p-methoxybenzyl iodide) 
A solution of anisyl alcohol (13.82 gms., 0.1 mole) in 10'-
15 mls. benzene was transferred to a 200 mI., round-bottomed 
flask. Pyridine, 0.28 gm. (0.004 mole), was added to the solu-
tion, and the flask was set under a reflux condenser. An excess 
of thionyl chloride (20.83 gms., 0.18 mole) in 40 mls. benzene 
was added in divided portions through the top of the condenser 
as the reaction mixture was stirred and warmed. After the 
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addition of the thiony1 chloride, the condenser was rinsed down 
with 40 mls. benzene, and the mixture was boiled under the reflux 
condenser for 3 hours. The solution was then concentrated to 
about 30 mls., 60 mls. of anhydrous ether Was added and the solu-
tion was washed with several portions of distilled water. The 
benzene-ether solution was dried with anhydrous sodium sulfate. 
The solvent was evaporated and gave 10.29 gms. of p-methoxyben-
zyl chloride (65.71% yield). 
Allowing for a 20 per cent excess, 11.S2 gms. (O.OS mole) 
sodium iodide, Merck A.R., was dissolved in 65 mls. acetone and 
added to an acetone solution of the p-methoxybenzyl chloride. 
Several hours later the solution was filtered to remove the pre-
cipitated sodium chloride. The precipitate was extracted with a 
small portion of anhydrous ether which was then combined with the 
filtrate. The filtrate was concentrated to about one-half its 
volume. A small portion (about 5 mls.) of the concentrate was 
transferred to a separatory funnel and shaken with an ice cold 
solution of sodium bisulfite. This converted or liberated the 
iodide as a pale yellowish-white, waxy, crystalline solid which 
was then collected on a chilled Buchner funnel. The iodide was 
pressed between filter paper to remove adhering water and trans-
ferred to a beaker. Subsequent portions of the concentrated ace-
tone were treated in a like manner until it all had been pro-
cessed. The weight of p-methoxybenzyl iodide collected was 13.60 
gms . 
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(83.4% yield) which had a melting point of 28.0 - 30.00 
o (Lit. m.p. 32.5 - 32.8 (85». The product was used in the syn-
thesis of the quaternary derivative without recrystallization. 
b. Alkylation of pilocarpine with p-methoxybenzyl 
iodide: A 10.72 gm. sample of pilocarpine hydro-
chloride, representing 9.12 gms. (0.04 mole) pilocarpine base, 
was extracted in the manner previously described. A 10.52 gm. 
(0.04 mole) sample of the p-methoxybenzyl iodide obtained from 
the synthesis just discussed was added to the flask containing 
the pilocarpine. Almost immediately, the pilocarpine began to 
acquire a yellowish color, and the temperature of the reaction 
mixture rose from 28 to 550 without the application of heat from 
an external source. On cooling, the material in the flask became 
quite thickened and sticky, but could not be crystallized. The 
flask was stoppered and allowed to stand overnight at room tem-
perature. Sixteen hours later, the product was triturated with 
three successive 25 ml. portions of anhydrous ether. Crystalli-
zation could not be induced. The spent ether was discarded, and 
the product was dissolved in 100 mls. absolute' ethanol by gentle 
warming. The alcohol solution was transferred to a separatory 
funnel, and anhydrous ether was added in divided portions just 
until the development of a persistent cloudiness. The funnel was 
placed in a refrigerator. Soon afterwards a cloudy, amber-colo~ 
oil was deposited, which settled to the bottom of the vessel. 
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The oil was drawn off into a beaker. Additional ether was added 
to the point of clouding as before, and the funnel was returned 
to the refrigerator. After several hours, the uncovered beaker 
containing the collected oil showed some crystal formation on the 
bottom of the beaker. A few of these crystals were removed and 
added to the separatory funnel. The oil which had begun to be 
deposited in the funnel Was crystallized, and this initiated fur-
ther crystallization. Scratching the sides of the beaker con-
verted the rest of the product to a tacky, crystalline mass. The 
product from both the beaker and separatory funnel Was combined 
and recrystallized from absolute ethanol-anhydrous ether in the 
manner previously described. This recrystallization yielded 
16.08 gms. (80.4%) of a dark yellow, crystalline product. After 
five more recrystallizations, white, shiny plates were obtained, 
o 
which after drying melted at 101.0 - 102.5 . 
Anal. - for p-methoxybenzyl pi10carpinium iodide (C19H25N203I): 
Calcd.: C 50.01; H 5.52; N 6.14; I 27.81: o (by difference)10.52 
Found: C 49.84; H 5.42; N 6.13; I 27.77; o (by difference)10.84 
18. Preparation of Veratryl Pilocarpinium Iodide (3,4-
dimethoxybenzyl pilocarpinium iodide) - The veratryl 
quaternary derivative of pilocarpine was synthesized in a four 
step reaction. Veratra1dehyde was converted to veratryl alcohol 
in a manner similar to those employed in the industrial synthe-
sis of papaverine (184) and in the preparation of p-toly1 carhmo1 
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from p-toluic aldehyde (60). The alcohol Was converted to the 
chloride by the action of thionyl chloride (151). The aryl io-
dide was prepared by halogen exchange, and this product was used 
in the alkylation of pilocarpine. 
a. Conversion of veratraldehyde (3,4-dimethoxybenzal-
dehyde)to vertryl alcohol _t3i 4-dimethoxvbenzvl alco-
hoI) by a crossed Cannizzaro reaction: Twenty-five 
gms. (0.44 mole) potassium hydroxide was transferred to a 200 
mI., 3-necked, round-bottomed flask and dissolved in 40 - 45 mls. 
absolute methanol. After the alkali had dissolved, the flask was 
surrounded by a cold water bath. A mixture of 24.8 gms. (0.15 
mole) veratraldehyde, 15 mls. formaldehyde (36.3%, 0.18 mole) and 
15 mls. absolute methanol was added in divided portions to the 
potassium hydroxide solution at a rate such that the temperature 
of the contents did not go above 650 • The addition required 
about three to five minutes. The flask was connected to a con-
o denser and refluxed at a temperature of 65 - 70 for one and a 
half hours. The reflux condenser Was replaced by a straight 
downward condenser, and the methanol was removed by distillation. 
Heating was continued until the internal temperature reached 1010 • 
After slight cooling, the residue Was transferred to a separatory 
funnel, and 50 mls. cold distilled water was added to the brown-
ish liquid. The resulting layers were separated, and the aqueous 
layer was extracted with three, 10 mI. portions of benzene. The 
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benzene was combined in a second separatory funnel with the sep-
arated darker brown, oily layer, and the combined product and ex-
tracts were washed with three, 25 mI. portions of ice cold dis-
tilled water. The aqueous washes were discarded, and the benzene 
layer was cleared by the addition of a few grams of anhydrous 
sodium sulfate. The benzene solution was filtered into a beaker, 
and the solvent was evaporated by heating the beaker by means of 
a Glas-col mantle. Heating was continued until the temperature 
o had reached 125. A yellowish-brown liquid having only a faint 
trace of benzene odor remained. The product weighed 14.55 gms., 
which was a 58 per cent yield. 
b. Preparation of veratryl chloride from veratryl alco-
hoI: The 14.55 gms. (0.09 mole) veratryl alcohol ob-
tained in the preyious synthesis and 15.5 gms. (0.13 mole) 
N-dimethylaniline were dissolved in 19 mls. dry chloroform in a 
250 mI. beaker. The beaker was cooled in an ice bath. A solution 
of 15.5 gms. (9.5 mls., 0.13 mole) thionyl chloride, dissolved 
in 20 mls. dry chloroform and contained in a separatory funnel, 
was added dropwise to the beaker with continuous stirring during 
the course of 20 minutes. The mixture was stirred for an addi-
tional 15 minutes. The beaker was then removed from the ice bath 
and heated on a steam bath for 10 minutes. The solution was 
cooled to room temperature and then poured into a 400 mI. beaker 
containing 207 mls. of cold, 1 N hydrochloric acid. The aqueous 
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phase was transferred to a large separatory funnel and extracted 
with two, 20 mI. portions of chloroform. These chloroform ex-
tracts were combined with the precipitated chloroform retained 
from above, and the combined chloroform was washed successively 
with 1 N hydrochloric acid, 2 portions of distilled water, 2 por-
tions of 2 N sodium bicarbonate solution and finally 2 portions 
of distilled water. The washed chloroform Was cleared with 2 gms. 
anhydrous sodium sulfate and filtered into a 100 ml., round-bot-
tomed flask. The solution was concentrated by removing the chlo-
roform in vacuO. The flask containing the slightly thickened 
liquid product was stoppered and placed in the freezing compart-
ment of a refrigerator for about one-half hour. After the flask 
was removed, and as the contents warmed to room temperature, 
crystallization was initiated and the contents became solid. The 
solid was broken up with a glass rod and formed a yellowish-white 
powder, which after desiccation, weighed 13.08 gms. (81.3% yielq). 
The melting point of the crude material was 47.0 - 49.50 (Lit. 
o 
m.p. 50.0 - 50.5 (14». 
c. Conversion of veratryl chloride (3,4-dimethoxybenzyl 
chloride) to veratryl iodide (3,4-dimethoxybenzyl 
iodide): Sodium iodide, 11.56 gms. (0.08 mole)1 a 
calculated 10 per cent excess, was dissolved in 60 mls. acetone. 
This solution was added to an Erlenmeyer flask containing the 
13.08 gms. (0.07 mole) of veratryl chloride which had been 
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dissolved in 20 mls. acetone. Almost immediately, a turbidity 
began to develop with the subsequent precipitation of sodium 
chloride. After 2 hours, the mixture was filtered through a 
Buchner funnel. The filtrate had a dark-reddish iodine color. 
The precipitate was rinsed with a few small portions of anhydr~ 
ether, and the ether washings were combined with the acetone fil-
trate. The filtrate Was transferred to a 200 mI., round-bottomed 
flask and concentrated in vacuo to about half its volume. Small 
portions of the concentrated acetone solution were transferred 
to a separatory funnel and shaken with ice cold sodium bisulfite 
solution in a manner similar to that described for the recovery 
of p-methoxybenzyl iodide (dissertation, pagelll). In this in-
stance, veratryl iodide formed a slightly darker yellowish, waxy 
solid. The fractions of product treated in this manner were col-
lected on a chilled Buchner funnel, pressed between filter paper 
to remove adhering moisture and transferred to a tared beaker. 
The total weight of veratryl iodide collected was 13.52 gms., 
which represents a 69.4 per cent yield in the conversion. The 
melting point obtained on the crude material was 44 - 460 • 
d. Preparation of veratryl pilocarpinium iodide (3,4-
dimethoxybenzyl pilocarpinium iodide): A 7.32 gm. 
sample of pilocarpine hydrochloride, representing 6.23 gms. (0.03 
mole) pilocarpine base, was transferred to a separatory funnel. 
The salt was dissolved in 20 mls. distilled water, and the 
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solution Was rendered alkaline by the addition of 15 mls. ammo-
nia T.S. The alkaline solution Was extracted with successive 
portions of chloroform in the manner previously described. 
Ten grams (0.04 mole) of veratryl iodide was added to the 
pilocarpine remaining after the evaporation of the chloroform. 
The reaction was initiated almost immediately, with the material 
in the flask acquiring a dark iodine color and the temperature 
in the flask rising rapidly to about 60 - 650 • Upon cooling, the 
reaction mixture became quite thickened, and on mixing or stir-
ring with a spatula the mixture solidified. The solid was broken 
up and dissolution was attempted by the addition of 200 mls. ab-
solute ethanol. In spite of warming on a hot plate, it was neces-
sary to add 50 mls. absolute methanol to effect solution. The 
solution was transferred to a separatory funnel, and anhydrous 
ether was added in divided portions until the first appearance 
of a permanent turbidity. The solution continued to cloud up 
still further, and within a short period of time began to deposit 
an oily, reddish-brown liquid. This liquid was collected in a 
beaker, and additional ether was added to the clearing solution 
until it once again Was turbid. After the addition of a third 
portion of ether, minute crystals began to form on the sides of 
the vessel. When these were scraped from the sides, additional 
crystallization was induced. Some of the crystals were used to 
seed the beaker containing the first portions of product which 
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been collected. The following morning (some 16 hours later), 
material which had crystallized in the separatory funnel was 
collected. The product consisted of a mixture of dark yellowish 
crystals and some darker brown solid particles. When combined 
with the solid material which had formed in the beaker that had 
been seeded, 10.19 gms. of veratryl pilocarpinium iodide (a 70% 
yield) was obtained. Four recrystallizations from an absolute 
methanol plus anhydrous ether solvent, in the manner previously 
described, led to the production of a fine, whitish, microcrys-
talline powder which had a melting point of 163.5 - 165.00 • 
Anal. - for veratryl pilocarpinium iodide (3,4-dimethoxybenzyl 
pilocarpinium iodide) (C20H27N204I): 
Calcd.: C 49.39; H 5.60; N 5.76; I 26.09; O(by difference)13.l6 
Found: C 49.34; H 5.47; N 5.62; I 26.36; O(by difference)13.2l 
19. Preparation of Methyl Isopilocarpinium Iodide (Iso-
pilocarpine Methiodide) 
a. Conversion of pilocarpine hydrochloride to isopilo-
carpine hydrochloride: Several methods have alre~ 
been discussed for the conversion of pilocarpine into isopilocar-
pine. In this work, isopilocarpine hydrochloride was obtained 
using the method first described by Petit and Polonovsky (193) 
and later confirmed by Jowett (135). In this procedure, pilocar-
pine hydrochloride was converted into isopilocarpine hydrochlo-
ride by heating the salt at 2000 • 
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TWenty grams of pilocarpine hydrochloride was transferred 
to a 100 ml. beaker and then placed uncovered into a dry heat 
oven which had been previously heated to 2000 • After three hour.s, 
the beaker containing the melted material Was removed from the 
oven and allowed to cool. When cool, it formed a transparent, 
blackish-brown glass. The contents of the beaker were dissolved 
in 60 mls. absolute ethanol by warming on a hot plate. The re-
sulting light yellowish-brown solution was decolorized as much 
as possible by the addition of 2 gms. Norit A and filtered into 
an Erlenmeyer flask. The beaker and filter were rinsed with sev-
eral additional milliliters of hot alcohol. These washings were 
added to the filtrate. Anhydrous ether was added to the alcohol 
solution in divided portions until the development of a persis-
tent turbidity. The flask was stoppered and placed in the fre~ 
compartment of a refrigerator. After about 18 hours, clumps or 
tufts of crystals had formed in the solution. In addition, the 
flask also contained an oily material which could not be induced 
to crystallize. The crystalline material Was collected on a 
Buchner funnel. The crystals collected on the filter were washed 
with small portions of anhydrous ether in an attempt to free them 
from the adhering oily residue. When the ether washings came in 
contact with the filtrate the solution clouded up again, but when 
the solution cleared it had only deposited additional amounts of 
a brownish oil. The crystals were redissolved in 50 mls. absolllte 
--
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ethyl alcohol. One gram of Norit A was added to the alcohol, 
and the solution was filtered into an Erlenmeyer flask. Ether 
was added in divided portions almost to the point of a persis-
tent turbidity. The flask was seeded with some of the crystals 
which had been reserved for this purpose, and the flask was then 
placed in a refrigerator. After a time, crystals had been de-
posited in the flask. These were loosened from the bottom and 
sides of the flask with a polyethylene rod. Another portion of 
ether was added to the clearing supernatant, and the flask was 
returned to the refrigerator overnight. The following morning, 
the crystals were separated from the solution by vacuum filtra-
tion, and the filtrate was discarded. The product still showed 
some discoloration and was recrystallized once more from abso-
lute ethanol-anhydrous ether as previously described. Following 
this recrystallization, 1.86 gms. (an 18.6 per cent yield) of 
white, fluffy, needlelike crystals were collected. The product 
was placed in a desiccator overnight. A melting point determi-
nation showed some initial liquification at 1480 with most of 
the material on the cover slip melting in the range of 159.0 -
o 160.0 . 
The melting point of pure, air-dried, isopilocarpine hydro-
chloride as reported by Jowett (125) was 1270 • He also reported 
that isopilocarpine hydrochloride contains a half-mole of water 
of crystallization, and when dried to constant weight at 1100 , 
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the melting point of the anhydrous salt rises to 1590 • 
The isopilocarpine hydrochloride that was obtained was 
placed in an oven at 1100 and dried for four hours. The melting 
range of the dried salt was 159.0 - 161.00 , with no preliminary 
1iquification phase as was seen in the sample before it was dried 
at 1100 • 
An amount of isopilocarpine hydrochloride sufficient to de-
termine its acute toxicity, as well as to prepare the quaternary 
methiodide, was needed. Therefore, additional batches were 
worked up to provide an ample supply of isopilocarpine hydro-
chloride. In two subsequent experiments, the yields obtained 
were 21.9 and 30.0 per cent of theory. The melting points of 
the purified salt dried at 1100 were 160.0 - 161.00 and 160.0-
162.00 respectively. 
b. Preparation of methyl isopilocarpinium iodide (iso-
pilocarpine methiodide): A 4.0 gm. sample of iso-
pilocarpine hydrochloride, representing 3.40 gms. (0.016 mole) 
isopilocarpine base, was transferred to a 125 ml. separatory 
funnel and dissolved in 20 mls. distilled water. The solution 
was made alkaline (pH @ 8.0, pHydrion test paper) by the ad-
dition of 15 mls. dilute ammonia T.S. and extracted with six 
portions of reagent grade chloroform, i.e. 20, 15, 15, 10, 10 
and 10 ml. portions respectively. The chloroform extracts were 
treated in a manner similar to that which was employed for ob-
taining pilocarpine base. 
... 
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An excess (10 mls.) of methyl iodide was added to the 
mobile oil which remained after evaporation of the chloroform. 
The contents of the flask almost immediately and spontaneously 
began to warm upon the addition of the alkylating agent. The 
flask was cooled under cold water, stoppered and set aside over-
night at room temperature. After about 18 hours, the flask was 
connected through a trap to a vacuum line and the excess alky-
lating agent was removed under reduced pressure. After one-half 
hour, a yellowish-white crystalline mass remained in the flask. 
The material was dissolved in 25 mls. absolute ethanol by slight 
warming and decolorized as much as possible by the addition of 
1 gm. Norit A. The solution was filtered into an Erlenmeyer 
flask. The reaction flask and filter were washed with addition-
al portions of warm ethanol totaling about 25 mls. Anhydrous 
ether was added to the alcohol solution in divided portions un-
til the appearance of a persistent turbidity. This was followed 
shortly thereafter by the formation of some small crystals. The 
flask was placed in a refrigerator to hasten and enhance complete 
precipitation. After 4 hours, the crystals were collected by 
vacuum filtration on a Buchner funnel. Recrystallization of the 
methiodide from absolute ethanol-ether yielded 4.31 gms. (75.4%) 
of tufts of white, needlelike crystals which had a melting point 
of 112.0 - 114.00 (Lit. m.p. 1140 (125,192» • 
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Anal. - for methyl isopilocarpinium iodide (C12H19N202I): 
Calcd .: C 41.16; H 5.47; N 8.00; I 36.23; O(by difference) 9.14 
Found: C 41.10; H 5.36; N 7.91; I 36.46; ° (by difference) 9.17 
20. Formation of the Picrates of Pilocarpine and Isopilo-
carpine, and the Picrates of the Quaternary Salts 
-
pilocarpine and isopilocarpine can be identified in the form of 
their picrate salts. Therefore, the picrates of the synthesized 
pilocarpinium compounds were prepared for the purpose of serving 
as an additional means of identification for these compounds. 
one of three general methods which were employed resulted in the 
production of a solid picrate. Descriptions of the general 
methods are given below. 
A stock solution of trinitrophenol (picric acid) was pre-
pared by warming a test tube containing absolute alcohol and an 
excess of crystalline picric acid under a hot water tap. Before 
it was used, the solution was allowed to cool to room tempera-
ture. This produces a saturated solution of picric acid in ab-
solute alcohol (approx. 8.3% w/v). 
Method a: A sufficient amount of the compound Was dis-
solved in about 5 mls. absolute ethanol in a test tube. Approx-
imately 2 - 3 mls. of the alcoholic picric acid solution was 
added, and the test tube was shaken and/or scratched with a 
glass rod. If this did not induce crystallization, the test 
tube was cooled for a short time in a refrigerator. Cooling or 
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agitation of the cooled solution usually resulted in crystalli-
zation. Once the picrate salt had crystallized, the product 
was collected on a Buchner funnel. 
Method b: This method was employed only in the event 
that crystallization by Method a was unsuccessful. Distilled 
water was added dropwise to the test tube that had been cooled 
in Method a (but which showed no evidence of crystallization) 
until the solution became slightly turbid. The picrate either 
crystallized from solution after agitating and scratching the 
sides of the tube or after the turbid solution was chilled again 
in a refrigerator. The solid picrate was separated from the 
solution by collecting it on a Buchner funnel. 
Method c: The procedure followed in Method c was the 
same as that described for Method b, except that the quaternary 
derivative had initially been dissolved in absolute methanol 
rather than absolute ethanol because of its greater solubility 
in this alcohol. The precipitated picrate was collected on a 
Buchner funnel. 
All picrates, regardless of the method used to form them, 
were recrystallized from absolute ethyl alcohol and dried in a 
desiccator before the determination of their melting points. l 
lAll melting points were obtained on a Fisher-Johns hot 
stage melting point apparatus. 
A description of the method of synthesis, appearance, 
color and melting point of the individual picrates follows. 
This information is also summarized in Table III. 
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a. Pilocarpine picrate: The salt was obtained by 
Method a. The picrate crystallized after scratching the sides 
of the test tube. After recrystallization from hot ethanol, 
coarse, lemon yellow, needlelike crystals were obtained which 
had a melting point of 162.0 - 163.50 (Lit. m.p. 159 - 1600 , 
163 - 1640 (40,192,229». 
b. Isopilocarpine picrate: The picrate was formed from 
the hydrochloride salt by Method a. Recrystallization from 
ethanol gave fine, shiny, lemon yellow needles which melted at 
163.5 - 164.00 (Lit. m.p. 160 - 161.50 (125,192». 
c. Methyl pilocarpinium picrate (pilocarpine metho-
picrate): The picrate readily formed by Method a from the 
quaternary iodide salt. Recrystallization yielded fine, shiny, 
orange needles which had a melting point of 145.0 - 146.50 (Lit. 
m.p. 142 - 1430 (229». 
d. Methyl isopilocarpinium picrate (isopilocarpine 
methopicrate): The picrate salt readily crystallized from solu-
tion using Method a. After recrystallization, shiny, orange-
yellow plates were obtained which had a melting point of 121.0 -
122.00 (Lit. m.p. 119 - 1200 , 1360 (128,133,229». 
e. Ethyl pilocarpinium picrate: The picrate salt was 
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obtained as a crystalline solid by Method a, only after agita-
tion of a cooled solution. Recrystallization from absolute 
ethanol gave fine, golden yellow needles which melted at 155.5 -
156.50 (Lit. m.p. 153.0 - 154.50 (264». 
f. n-Propyl pilocarpinium picrate: This was produced 
by Method a from the quaternary iodide salt. Orange needles 
were obtained after recrystallization which had a melting point 
o 
range of 131.5 - 133 . 
g. Isopropyl pilocarpinium picrate: This picrate salt 
was also formed by Method a. After recrystallization, a fine, 
golden yellow crystalline powder was obtained, which melted at 
o 139.0 - 140.0 . 
h. Allyl pilocarpinium picrate: This last of the three-
carbon quaternary derivatives was readily obtained by Method a. 
Recrystallization from absolute alcohol yielded fine, lemon yel-
o low needles, which after drying melted at 129.0 - 130.0 . 
i. n-Butyl pilocarpinium picrate: The butyl picrate 
was obtained by Method a after cooling and scratching the sides 
of the test tube with a glass rod. After recrystallization, 
light orange needles were obtained which had a melting point of 
126.0 - 127.00 (Lit. m.p. 123 - 1250 (264». 
j. sec-Butyl pilocarpinium picrate: The sec-butyl pic-
rate derivative was obtained by Method b. Recrystallization 
from absolute ethanol yielded fine, golden yellow, needlelike 
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crystals. The melting point of the picrate was 140.0 - 143.00 • 
k. Isobutyl pilocarpinium picrate: The picrate Was 
obtained by Method b after cooling and scratching the sides of 
the test tube containing the solution. The product was re-
covered as a fine, yellowish, powdery precipitate. During re-
crystallization of the picrate, the product was deposited as an 
oil which solidified upon standing, forming a dark yellow, fine, 
crystalline powder. The melting point of the picrate was 117.0 
o 
- 117.5 . 
1. "tert-Butyl pilocarpinium picrate": Following the 
synthesis which was described for tert-butyl pilocarpinium io-
dide, it was suggested that the product of the reaction, based 
on the microanalytical results, Was not a quaternary derivative 
of pilocarpine but pilocarpine hydroiodide. The presumed qua-
ternary compound produced a picrate readily by Method a. When 
recrystallized from absolute ethanol, lemon yellow needles were 
o 
obtained which had a melting point of 162.5 - 163.5. The simi-
larity in melting points and physical appearances between pilo-
carpine picrate and the "tert-butyl picrate" would suggest tJ;1at 
they were one and the same. 
m. n-Amyl pilocarpinium picrate: The picrate salt Was 
obtained by Method c from n-amyl pilocarpinium iodide. Recrys-
tallization of the picrate compound from absolute alcohol gave 
orange-yellow, needlelike crystals which had a melting point of 
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95. 5 _ 96.5°. n-Amy1 pilocarpinium picrate Was the only form of 
the n-amy1 quaternary derivative of pilocarpine which was ob-
tained as a solid product. The quaternary iodide salt, it will 
be remembered, was obtained as a viscid, semisolid oil. 
n. Isoamyl pi10carpinium picrate: The picrate was 
formed from the iodide by Method b. The salt was obtained by 
agitation of the solution after it had been cooled for awhile in 
a refrigerator. Recrystallization yielded coarse, orange-yellow 
needles which melted at 78.0 - 79.0° (Lit. m.p. 75.5 - 77.00 
(264) ) • 
0. Acetoxyethyl pilocarpinium picrate: The picrate 
salt readily crystallized from solution using Method a. Recrys-
tallization from absolute alcohol gave fine, golden yellow nee-
dles, which after drying melted at 114.5 - 115.5°. 
p. Benzyl pi10carpinium picrate: This picrate salt Was 
also formed by Method a from benzyl pilocarpinium iodide. Shiny, 
orange needles were collected after recrystallization, which had 
a melting point of 127.5 - 128.5°. 
q. Pheny1ethyl pi10carpinium picrate: The picrate was 
formed from the iodide salt by Method c. The picrate salt crys-
tallized after the solution was agitated and the sides of the 
test tube were scratched with a glass rod. Recrystallization 
yielded shiny, lemon yellow needles which melted at 105.5 -
106.5°. 
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r. Phenoxyethyl pilocarpinium picrate: The picrate was 
formed from phenoxyethyl pilocarpinium bromide by Method a. The 
salt, recrystallized from absolute ethanol, yielded a shiny, 
yelloW, crystalline powder which had a melting point of 121.0 -
122.00 • 
s. p-Methoxybenzyl pilocarpinium picrate: The picrate 
was produced from the iodide salt by Method b. The initial por-
tions of the product were deposited as a dark yellowish oil. 
Almost half of the volume of the clearing supernatant was trans-
ferred to a second test tube, and distilled water was added un-
til the solution was turbid. After standing overnight, the pic-
rate was deposited as a crystalline solid. When some of the 
crystalline product was transferred to the first test tube, the 
product which had been deposited as an oil was immediately crys-
tallized. The picrate from both test tubes was collected and 
recrystallized from absolute alcohol. A very fine, canary yel-
low, crystalline powder Was obtained which had a melting point 
o 
of 104.0 - 106.0 . 
t. Veratryl pilocarpinium picrate: Using the procedure 
outlined in Method c, the picrate was deposited as a fine crys-
talline powder after stand~ng overnight at room temperature. 
Recrystallization from absolute ethanol gave a very fine, canary 
yellow, crystalline powder. The melting point of the dried pic-
rate was 111.0 - 112.5°. 
• 
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c. Infrared Analysis 
Infrared analyses were performed on the halide salts, the 
hydrochloride salts of pilocarpine and isopilocarpine, and on 
pilocarpine alkaloid. The solids were run either as dispersions 
in potassium bromide (pressed disc technique) or in refined min-
eraloil (Nujol). Pilocarpine alkaloid and n-amyl pilocarpin-
ium iodide, both oily liquids, were dissolved in a spectrograph-
ic grade of chloroform, and spectra were determined on these 
solutions using a matched pair of liquid cells. The spectra 
(A-T) were obtained on a Beckman model IR 4 double beam spec-
trophotometer at a scanning speed of one micron per minute • 
CHAPTER III 
RESULTS - CHEMISTRY 
guaternary Pilocarpine and Isopilocarpine Derivatives 
Alkylation of pilocarpine and isopilocarpine was attempted 
with some seventeen different alkyl, aryl and aralkyl halides. 
Table I depicts the various members of this series which were 
synthesized. The halides were chosen so that a fairly represen-
tative series of alkyl and aromatic quaternary ammonium deriva-
tives would be obtained. Yields from the alkylation reactions 
varied from 46.4 to 95.0 per cent. In general, yields lower than 
70 per cent probably reflect losses in purification. All com-
pounds were analyzed for carbon, hydrogen, nitrogen and halogen,l 
and the results of the analyses are reported in Table II. Melt-
ing points of the compounds (Table I) were determined on a 
Fisher-Johns hot stage melting point apparatus. Melting points 
on the straight-chain alkyl derivatives were found to decrease 
as you advance in the homologous series. The n-amyl pilocarpin-
iurn derivative, for example, was a viscid, semisolid oil which 
could not be crystallized. It was shown in earlier work (264) 
that the n-hexyl and n-octyl derivatives were oils. 
The branched-chain alkyl members respond in much the same 
way as their straight-chain analogues in their melting point 
lMicro-Tech Laboratories, Skokie, Illinois 
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TABLE I 
Melting Points and Yields of the Quaternary Pilocarpine Salts 
--
compound 
Methyl pilo-
carpinium Iodide 
Methyl Isopilo-
carpinium Iodide 
Ethyl pilo-
carpinium Iodide 
n-Propyl Pilo-
carpinium Iodide 
Isopropyl Pi1o-
carpinium Iodide 
Allyl Pilo-
carpinium Iodide 
n-Buty1 Pilo-
carpinium Iodide 
sec-Butyl Pilo-
carpinium Iodide 
Isobutyl Pilo-
carpinium Iodide 
n-Amyl Pilo-
carpinium Iodide 
Isoamyl Pilo-
carpinium Iodide 
Acetoxyethyl Pilo-
carpinium Bromide 
Benzyl Pi1o-
carpinium Iodide 
o M. P. C.. Found 
124.5-126.0 
112.0-114.0 
114.5-116.0 
92.5-94.0 
158.0-159.5 
109.0-110.0 
108.0-109.5 
120.0-122.5 
83.0-87.0 
oil 
105.0-107.0 
135.0-137.0 
151.5-153.0 
Yield 
(%) 
87.0 
75.4 
85.0 
92.5 
92.0 
94.0 
85.5 
90.9 
76.9 
61.0 
93.3 
o M.P. C., Reported 
in Literature 
122.5-125 
(265) 
114 
(125, 192) 
114 
(125) 
106-108 
(264) 
102.5-104 
(264) 
TABLE I (Continued) 
-
compound o M. P • C.,Found 
Pheny1ethy1 Pi1o- 168.0-170.0 
carpinium Iodide 
Phenoxyethy1 Pi1o- 83.0-85.0 
carpinium Bromide 
p_Methoxybenzy1 101.0-102.5 
pi10carpinium Iodide 
Veratry1 Pi1o- 163.5-165.0 
carpinium Iodide 
Yield 
('%) 
95.0 
46.4 
80.4 
70.0 
134 
o M.P. C., Reported 
in Literature 
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TABLE II 
Microanalysis of the Quaternary Pilocarpine Salts 
Microanalysis 
Carbon Hydrogen Nitrogen Halogen 
compound % % % % 
Methyl pi1o- Found: 41.50 5.06 8.29 36.55 
carpinium Iodide Calc. : 41.16 5.47 8.00 36.23 
Methyl Isopi1o- Found: 41.10 5.36 7.91 36.46 
carpinium Iodide Calc. : 41.16 5.47 8.00 36.23 
Ethyl pi1o- Found: 42.76 5.80 7.69 34.76 
carpinium Iodide Calc. : 42.87 5.81 7.69 34.84 
n-Propy1 Pi1o- Found: 44.19 6.02 7.32 33.48 
carpinium Iodide Calc. : 44.46 6.13 7.41 33.55 
Isopropyl Pi1o- Found: 44.04 6.21 7.75 33.59 
carpinium Iodide Calc. : 44.46 6.13 7.41 33.55 
Allyl pi1o- Found: 44.58 5.68 7.50 33.63 
carpinium Iodide Calc. : 44.69 5.63 7.44 33.73 
n-Buty1 Pi1o- Found: 45.82 6.00 7.25 32.57 
carpinium Iodide Calc. : 45.93 6.42 7.14 32.35 
sec-Butyl Pi1o- Found: 46.41 6.35 7.39 32.60 
carpinium Iodide Calc. : 45.93 6.42 7.14 32.35 
Isobutyl Pi1o- Found: 
carpinium Iodide Calc. : 45.93 6.42 7.14 32.35 
n-Amy1 Pi1o- Found: 46.16 6.81 6.83 30.51 
carpinium Iodide Calc. : 47.30 6.70 6.89 31.23 
Isoamyl Pi1o- Found: 47.44 6.85 6.96 31.62 
carpinium Iodide Calc. : 47.30 6.70 6.89 31.23 
Acetoxyethy1 Pi1o- Found: 47.68 6.50 8.15 21.64 
carpinium Bromide Calc. : 48.01 6.18 7.46 21.29 
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TABLE II (Continued) 
-
Microanalysis 
Carbon Hydrogen Nitrogen Halogen 
compound % % % % 
Benzyl Pi1o- Found: 50.83 5.69 6.82 29.51 
carpinium Iodide Calc. : 50.72 5.44 6.57 29.77 
Phenyl ethyl Pi1o- Found: 51.93 5.71 6.80 28.96 
carpinium Iodide Ca1cd: 51.83 5.72 6.36 28.82 
Phenoxy ethyl Pi1o- Found: 54.00 6.38 6.48 19.11 
carpinium Bromide Calc. : 55.75 6.16 6.84 19.52 
p-Methoxybenzy1 Found: 49.84 5.42 6.13 27.77 
pilocarpiniurn Calc. : 50.01 5.52 6.14 27.81 
Iodide 
Veratry1 Pi1o- Found: '49.34 5 .. 47 5~62 26.36 
carpinium Iodide Ca1cda 49.39 5.60 5.76 26.09 
behavior, i.e., with increasing molecular weight there is a 
decrease in the melting point of the compound. 
B. picrate Derivatives of Pilocarpine, Isopilocarpine and 
Their Quaternary Salts 
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The picrate derivatives which were prepared are listed in 
Table III, along with their methods of preparation, their physi-
cal appearances and melting points. Melting points of the pic-
rate derivatives were determined on a Fisher-Johns hot stage 
melting point apparatus. The melting points of pilocarpine pic-
rate (162.0-163.50 ) and its stereoisomer, isopilocarpine picrate 
(163.5-164.00 ), were too close to one another to provide a re-
liable basis for distinguishing between them. On the other hand, 
the picrates of the quaternary methiodides of these isomers were 
sufficiently far apart in their melting behavior and could be 
used as a means of distinguishing one isomer from another. With 
the exception of the ethopicrate, as you advanced in the homolo-
gous series of normal alkane derivatives, there was a decrease 
in their melting points. Methyl pilocarpinium picrate had a 
melting point of 145.0-146.50 , whereas n-arnyl pilocarpinium pic-
rate melted at 95.5-96.50 • A point of special interest in the 
series is that involving the n-amyl derivative. N-arnyl pilocar-
piniurn picrate was the only solid form of that quaternary pilo-
carpine compound which was obtained; amyl pilocarpinium iodide 
Was not crystallizable. 
Compound 
Pilocarpine 
Picrate 
Isopi1ocarpine 
Picrate 
Methyl Pi1o-
carpinium 
Picrate 
Methyl Isopi1o-
carpinium 
Picrate 
Ethyl Pi1o-
carpinium 
Picrate 
n-Propy1 Pi1o-
carpinium 
Picrate 
TABLE III 
Melting Points and Crystalline Appearance of Picrates 
Appearance and 
Method ' Recrystallization 
of Synthesis M.P. °c., Found Solvent 
a 162.0-163.5 Coarse lemon 
yellow needles 
(EtOH) 
a 163.5-164.0 Shiny lemon 
yellow needles 
(EtOH) 
a 145.0-146.5 Shiny orange 
needles 
(EtOH) 
a 121.0-122.0 Shiny orange-
yellow plates 
(EtOH) 
a 155.5-156.5 Fine golden 
yellow needles 
(EtOH) 
a 131.5-133.0 Orange needles 
(EtOH) 
M.P.oC.,Reported 
in Literature 
159-160,163-164 
(40,192,229) 
160-161.5 
(125,192) 
142-143 
(229) 
119-120,136 
(128,133,229) 
153.0-154.5 
(264) 
I-' 
W 
00 
r 
Compound 
!sopropy1 Pi1o-
carpinium 
Picrate 
Allyl Pi1o-
carpinium 
Picrate 
n-Buty1 pi1o-
carpinium 
Picrate 
sec-Butyl pi1o-
carpinium 
Picrate 
Isobutyl Pi1o-
carpinium 
Picrate 
n-Arny1 Pi1o-
carpinium 
Picrate 
TABLE III (continued) 
Method 
Appearance and 
Recrystallization 
of Synthesis M.P. °C., Found Solvent 
a 139.0-140.0 Golden yellow 
crystalline 
powder (EtOH) 
a 129.0-130.0 Fine lemon 
yellow needles 
(EtOH) 
a 126.0-127.0 Light orange 
needles 
(EtOH) 
b 140.0-143.0 Fine golden 
yellow needles 
(EtOH) 
b 117.0-117.5 Dark ye11ow,fine 
crystalline 
powder (EtOH) 
c 95.5-96.5 orange-yellow 
needles 
(EtOH) 
M.P. °C.,Reported 
in Literature 
123-125 
(264) 
I-' 
W 
1.0 
r 
Compound 
Isoamyl pilo-
carpinium 
Picrate 
Acetoxyethyl 
Pilocarpinium 
Picrate 
Benzyl Pilo-
carpinium Picrate 
Phenylethyl 
Pilocarpinium 
Picrate 
Phenoxy ethyl 
Pilocarpinium 
Picrate 
p-Methoxybenzyl 
Pilocarpinium 
Picrate 
Veratryl Pilo-
carpinium 
Picrate , 
TABLE III (continued) 
Method 
of Synthesis M.P. °C., Found 
b 78.0-79.0 
a 114.5-115.5 
a 127.5-128.5 
c 105.5-106.5 
a 121.0-122.0 
b 104.0-106.0 
c 111.0-112.5 
Appearance and 
Recrystallization 
Solvent 
Coarse orange-
yellow needles 
(EtOH) 
Fine golden 
yellow needles 
(EtOH) 
Shiny orange 
needles 
(EtOH) 
Shiny lemon 
yellow needles 
(EtOH) 
Shiny yellow 
crystalline 
powder (EtOH) 
Fine canary 
yellow crystal-
line powder 
(EtOH) 
Fine canary 
yellow crystal-
line powder 
(EtOH) 
";:";'~"""7f,~ 
M.P. °C.,Reported 
in Literature 
75.5-77.0 
(264) 
I-' 
~ 
o 
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Taken separately, there Was too much of an overlap or simi-
larity in the color and appearance of the picrates for these 
criteria ruone to be of any value in the identification of the 
various derivatives. However, when coupled with a melting point 
determination, it could contribute to the identification of a 
quaternary pilocarpine derivative. 
C. Infrared Spectra 
The infrared spectra obtained on pilocarpine base, the hydr 
chloride salts of pilocarpine and isopilocarpine and the quater-
nary alkyl and aryl derivatives of these alkaloids (spectra A-S) 
were analyzed in several regions for the presence or absence of 
characteristic peaks of absorption. The data which were obtained 
and the correlations that may be made are presented in summary 
fashion. Absorption bands in the shorter wavelength, from 2-10 
microns (5000-1000 cm-l ), are said to result from the stretching 
and bending vibrations of individual bonds and are considered to 
be characteristic of the diatomic structural units of functional 
groups. Bands at the longer wavelengths, from 7-16 microns 
(1430-625 em- l ), are considered to result from vibrations of 
polyatomic units and vibrations of the molecule as a whole. This 
latter area has also been referred to as the "fingerprint" re-
gion (50,172). 
There were some shifts in the absorption bands from spec-
trum to spectrum, and this is reported as a range. The 
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pilocarpine molecule, as well as the quaternized derivatives, 
possess many functional groups which manifest absorptions in the 
same or in overlapping regions. This introduces some difficul-
ties in correlation studies, and where no definite region may be 
assigned, the several possibilities for this are given. The 
wavelength values in parentheses following our results are the 
assignments made to the groups which are reported in the 1itera-
ture. 
summary of spectra: 
1. A five-membered ring lactone was present in all spectra 
(A-S), based on the absorbing peaks of its constituents 
which are: 
(a) c=o (stretching 
band (1780-1760 
-1 
vibration), a strong 1780-1650em 
cm- 1 ) (27). Th . t f e range 1n mos 0 
the compounds was from 1780-1740 cm-1 ; the presence 
of the second C=O group in the acetoxy derivative 
(spectrum K) resulted in the formation of a very 
much wider band in this region. 
(b) c-o-c (stretching mode), two absorbing areas due to: 
i. asymmetric stretching, a medium 1280-1220 em-1 
band (1275-1185 cm -1) (50). 
ii. symmetric stretching, strong 1220-1130 em-1 band 
(1200-1150 em -1) (27). 
The strong band at 1220-1130 em-1 cannot be 
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unequivocally assigned to the symmetric c-o 
vibration, because this overlaps with the strong 
band reported by Garfinkel et a1 (86) at 
-1 1185 cm , which reportedly is due to imidazo1ium 
ion. In most spectra, the band was split or had 
a shoulder which may be indicative of overlapping 
group absorption. Pilocarpine base (spectrum R), 
for example, showed a single, unsplit band which 
was presumably due to c-o vibration, since the 
ionic imidazo1ium species ~as absent. 
2. An unsaturated heterocycle (imidazole nucleus) was pres-
ent. Many characteristic bands which can be assigned to 
the imidazole nucleus were present. Unfortunately, the 
regions of absorption overlap to some extent. It would 
probably be better to consider the group of absorptions 
as a whole rather than in relation to a particular struc-
tura1 unit, but a few correlations will be attempted in 
order that some of the structural elements which contri-
bute to the spectra may be presented. 
C=N absorptions of conjugated cyclic systems cannot be 
considered in isolation as they interact with other double 
bonds. In this case, the conjugation is with C=C links 
and the frequencies of the two are relatively close to 
one another. The band normally assigned to C=N absorp~s 
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in cyclic systems is reported within the range 
1660-1480 em-I. The c=c absorption in conjugated systems 
-1 is near 1600 em • In imidazole, the C=C absorptions due 
to skeletal in-plane vibrations are reported to appear at 
1550, 1492 and 1451 em-I (86,139). 
Various alkaloids containing pyridine or quinoline 
rings absorb between 1600 cm-l and 1560 em-I Pyrimidine 
shows two bands, at 1570 cm- l and at 1610 em-lor 
1650 em-I, which are thought to arise from interaction 
effects of the ring double bonds (27). 
In pilocarpine as well as in the series of pilocarpinfum 
derivatives, two bands were found-in the 1600-1500 em-l 
region. These bands can probably be assigned as follows: 
(a) C=C (skeletal, in-plane vibrations) strong, 
1565-1500 em- l • 
(b) C=N (skeletal, stretching vibrations) medium to 
strong, 1605-1595 em-l • 
The two bands were conspicuously absent in the spectrum 
(spectrum T) for Nujol, a saturated hydrocarbon. The C=C 
band was more intense in the benzyl and phenylethyl deriv-
atives (spectra Land M), because of the additional con-
tributions to the C=C stretch from the aromatic ring. 
The intensities of the C=C and C=N bands were about equal 
(and diminished) in the aromatic ether compounds, 
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phenoxyethyl, p-methoxybenzyl and veratryl) (3,4-
dimethoxy-) pilocarpinium halides (spectra N,O,P). The 
reasons for the decreased intensity can probably be cor-
related with the electronic nature of these substituents. 
3. Vibrations due to in-plane C-H bending and ring breathing 
modes: 
Another characteristic strong band found in the range 
1020-980 cm- l in heterocyclic compounds (and perhaps some 
mono- or unsubstituted aromatics) may be correlated to 
either C-H in-plane deformation or ring vibration. This 
peak was absent in the Nujol spectrum. 
4. C-H stretching vibrations: 
All spectra showed an absorption band of variable in-
tensity in the range 3150-2850 cm- l • This is due to 
carbon-hydrogen stretching vibrations. In some of the 
spectra several distinct peaks were discernible, but it 
would be necessary to use higher resolution in order to 
unequivocally correlate the absorptions. Absorptions in 
this region are due to asymmetric and symmetric methyl 
and methylene stretching vibrations of alkanes. These 
vibrations are assigned wavenumbers in the range 
2962-2853 cm-l • The C-H stretching vibrations of alkenes 
also appear in this region, but at slightly higher fre-
quencies (higher wavenumbers} than the saturated methylene 
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groups. Asymmetric and symmetric olefinic methylene 
(=CH2 ) stretching vibrations are reported at wavenumbers 
of 3090-3070 and 2985-2965 cm- l respectively. To further 
complicate correlations in this region, aromatic carbon-
hydrogen stretching vibrations (=C-H) appear in the 
3100-3000 em- l region (50). All three groups are present 
in some of the derivatives. 
A carbon-hydrogen stretching vibration (=C-H) has been 
reported for imidazole at 3125 cm- l (86). The wavenumber 
of this vibration is further to the left (at a higher 
frequency) than any of the other C-H stretching vibra-
tions discussed and could therefore be a good peak for 
identification and correlation. In almost all of the 
spectra (A-S), a fairly sharp peak appeared in the range 
3125-3040 cm- l • An assignment to imidazole C-H stretch-
ing can probably be made for this peak. 
5. Methyl and methylene group deformations (bending vibra-
tions) in alkanes and methyl-nitrogen (CH3-N) deforma-
tions: 
There are several frequencies in the infrared which re-
portedly are due to the bending (deformation) of the 
hydrogen atoms about methylene and methyl groups. The 
asymmetric CH3 deformation vibrations absorb at 
-1 -1470-1430 em ,whereas the symmetric methyl mode is 
responsible for the band near 1385-1370 em-I 
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The methy-
lene scissoring deformation is reported to occur about 
-1 1468 cm , and overlaps with the asymmetric methyl bend-
ing vibration. The methylene "wagging" deformation is a 
relatively weak absorption peak found at 1306-1303 cm-l 
(50). All spectra showed peaks of varying intensity in 
the region 1500-1300 cm-l • These peaks can be correlated 
with methyl and methylene group deformations. 
In pilocarpine and the pilocarpinium compounds, a methyl 
group is attached to nitrogen. This would be a good peak 
to correlate; however, it is reported that the absorptions 
due to this group usually are not strong. In simple mol-
ecules, the CH3-N absorption occurs in the 1460-1430 em-I 
region. In more complex molecules, this band is known to 
shift closer to 1430 em-I (27). It has just been pointed 
out that the main carbon-hydrogen deformations of CH2 
-1 
and CH3 (asymmetric) also occur near the 1460 em region. 
Therefore, even if the absorption of CH3-N vibrations 
were strong enough, they would probably not be distin-
guishable enough from these other modes to afford any 
useful correlation. 
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CHAPTER IV 
DISCUSSION - CHEMISTRY 
A. Quaternary Pilocarpine and Isopilocarpine Derivatives 
1. Synthetic Method - The various quaternary derivatives 
were prepared by reacting a calculated excess of the appropriate 
alkyl, aryl or aralkyl halide with the alkaloidal base either 
in the presence or absence of an inert solvent. 
Isopilocarpine hydrochloride was prepared from pilocarpine 
hydrochloride according to the method reported by Jowett (135) 
which consisted of heating pilocarpine hydrochloride at 2000 in 
an oven for at least three hours. Yields of isopilocarpine 
hydrochloride by , this method generally were poor, amounting to 
21.9 to 30.0 per cent of theory. 
The alkaloidal bases, pilocarpine and isopilocarpine, were 
obtained by extracting ammoniacal solutions of their hydrochlo-
ride salts with several successive portions of chloroform. The 
bases were recovered from the chloroform by evaporation. To 
hasten evaporation, the solvent was warmed by means of a heating 
mantle, but at no time was the temperature allowed to exceed 750 • 
The products were recovered from the reaction by a variety 
of methods. 
2. Reactivity of Alkylating Agents - In order to take 
168 
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advantage of their greater reactivity, alkyl and aryl iodides 
were used in the quaternization reaction whenever possible. The 
addition of allyl, benzyl, p-methoxybenzyl and veratryl iodides 
to the alkaloidal bases resulted in an almost immediate exother-
mic reaction. The heightened reactivity of the allyl and aryl 
halides was not totally unexpected, since it has been reported 
that the central carbon atom in these compounds, i.e., that car-
bon atom which is undergoing' nucleophilic attack, has some of 
the character of a carbonium ion (51). This electronic configu-
ration would favor the withdrawal of the unshared pair of elec-
trons from the unsubstituted nitrogen atom of pilocarpine and 
would enhance the reaction. There is still another possible cor-
relation which appears to reflect the completeness with which 
these reactive halides form the quaternary salts. Allyl, benzyl 
arid veratryl pilocarpinium iodides crystallized in the reaction 
vessel as the product mass cooled down. On cooling, the anisyl 
mixture became quite tenacious, but did not crystallize. The 
product did, however, crystallize spontaneously following the 
first purification. 
When pilocarpine and its stereoisomer, isopilocarpine, were 
reacted with methyl iodide, the reaction was also spontaneously 
initiated and exothermic. In the preparation of the methiodides, 
it was interesting to observe the course of the reaction and to 
attempt to correlate the formation of the quaternary ammonium 
~ .. ----------------------------
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derivatives with the stability of the parent alkaloids. Although 
there is some discrepancy in the literature, more citations than 
not regard isopilocarpine as the trans isomer and pilocarpine as 
the cis isomer. Trans isomers in general are said to possess a 
geometry which creates a greater inherent stability. This is 
perhaps reflected in the alkaloids, pilocarpine and isopilocar-
pine~ Pilocarpine can be converted to isopilocarpine by a vari-
ety of methods (l35,l92,l93), but isopilocarpine has not been 
converted into pilocarpine. In the formation of the quaternary 
methiodides, it appeared that methyl iodide was equally effective 
in reacting with pilocarpine or isopilocarpine, as evidenced by 
the onset of the reaction and the heat generated in the reaction. 
Methyl isopilocarpiniurn iodide solidified in the reaction flask 
when the excess alkylating agent was removed with the vacuum 
created by a water aspirator. Methyl pilocarpinium io~ could 
be induced to crystallize only after the flask was seeded with 
a few crystals of the iodide. The acquisition of these seed 
crystals was shown to be contingent upon persistent attempts at 
purification. 
Benzyl pilocarpinium iodide was synthesized either directly 
by the alkylation of pilocarpine with benzyl iodide or indirectly 
by halogen exchange between benzyl pilocarpinium chloride and 
sodium iodide. Both methods yielded a product with an identical 
melting point that was not depressed in a mixed melting point 
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determination. The syntheses of the two aromatic halides raises 
several questions about reactivity and solubility which have not 
been resolved. Benzyl chloride and benzyl iodide are both aryl 
halides, and on the basis of their electronic configuration and 
the likelihood of carbonium ion formation, they could be expected 
to be equally reactive in the alkylation of pilocarpine. Based 
on the argument that iodides are better leaving groups than chlo-
rides, benzyl iodide should be more reactive than benzyl chlo-
ride. A few minutes after the addition of benzyl iodide to pilo-
carpine alkaloid, a spontan~ous reaction was initiated, and with-
in half an hour a solid product filled the reaction flask. This 
product readily crystallized in subsequent purifications. The 
addition of benzyl chloride to the alkaloidal base did not result 
in an immediate exothermic reaction. Before waiting too long, 
25 mls. nitrobenzene was added to the flask, and the mixture was 
heated under a reflux condenser at 500 for four hours. After 
standing overnight, the quaternary chloride was recovered as a 
clear, colorless oil which could not be crystallized. After con-
version to the iodide, the salt readily crystallized. 
With increasing molecular weight of the alkylating agent, 
the reaction tended to become more sluggish. T·o initiate and 
to increase the rate of reaction with these members, after the 
alkylating agent had been added to the flask, the reactants were 
heated under a reflux condenser. With the exception of the syn-
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theses involving the a1ky1ating agents, 2-Bromoethy1 acetate and 
~-Bromopheneto1e, all other reactions were carried out in the 
absence of an inert solvent. 
Isopropyl pilocarpinium iodide crystallized in the flask 
after heating the reaction mixture for an hour. The temperature 
had just reached 500 at the time. In the preparation of the 
phenyl ethyl derivative, the reactants were heated to initiate 
the reaction, but heating was discontinued after an hour. The 
flask was stoppered and allowed to stand over the week end. At 
some time within this period, a pale yellowish-white, waxy solid 
was formed. 
Temperatures in excess of 800 , or heating the reaction mix-
tures for prolonged periods of time, were avoided in order to 
decrease the likelihood of decomposing the quaternary products. 
With the exception of those reactions which were conducted in 
the presence of a solvent, the remaining quaternary derivatives 
were recovered as thickened oils or gels. 
3. Crystallization - Based on the number of derivatives 
which had crystallized, there was every reason to believe that 
the gel-like compounds could also be induced to crystallize if 
some of the impurities could be removed. In general, the prod-
ucts were dissolved in either methyl or ethyl alcohol, and the 
solutions were filtered into a separatory funnel. Quaternary 
ammonium salts, being very polar compounds are relatively 
p 
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insoluble in ether. Anhydrous ether was added to their alcohol 
solutions until each solution was just permanently turbid. The 
solution was then allowed to sit undisturbed for awhile or trans-
ferred to a refrigerator to cool. In the first precipitations, 
the product was usually thrown out of solution as an oil. In a 
few instances it was found that if the oil was decanted and addi-
tional ether was added to the solution to just the point of in-
cipient clouding, there was a chance of forming crystals. Forma-
tion of crystals by this technique is illustrated in the syn-
theses reported for the n-butyl derivative and the sec-butyl 
derivative. Another variation which was employed was to dissolve 
a small portion of the precipitated oil in 1-2 mls. distilled 
water. The water was evaporated, and the residue was spread in 
a thin film on the sides of the vessel. The small beaker or 
crucible was then placed in a vacuum desiccator for a day or so • 
. The material would then completely crystallize or could-some-
times be induced to crystallize by scratching the tacky residue 
with a glass rod. Formation of seed crystals by this method is 
illustrated in the write-up of the ethyl and n-propyl deriva-
tives. Once seed crystals had been obtained, subsequent re-
crystallizations could many times be accomplished without the 
formation of an intervening oil phase. 
Trituration of the crude product with portions of anhydrous 
ether, while effective in the removal of the excess alkylating 
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agent, usually did not result in crystallization. However, once 
seed crystals were available, they could be added to the ether-
washed "crude" product and usually induce crystallization (see 
second syntheses, sec-butyl, page 92, n-propyl, page 82). 
Recrystallization of the phenoxyethyl derivative was accom-
plished from a solvent of ethyl acetate-absolute ethanol, fol-
lowed by the addition of anhydrous ether. 
4. Solvate Formation - Hydrogen-Bonding - Complicating 
factors in the crystallization and purification of the quaternary 
pilocarpinium compounds were the tendencies for hydrogen-bonding 
to occur or for solvate complexes to form between the compounds 
and the alcohols used to purify them. This is perhaps best 
illustrated in the attempted syntheses of the isobutyl deriva-
tive. The appearance of white needlelike crystals in some of 
the recrystallization solvent mixtures encouraged one to contin-
ually try to synthesize this compound. The only product ever re-
covered from water or from a varied mixture of different solvents 
was a tacky, yellowish-white solid which had a wide melting range 
o 
of 83.0 - 87.0 • 
A more concrete example of hydrogen-bonding or solvate com-
plex formation is illustrated in the behavior of the n-propyl 
derivative. Seed crystals were recovered when a few milliliters 
of an aqueous solution obtained from the crude product was evap-
orated. Some of these crystals added to the oil collected from 
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a solvent of absolute ethanol-anhydrous ether induced crystalli-
zation in the oil. In a second purification, the product was 
dissolved in absolute methanol rather than ethanol. 'After ether 
was added to this solution, the product was precipitated as an 
oil which could not be crystallized in spite of repeated seeding 
with crystal nuclei. After a few days, the oily product had 
formed only a few crystals and had a strong methanol odor. The 
addition of n-amyl alcohol to this product resulted in the imme-
diate deposition of fine, yellowish-white crystals. It would 
appear that amyl alcohol extracted the methanol which had been 
bound to the product, and since the quaternary salt was probably 
only slightly soluble in amyl alcohol, it crystallized from solu-
tion. Amyl alcohol was not a good recrystallization solvent h6w-
ever, because the product recovered from it retained some yellow-
ish color. Recrystallization was accomplished from an absolute 
ethanol-anhydrous ether solvent system. There was a tendency for 
some of the product to be precipitated as an oil along with the 
well-formed crystals in this solvent system, but the oil was 
readily converted into a crystalline solid on standing. Evidence 
for hydrogen-bonding or solvate complexes was also seen with the 
acetoxyethyl and phenoxyethyl derivatives. The carbonyl group 
in the lactone portion of pilocarpine or the oxygen groups in 
these other derivatives may very well serve as bonding sites with 
lower alcohols. 
B. Picrate Derivatives of Pilocarpine. Isopilocarpine and 
Their Quaternary Salts 
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The formation of picrate salts of the alkaloids has long 
been used as a means of identifying these substances. The pic-
rates provide not only insoluble forms which have definite melt-
ing points, but many times their crystalline appearances and 
habits have been characteristic enough to aid in the identifica-
tion of the alkaloids. For the most part, the picrates of the 
quaternary pilocarpine and isopilocarpine salts were readily ob-
tained after the addition of picric acid to alcohol solutions 
of the salts. 
Several preparative methods (a,b,c-dissertation pages 124-5) 
have been described. The utilization of anyone of these meth-
ods depended upon the ease of crystallization of the picrat~ sal 
Any difficulty in recovering the picrates from alcohol probably 
could be attributed to the increasing solubility of the picrates 
with an increase in the length of their hydrocarbon chain. In 
method a for example, agitation or cooling the solution of pic-
ric acid and quaternary salt resulted in crystallization of the 
picrate derivative. In method b, agitation or cooling had little 
or no effect on the formation of the picrate, but when distilled 
water was added in a dropwise fashion to incipient clouding, 
crystallization was initiated. It will be noted that method b 
was employed in the higher homologues of the series. These 
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quaternary derivatives were not as water soluble as the lower 
members. In other words, the derivatives were initially more 
lipophilic in character, and it could reasonably be expected that 
this quality would be carried over into their picrate salts. 
Method c differed from method b only in the alcohol used to dis-
solve the quaternary salt. Not only were phenylethyl and vera-
tryl pilocarpinium iodides relatively insoluble in water, but 
they were also poorly soluble in ethanol. These quaternary com-
pounds were soluble in methanol, and the picrates could be re-
covered only after the addition of water to their methanol solu-
tions. 
c. Infrared Spectra 
The infrared spectra (A-T) were analyzed in an attempt to 
gain some insight into the structural features of the quaternary 
pilocarpine compounds. Recent works (86,139) on the-infrared 
spectra of heteroatomic molecules have provided additional in-
sight into the structural characteristics of these complex sub-
stances and have been of some value in interpreting the spectra 
of the synthesized quaternary salts. As would be expected, there 
are many points of similarity in the absorption spectra of pilo-
carpine, its hydrochloride salt, and the quaternary pilocarpin-
ium derivatives. By virtue of the many points of similarity, 
as well as the overlapping areas of absorption of the many dif-
ferent structural elements, any changes in the infrared spectra 
..... ------------------........ 
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due to quaternization may be expected to be minimal. The strong 
-1 line in the Raman spectrum at 1185 cm reported by Garfinkel 
and Edsall to represent the imidazolium ring structure is present 
in the spectra of all of the pilocarpinium salts as a band or as 
-1 part of a split band in the 1200-1150 em range. However, an 
unequivocal assignment to imidazolium ion cannot be made for 
this band in the pilocarpinium salts, because of the absorption 
peak due to both asymmetric and symmetric c-o-c vibrations of 
the butyric acid lactone group of the pilocarpine molecule. Be-
cause of this overlap in absorption peaks, it is difficult to 
see any major differences in the spectra due to the effect of 
quaternization. . Indeed, the spectra of all compounds at best 
allows one to point out the absorptions due to a five-membered 
lactone ring, the elements that may be found in the imidazole 
ring and some of the structural elements that have been added to 
the molecule by the alkylating agent. In a more positive sense, 
one can also say that after the reactions had been completed 
there was no apparent loss or degradation of structural compon-
ents in the pilocarpine part of the molecule. The absorbing 
peaks which were present before quaternization are present in 
the spectra after the reaction. 
..... ----------------.......... 
CHAPTER V 
PHARMACOLOGICAL SCREENING TESTS ON THE QUATERNARY 
PILOCARPINE AND ISOPILOCARPINE DERIVATIVES 
A. Materials and Methods 
1. Inclined Screen Test and Acute Toxicity - In the initial 
screening of all the quaternary pilocarpine compounds, a combined 
test employing the inclined screen and a toxicity evaluation was 
instituted. The inclined screen test was first used by Thompson 
(235) as a method for determining the presence or absence of ad-
verse insulin symptoms in mice. The test has since been adapted, 
with some slight modification, for the quantitative evaluation 
of curariform activity in mice and rats by quite a few investi-
gators (117,203,227,226). 
White mice (SWiss-Webster) of both sexes, weighing between 
16 to 28 gms., were used in the inclined screen and acute toxic-
ity tests. At least five dose levels were administered to groups 
of mice, each group consisting of at least ten mice. The quater-
nary compounds, dissolved in 0.9 per cent saline or as fine sus-
pensions in either saline or distilled water containing traga-
canth as a suspending agent, were injected intraperitoneally in 
a volume of 0.1 mlllO gms. of body weight. The acute toxicity 
of pilocarpine hydrochloride was also determined. A fine mesh 
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wire screen inclined at an angle of 60 from the horizontal 
plane was employed. The screen was divided into six rectangular 
compartments measuring about 9 x 41 em. After injection, a 
mouse was placed in one of the compartments. The test was con-
ducted for a period of fifteen minutes. During this observation 
period, if a mouse was a reactor, it was unable to cling onto 
and slid off of the screen. This animal was immediately trans-
ferred to a well perforated plastic box. If a mouse was still 
on the screen at the end of the fifteen minutes, it was removed 
and also placed in another plastic box. All the mice in the 
plastic boxes were observed for an additional two hours as part 
of the acute toxicity determination. 
In the inclined screen test, th~ percentage of mice which 
were the reactors was determined at each dose level. This value 
was transformed into a probit, and the median effective dose 
(ED50) was determined by calculating the "least squares" regres-
sion line. The standard error (S.E.), slope (b) and 95% confi-
dence limits were also determined. The linearity of the regres-
sion was tested by an analysis of variance of the data. 
In the determination of the acute LD50, the proportion of 
mice which died at each level was transformed into probits. The 
median lethal dose (LD50) was determined by calculating the 
"least squares" regression line. The standard error, slope and 
95% confidence limits of the LD50 were also determined. As in 
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the case of the inclined screen data, the linearity of the re-
gression for the toxicity determinations was tested by an analy-
sis of variance. 
The ratios of the LD50's to the ED50's were calculated in 
order to have some indication as to the margin of safety of the 
quaternary pilocarpine compounds. 
2. Ophthalmologic Investigation - Ophthalmic effects of 
some of the alkyl quaternary derivatives of pilocarpine and iso-
pilocarpine were determined in adult albino rabbits of both 
sexes. The rabbits were placed into wooden stalls which firmly 
held the rabbits, but allowed complete freedom of the head and 
neck. Miosis or mydriasis could be measured by comparing the 
size of the pupil with a series of holes drilled in a plastic 
disk. The diameters of these holes ranged from 2.5 to 9.0 rom in 
0.5 rom graduations. A series of control readings were obtained 
on both eyes of each rabbit before the instillation of any drug 
solution. Drug solutions were instilled into the left (experi-
mental) eye of a rabbit. The right eye, untreated, served as a 
control. The solution to be tested was applied to the eye by 
pinching the lower eyelid together and pulling it away from the 
eye, forming a reservoir into which the solution could be intro-
duced. In this way, 0.15 mI. of solution was introduced from a 
tuberculin syringe into the lower conjunctival sac. The lower 
lid was then gently pulled up over the cornea and held in this 
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fashion for about half a minute. Measurements were repeatedly 
made on both eyes under constant conditions of illumination dur-
ing the course of a 2.5 to 3 hour observation period, so that 
effects noted in the experimental eye (left) were in contrast 
to the control eye (right). 
In addition to the pupillary measurements, the presence or 
absence of the corneal reflex was determined at intervals by 
lightly touching the surface of the eye with a bent, blunt-ended 
glass rod. 
A 1.6 per cent solution of pilocarpine hydrochloride in 0.9 
per cent sterile saline solution was used as a standard. One 
and six-tenths per cent solutions of the following quaternary 
derivatives in the same vehicle were included in the test: 
methyl iso- and methyl pilocarpinium iodides, ethyl, n-butyl 
and isoamyl pilocarpinium iodides. 
3. Rat Isolated Phrenic Nerve - Diaphragm - The phrenic 
nerve-diaphragm preparation was dissected as described by 
Bulbring (37) and suspended in a 50 mI. organ bath. The prepara-
tion was bathed with Krebs-Henseleit solution (149) of the fol-
lowing composition (in gms/L): NaCl 6.60: KCl 0.35: caC12 0.28: 
NaHC03 2.1: Dextrose (d-glucose) 2.08: KH2P04 0.162: 
MgS04 ·7H200.294. The solution bathing the muscle strip was 
maintained at 370 and was vigorously aerated with a mixture con-
taining 95 per cent oxygen and 5 per cent carbon dioxide. The 
fan-shaped muscle strip was stimulated indirectly through the 
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phrenic nerve by single shocks delivered by a Model S 4 Grass 
stimulator at twice maximal voltage at a frequency of one every 
10 seconds with a duration of 2 milliseconds. Contractions were 
recorded by a light spring loaded lever with a Model ST-2 Phipps 
and Bird linear motion transducer coupled to a Texas Instrument 
single channel Oscillo-riter. 
Drugs were made up in 0.9 per cent saline and were added 
directly to the bath. The drugs used were d-tubocurarine chlo-
ride, edrophonium chloride, and benzyl pilocarpinium iodide. 
Doses are expressed as micrograms per milliliter of bath fluid. 
The percentage " block or inhibition of neuromuscular transmission 
was expressed as the percentage by which the control twitch re-
sponse was reduced by the drug. 
4. Neuromuscular Paralysis in Chicks - Four to five day 
old chicks, obtained from the Animal Behavior Laboratory of the 
University of Chicago, were used to determine the mode of action 
of the neuromuscular block observed with the quaternary pilocar-
pine salts. The compounds, dissolved in saline, were injected 
into the external jugular vein. The birds were observed until 
they died or recovered from the injection. Decamethonium iodide 
in a dose of 0.05 mg/kg, a depolarizing blocker, and tubocura-
rine chloride in a dose of 0.5 mg/kg, a competitive neuromuscu-
lar blocking agent (41), were included in the test for purposes 
of comparison. 
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The alkyl quaternary derivatives used in this screening 
test were methyl, n-propyl, n-butyl, and n-amyl pilocarpinium 
iodides. The aromatic quaternary members in the series were 
benzyl, phenylethyl and p-methoxybenzyl pilocarpinium iodides. 
5. Isolated Guinea Pig Ileum - Young adult guinea pigs, 
usually males, weighing between 200 to 300 grams, were obtained 
from a local animal dealer (Sharp Animal Suppliers, Glen Ellyn, 
Illinois). Animals were sacrificed by a sharp blow on the head 
and exsanguinated. The ileum was excised and placed in a beaker 
of aerated Tyrode's solution having the following composition 
(gms/L): NaCl 8.0; KCl 0.2; CaC12 0.2; MgC12 0.1; NaHC03 1.0; 
NaH2P04 0.05; dextrose (d-glucose) 1.0. 
Pieces of ileum, 2.0 to 2.5 cm. in length, were cut from 
the terminal (about 5 cm. above the ileo-caecal junction) and 
middle section of the ileum. The ileal segments, freed from ad-
hering mesentery, were mounted in a 25 ml. overflow organ bath 
(Metro Glass Company) containing Tyrode's solution maintained at 
370 • Laboratory air was continuously bubbled through the bath 
to oxygenate the tissue and to assure adequate mixing when drugs 
were added to the bath. Longitudinal, isotonic contractions of 
the tissue were recorded with a Phipps-Bird displacement trans-
ducer (Model ST-l) coupled with an Exciter-Demodulator unit. 
The output of the Exciter-Demodulator was fed into a d.c. driver 
amplifier unit of a Grass Model 5 Polygraph. The sensitivity of 
pz 
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the Exciter-Demodulator unit was adjusted so that a 4 to 6X 
magnification of the response was obtained. 
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The antispasmodic activity of the quaternary pilocarpine 
compounds was determined in a manner similar to that described 
by Jaques and Doepfner (123). The technique involves the assess-
ment of antispasmodic activity by the preventive method. The 
spasmogenic substance is added to the bath fluid in the presence 
of the antagonist (antispasmodic). When screening the quater-
nary derivatives for their antagonistic ability, reproducible 
, 
contractions to acetylcholine, histamine and barium chloride 
were first elicited at decidedly r~gular time intervals. One 
minute prior to eliciting the next contraction, the particular 
quaternary derivative under test was introduced into the bath. 
Both antagonist and agonist were washed out 15 seconds after the 
addition of the agonist. 
All of the quaternary derivatives were dissolved in either 
saline or distilled water. Dissolution of the relatively insolu-
ble phenyl ethyl , p-methoxybenzyl and veratryl pilocarpinium 
salts was accomplished when dimethylsulfoxide (DMSO) in a con-
centration of 0.1 to 0.2 per cent was included in the vehicle. 
The quaternary compounds were added to the bath in a series of 
doses such that with the addition of each successive dose, an 
ascending geometric progression of doses was followed. The ser-
ies of doses varied with the particular quaternary derivative 
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being tested and with the three spasmogens employed. 
Acetylcholine and histamine were administered on a two min-
ute dose cycle, whereas barium chloride was administered on a 
three minute cycle. For example, once the responses to acetyl-
choline had become constant, a dose of acetylcholine which caused 
a sUbmaximal contraction was chosen. This dose was utilized for 
the duration of the test. This dose of acetylcholine was added 
to the bath and allowed to remain in contact with the tissue for 
fifteen seconds before it was washed out of the bath. After one 
minute and forty-five seconds, the tissue received another chal-
lenge with acetylcholine which was then washed out fifteen sec-
onds later. A series of five to seven responses to acetylchol-
ine were obtained as a control before the addition of the test 
substance, a quaternary member of the series. The test sub-
stance, as previously mentioned, was added to the bath one min-
ute before the spasmogen was to be added, in order that the dose 
sequence which had been established would be maintained. The 
next dose of quaternary compound was added when the tissue had 
fairly well recovered its original sensitivity to the spasmogen 
and a series of control contractions had been obtained. The time 
which elapses until the piece of ileum recovers its sensitivity 
toward the agonist allows a further evaluation of the tenacity 
or interaction of the quaternary compound with tissue receptors. 
The dose of histamine which caused a submaximal contraction 
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was chosen in a manner similar to that which was employed for 
acetylcholine. When histamine was introduced into the bath, a 
fifteen second contact time with the tissue was allowed before 
the spasmogen was washed out of the bath. The time interval be-
tween washes and the introduction of the next constant dose of 
histamine was the same as that for acetylcholine, i.e., one min-
ute and forty-five seconds. 
More constant, reproducible tissue responses to barium chlo-
ride were obtained when the dose cycle was extended to three min-
utes. The dose of barium chloride which elicited a submaximal 
contraction of the ileal strip was washed out after a fifteen 
second contact time. The tissue and bath were washed several 
more times with Tyrode's solution before the introduction of the 
next dose of barium chloride two minutes and forty-five seconds 
later. A series of five to seven responses to barium chloride 
were obtained as a control before the addition of any dose of a 
quaternary derivative. This dose of the quaternary, as previous-
ly mentioned, was added to the bath one minute prior to the time 
when the next dose of barium chloride was to be added. Barium 
chloride was introduced into the bath in the presence of the 
quaternary compound, and both substances were washed out of the 
bath after fifteen seconds. 
An approximate quantitative evaluation of the antispasmodic 
activity of the quaternary pilocarpine compounds was obtained by 
p 
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adapting the method reported by Miller, Becker and Tainter (175). 
From three to seven dose levels of the quaternary pilocarpine 
derivatives were employed to antagonize the contractions of the 
ileum to selected fixed doses of either acetylcholine, histamine 
or barium chloride. The height of the contraction (in rom.) pro-
duced by the spasmogen in the presence and in the absence of the 
various doses of the quaternary pilocarpine derivative was mea-
sured from the polygraph record. The responses were expressed 
as the per cent reduction in height from the mean predrug control 
height. Transformation of per cent responses to probits, and 
concentration values to pD values (log of the reciprocal of the 
concentration), resulted in apparently a straight line relation-
ship when the data were plotted; however, the significance of 
the linearity was not tested. In order to determine the median 
antispasmodic concentration (the pD value of the ED50) and the 
slope of the line (b) with perhaps a little more precision, the 
"least squares" regression line (20) was calculated. The stan-
dard error (S.E.) of the ED50 was determined. 
6. Cardiovascular Responses in Normotensive Dogs - In this 
series of experiments, four mongrel dogs (8 - 12 kg.) unselected 
as to sex, were anesthetized with pentobarbital sodium (30 mg/kg) 
administered by intraperitoneal injection. Blood pressure was 
recorded from a cannulated femoral artery via a statham pressure 
transducer coupled to a Grass Model 5 polygraph. An indwelling 
p 
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polyethylene cannula was tied into the contralateral femoral 
vein for the administration of the test substances. Both left 
and right common carotid arteries were isolated in the neck, and 
loose ligatures were placed around them. Bilateral carotid oc-
clusion was performed by clamping the vessels for a period of 
20 seconds. Respiration was recorded by means of an iron-con-
stantan thermocouple, which was inserted into a glass tracheal 
cannula. Heart rate was determined from the blood pressure 
tracing. The pharmacodynamic activity of isoamyl pilocarpinium 
iodide was evaluated on the basis of its effects on the above 
mentioned parameters, as well as on the responses to the stan-
dard reference compounds employed in the following experiments. 
Initial responses were obtained to intravenous injections 
of histamine phosphate (5 and 10 mcg/kg) an~also to the isoamyl 
derivative in doses of 10 mg/kg. Following the intravenous ad-
ministration of diphenhydramine hydrochloride (3 mg/kg), re-
sponses to histamine phosphate and isoamyl pilocarpinium iodide 
were obtained again. The effects of histamine and the quater-
nary derivative on systolic and diastolic blood pressures, as 
well as on heart rate, were expressed as the per cent change 
from predrug control levels. Changes in these responses before 
and after the administration of the antihistaminic agent were 
studied. 
In two experiments, responses to acetylcholine chloride 
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(5 mcg/kg), pilocarpine hydrochloride (0.05 mg/kg) and isoamyl 
pilocarpinium (10 mg/kg) were recorded. Atropine sulfate 
(5 mg/kg, I.M.) was administered, and at intervals following a 
20 minute waiting period, challenges with these three agents were 
repeated. Changes in the cardiovascular. responses of the ani-
mals in the 'presence and absence of atropine were evaluated. 
In another phase of the experiments in this series, initial 
responses to the intravenous injection of epinephrine (2 mcg/kg), 
norepinephrine (2 mcg/kg), and 20-second bilateral carotid oc-
clusion were obtained. Isoamyl pilocarpinium iodide was adminis-
tered intravenously in doses of 10 mg/kg. Doses of the quater-
nary compound were repeated several times in an experiment at 
a time ~nterval which varied from one-half to one hour in several 
experiments. In the intervals between doses of the isoamyl de-
rivative, challenges with epinephrine, norepinephrine and bi-
lateral carotid occlusion were made. The effect of the quater-
nary pilocarpine compound on the responses to these three chal-
lenges was determined. 
CHAPTER VI 
RESULTS - PHARMACOLOGICAL SCREENING 
A. Inclined Screen Test and Acute Toxicity 
Immediately after being placed on the screen, the mice 
sought out the uppermost corner of their compartment and were 
relatively quiet. After about 1 - 2 minutes however, many 
groups displayed a short period of restlessness, going from the 
top of the screened area to the bottom and back again. The ani-
mals became quiet again as the first effects of the drugs began 
to appear. One of the first manifestations, though not present 
at all dose levels or in all mice, was muscular weakness, which 
began in the forepaws and progressed to the hind limbs. When 
the involvement became severe, the mice were unable to cling 
onto the screen and promptly slid down. The inability to cling 
onto the screen developed in the reactors within an average per-
iod of 2 - 10 minutes following the administration of the qua-
ternary compound. It appeared that with increasing dose levels, 
tD€ interval between the injection of the quaternary compound 
and the onset of muscular weakness was diminished. With some 
of the derivatives, especially at high dose levels, signs of 
respiratory embarrassment were apparent. In a few instances, 
~he progression toward toxic manifestations was so rapid that 
the animals fell from the screen in convulsions. At the point 
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when most of the animals slid from the screen, locomotion on a 
level surface was faulty, with many animals displaying ataxia. 
Among those animals in which it was tested (at random, through-
out the test series), the righting reflex was present. The re-
sults of the inclined screen test are summarized in Table V. 
The median effective dose, that dose at which 50 per cent of 
the mice might be expected to develop muscular weakness and not 
be able to remain on an inclined screen, ranges from 33.4 mg/kg 
for p-methoxybenzyl pilocarpinium iodide to 625.8 mg/kg for 
acetoxyethyl pilocarpinium bromide. In spite of this almost 
19-fold difference in activity, all compounds tested produced 
some muscular relaxation. 
In general, the aromatic quaternary pilocarpinium members 
were more active in mice than the alkyl members of the series. 
The EDSO's and standard errors (S.E.) for the aromatic compounds 
+ ranged from 33.4-1.1 mg/kg for p-methoxybenzyl pilocarpinium 
iodide to 197.9~7.0 mg/kg for veratryl pilocarpinium iodide, 
whereas the range of the aliphatic hydrocarbon compounds was 
from l29.0±3.0 mg/kg for n-amyl pilocarpinium iodide to 
+ 448.1-11.6 mg/kg for methyl pilocarpinium iodide. 
A test of significance (F test) of the regression lines 
indicated that there was a significant linear relationship over 
and above any curvilinear relationship for almost all of the 
quaternary compounds. The low level of significance obtained 
-TABLE V 
summary of the Inclined Screen Test and the Margin of 
Safety (S.M.) Following the Intraperitoneal 
Administration of the Quaternary 
Pilocarpine Derivatives 
to Mice 
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Compound ED50 ± S.E. Slope 95% CL of ED50 LD50 
(mSl/k2) (b) (m2/k2) S.M·=ED50 
Hethy1 Pilo- + 448.1 - 11.6 0.006 419.7 & 476.5 1.41 
carpinium 
Iodide 
Methyl Iso- 334.8 + 5.6 0.016 320.4 & 349.2 1.28 
-
pi1ocarpin-
ium Iodide 
Ethyl Pi1o- 429.1 ± 13'.9 0.017 369.3 & 488.9 1.44 
carpinium 
Iodide 
n-Propy1 284.4 ± 11.3 0.012 255.4 & 313.4 1.69 
Pilocarpin-
ium Iodide 
Isopropyl 350.2 + 12.0 0.016 312.0 & 388.4 1.68 
-
Pilocarpin-
ium Iodide 
Allyl Pi1o- 278.7 ± 13.5 0.009 235.8 '& 321.6 1.76 
carpinium 
Iodi'de 
n-Buty1 158.8 + 8.2 0.012 132.8 & 184.8 1.66 
-
Pilocarpin-
ium Iodide 
sec-Butyl 199.7 + 6.4 0.019 179.3 & 220.1 1.42 
-Pilocarpin- ' 
ium Iodide 
n-Amy1 Pi1o- 129.0 + 3.0 0.032 120.7 &,137.3 1.20 
-
carpinium 
Iodide 
> 
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TABLE V (continued) 
compound + Slope 95% CL of ED50 ED50 - S.E. LD50 
(m51Lk2) (b) (m2Lk2> S .M.=ED50 
Isoamyl Pi1o- + 196.6 - 5.7 0.023 180.8 & 212.4 1.45 
carpinium 
Iodide 
Acetoxyethyl 625.8 ± 29.9 0.004 542.7 & 708.9 1.34 
Pilocarpin-
ium Bromide 
Benzyl Pilo- 82.9 ± 6.4 0.019 65.1 & 100.7 1.51 
carpinium 
Iodide 
Pheny1ethyl 120.7 + 4.3 0.037 107.0 & 134.4 1.28 
-
pilocarpin-
ium Iodide 
Phenoxyethyl 170.0 + 14.4 0.010 130.0 & 210.0 1.33 -
Pilocarpin-
ium Bromide 
p-Methoxybenzyl 33.4 ± 1.1 0.065 30.4 & 36.4 1.49 
Pilocarpin-
ium Iodide 
Veratryl 197.9 + 7.0 0.021 178.4 & 217.4 1.56 
-
Pilocarpin-
ium Iodide 
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with the p-methoxybenzyl derivative (P slightly greater than 
0.05) would indicate that the predicted ED50 value may be some-
what lacking in precision. 
With the termination of the inclined screen test, all mice, 
as stated in the methods, were observed for an additional two 
hour period in order to determine the acute toxicity of the qua-
ternary compounds. All mice in the toxicity study were con-
tained in individual, perforated plastic boxes. Those animals 
that slid from the screen were immediately transferred, while 
the remainder were transferred to plastic boxes 15 minutes fol-
lowing drug administration. Rapidly ensuing manifestation of 
toxicity consisted primarily of respiratory difficulty, some 
convulsions, occasional gnashing of teeth and gasping for breath. 
Death was probably due to respiratory arrest. Muscarinic symp-
toms such as salivation, lacrimation, urination and defecation, 
the so-called "slud syndrome," which could be associated with 
and which were seen in pilocarpine and isopilocarpine-treated 
animals, were not observed in the mice receiving the quaternary 
compounds. 
The LD50 values calculated from their regression lines, as 
well as the standard errors, slopes and 95 per cent confidence 
limits, are summarized in Table IV for pilocarpine hydrochlo-
ride, isopilocarpine hydrochloride and the synthesized quater-
nary derivatives. The range of the toxicity for the quaternary 
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derivatives is from 49.7~2.3 mg/kg for p-methoxybenzyl pilocar-
pinium iodide to 841.7~3S.6 mg/kg for acetoxyethyl pilocarpinium 
bromide. 
The LDSO values obtained for pilocarpine hydrochloride and 
its stereoisomer, isopilocarpine hydrochloride, were 3l0.9~9.4 
mg/kg and 330.2~6.0 mg/kg respectively. The two salts, when com-
pared on the basis of their pharmacology and potency, confirm the 
observation reported in the literature, i.e., that both alkaloids 
are similar in their action, with isopilocarpine hydrochloride 
being somewhat weaker (169). The muscarinic symptoms observed 
after the administration of pilocarpine hydrochloride were also 
present in the mice which were injected with isopilocarpine hydro-
chloride. 
Although the potencies of the tertiary salts are essentially 
the same, the potencies of the quaternary methyl derivatives of 
the stereoisomers do differ significantly from one another (P less 
than 0.01). Methyl isopilocarpinium iodide, with an LDSO of 
427.7~6.S mg/kg, was found to be more toxic to mice than methyl 
pilocarpinium iodide (LDSO, 633.3~11.7 mg/kg). 
Quaternization of pilocarpine by aromatic halides yielded 
derivatives which were equally as toxic (veratryl, LDSO 309.2~S.9 
mg/kg) or 2 to 6.3 times more toxic (phenyl ethyl lS4.3~4.S mg/kg 
to p-methoxybenzyl 49.7~2.3 mg/kg) than the tertiary parent com-
pound. On the other hand, the lower alkyl quaternary derivatives 
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TABLE IV 
Acute Toxicity of Pilocarpine Hydrochloride, Isopilocarpine 
Hydrochloride and Their Quaternary Derivatives in Mice 
after Intraperitoneal Administration 
Compound + 95% CL of LD50 LD50 - S.E. Slope 
(mg/kg) (b) (mg/kg) 
Methyl Pilo- 633.3 ± 11.7 0.006 605.7 & 660.9 
carpinium 
Iodide 
Methyl Iso- 427.7 ± 6.5 0.012 411.8 & 443.6 
pilocarpinium 
Iodide 
Ethyl Pilo- 615.8 ± 15.8 0.010 577.1 & 654.5 
carpinium 
Iodide 
n-Propy1 481.2 ± 15.6' 0.008 441.1 & 521.3 
Pi10carpinium 
Iodide 
Isopropyl 588.9 + 11.2 0.006 557.8 & 620.0 ~ 
Pi10carpinium 
Iodide 
Allyl pi1o- 492.0 ± 17.1 0.008 444.5 & 539.5 
carpinium 
Iodide 
n-Buty1 pi1o- 263.0 ± 8.9 0.019 238.3 & 287.7 
carpinium 
Iodide 
sec-Butyl 283.9 ± 8.0 0.019 264.3 & 303.5 
Pi10carpinium 
Iodide 
n-Amy1 Pi1o- 154.7 ± 2.5 0.045 148.3 & 161.1 
carpinium 
Iodide 
3 
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TABLE IV (continued) 
Compound LD50 ± S.E. Slope 95% CL of LD50 
(m~/k2) (b) (m2Lk2) 
Isoamyl Pi1o- 284.6 ± 6.6 0.016 267.6 & 301.6 
carpinium 
Iodide 
Acetoxyethy1 841.7 + 35.6 0.004 754.5 & 928.9 
-
Pi10carpinium 
Bromide 
Benzyl Pi1o- 125.4 + 6.4 0.025 107.6 & 143.2 
-
carpinium 
Iodide 
Pheny1ethy1 154.3 + 4.5 0.043 141.8 & 166.8 -
Pi10carpinium 
Iodide 
Phenoxyethy1 226.8 + 9.0 0.012 206.0 & 247.6 
-
pi10carpinium 
Bromide 
p-Methoxybenzy1 49.7 + 2.3 
-
0.049 43.8 & 55.6 
Pi10carpinium 
Iodide 
Veratry1 Pi1o- 309.2 + 5.9 0.027 294.0 & 324.4 -
carpinium 
Iodide 
Pilocarpine 310.9 + 9.4 0.011 287.9 & 333.9 
-
Hydrochloride 
Isopilocarpine 330.2 + 6.0 0.022 315.5 & 344.9 
-
Hydrochloride 
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(methyl to allyl) were decidedly less toxic than pilocarpine~ it 
was not until the hydrocarbon chain of the substituent reached 
4 - 5 carbons in length that the toxicity approached or exceeded 
that of pilocarpine. 
As illustrated in Fig. 3, with increasing length of the alkyl 
side chain the LD50 decreased, or stated another way, the toxic-
ity of the quaternary compounds increased with an increase in the 
length of the alkyl substituent. The LD50 value of the branched 
chain members was always higher than their corresponding straight 
chain isomers. For example, the isopropyl derivative with an 
LD50 of 588.9 mg/kg was less toxic than n-propyl (LD50 481.2 
mg/kg). 
It was observed in the aromatic quaternary series, that as 
the distance between the quaternary nitrogen atom and the aro-
matic ring increased, the toxicity of the compounds decreased. 
Undoubtedly many factors are involved in this relationship, but 
it at least offered a means, albeit naive, for correlating a 
structure-activity relationship. Framework molecular models (as 
photographically illustrated in Fig. 1 and 2) of the aromatic 
compounds were carefully constructed on a scale of 1" equal to 
1 angstrom (~) unit. The distance from C-l of the benzene ring 
to the N atom in the imidazolium ring was measured as illustrated 
in the diagram in Fig. 4 by the broken arrows. The distance, 
evaluated in this way, for the various aromatic members of the 
s 
EFFECT OF INCREASING LENGTH OF ALKYL CHAIN IN QUATERNARY 
PILOCARPINE SALTS ON LD50 IN MICE 
700 
600 
500 
(!) 
~ 400 
(!) 
~ 
o 
all) 300 
...J 
200 
100 
• Isopilo-
carpinium 
2 
C isopropyl 
sec- buty I 
I . 
". ", •• m,1 
o 
3 4 5 6 
NO. CARBON ATOMS IN ALKYL SIDE CHAIN 
7 
200 
Fig. 3 - The effect of increasing length of alkyl side chain on 
the acute LDSO in mice. LDSO's determined by at least S 
dose levels administered to groups of mice, with at least 
10 mice per group. Normal, unbranched hydrocarbon chain,o. 
Branched chain,o. Unsaturated hydrocarbon chain,A. stereo-
isomer of pilocarpine, •• 
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series is tabulated in Fig. 4. When the data obtained were 
plotted (Fig. 5), the effect of increasing length and ring sub-
stitution on the acute toxicity of the aromatic quaternary com-
pounds summarized in Table IV perhaps becomes more meaningful. 
Fig. 5 illustrates that as the distance between the benzene ring 
and the quaternary nitrogen was increased, the toxicity (LD50) 
was decreased. The range of toxicity (LD50) decreased from ben-
zyl pilocarpinium iodide (125.4~6.4 mg/kg to phenoxyethyl pilo-
carpinium bromide (226.8~9.0 mg/kg). The introduction of a 
methoxyl group into the benzene ring (p-methoxybenzyl deriva-
tive) increased the toxicity over the unsubstituted benzyl mem-
ber of the series, LD50 of 49.7±2.3 mg/kg as compared to 
+ 125.4-6.4 mg/kg. The introduction of a second methoxyl group 
into the benzene ring (veratryl pilocarpinium iodide) decreased 
the toxicity of the aromatic quaternary compound to mice. 
The linearity of the toxicity regression, tested by an 
analysis of the variance (F test), indicated that there was a 
significant linear relationship over and above any curvilinear 
relationship for all of the quaternary compounds and for pilo-
carpine and isopilocarpine hydrochlorides as well. 
The safety margin, which was calculated as the ratio of 
the LD50 to the ED50, was low. In essence, the safety margin 
expresses the relationship between that dose of the compound 
which causes muscular weakness or paralysis of the limb muscles 
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PILOCARPINIUM LD 50 EVALUATED DISTANCE FROM C-I 
DERIVATIVE mo/ko OF BENZENE RING TO IMIDAZOLE 
N IN ANGSTROM UNITS 
BENZYL- 125.4 2.44 
PHENYLETHYL- 154.3 3.82 
PHENOXYETHYL- 226.8 4.61 
P-METHOXYBENZYL-
1 
49.7 2.44 
VERATRYL- 309.2 2.44 
Fig. 4 - Effect of varying aromatic substituents in pilocarpin-
ium compounds on the acute LD50 in mice. Broken arrows on 
structure in upper part of figure indicate the points in 
the molecule along which interatomic distances were mea-
sured. Table in the bottom of the figure lists the values 
obtained from these measurements for the various aromatic 
compounds along with their LD50's. 
/ EFFECT OF INCREASING LENGTH AND RING SUBSTI-
TUTION IN QUATERNARY ARALKYL PILOCARPINE SALTS 
ON ACUTE TOXICITY IN MICE 
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Fig. 5 - The effect of increasing length and ring substitution in 
quaternary aralkyl pilocarpine salts on acute toxicity in 
mice. LD50. in mg/kg on the ordinate. Abscissa represents 
evaluated interatomic distance from benzene ring to imida-
zole nucleus (see text for details). Unsubstituted ring 
compounds with increasing chain length,o. Monosubstitution 
in ring,~. Disubstitution in ring,e. 
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to that dose which causes complete respiratory paralysis. It 
is therefore a possible indication of the relative sensitivities 
of the diaphragm and other muscles of mice to the blocking or 
depressant effects of the quaternary derivatives. More than 
half of the quaternary derivatives had values less than 1.55, 
and all values were included in a range of 1.20 - 1.76. 
B. Ophthalmologic Investigation 
Within 10 minutes, a measurable miosis was evident in the 
left (experimental) eye of the rabbit which had received pilo-
carpine hydrochloride. The maximal reduction in pupil size, a 
35.7 per cent decrease in size from control, was obtained about 
40 minutes after instillation of the drug. The miosis was essen 
tially maintained at this level for the duration of the experi-
ment. No effect, neither miosis nor mydriasis, during an ob-
servation period of 2.5 to 3 hours, was found in those rabbits 
treated with the quaternary isopilocarpinium and pilocarpinium 
compounds. In addition, signs of irritation, lacrimation or 
anesthesia were also absent. 
c. Rat Isolated Phrenic Nerve - Diaphragm 
preliminary investigations with the quaternary pilocarpin-
ium compounds on the frog isolated sciatic nerve - gastrocnemius 
preparation and the cat tibial nerve - tibialis anterior muscle 
demonstrated a blocking ability on neuromuscular transmission 
which was further investigated on the isolated phrenic 
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nerve-diaphragm. Benzyl pilocarpinium iodide, one of the more 
potent members of the series in the mouse toxicity studies which 
was still relatively water soluble, was chosen for this investi-
gation. The results of an experiment on the rat phrenic nerve-
diaphragm with the benzyl derivative are shown in Fig. 6. The 
addition of d-tubocurarine chloride in a dose of 6 mcg/ml re-
sulted in a 35.5 per cent inhibition of the twitch. When the 
dose of tubocurarine chloride was increased to 8 mcg/ml, there 
was complete inhibition of the twitch in 1 minute. Recovery of 
the muscle to predrug control levels took about 5.5 minutes with 
frequent washing of the bath. 
Initial inhibition of the muscle twitch upon addition of 
the benzyl compound was obtained when concentrations of 258 and 
516 mcg/ml were present in the bath. The inhibition was minimal 
however, amounting to a 2 per cent reduction in twitch height 
from control. Following a 3 minute contact time, the response 
of the muscle to 516 mcg/ml was reduced 12 per cent from control 
levels. In Fig. 6 (C), 640 mcg/ml of benzyl pilocarpinium io-
dide produced a 12 per cent inhibition of twitch height after 
1 minute and a 44 per cent inhibition after 3 minutes. When the 
level of the benzyl derivative was increased to 800 mcg/ml, a 
complete block was produced in 3 minutes. After washing, the 
muscle twitch returned to control levels in slightly less than 
2 minutes. Complete blockade of the muscle (D) was maintained 
t 
TC 
6 
BZ 
640 
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Fig. 6 - Contractions of isolated rat diaphragm evoked by elec-
trical stimulation of the phrenic nerve once every 10 sec. 
Preparation was maintained at 37 0 in a 50 ml. isolated or-
gan bath containing Krebs-Henseleit solution. (A) and (B) 
represent the responses after the addition of 6 and 8 
mcg/ml d-tubocurarine chloride (TC) to the bath. At (C), 
the twitch response after the addition of 640 and 800 
mcg/ml of benzyl pilocarpinium iodide, (BZ). (D) illus-
trates recovery of the muscle after maintaining complete 
inhibition of twitch for a period of 2 min. At w, the 
bath was washed. 
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in the presence of the quaternary compound, but could readily 
be reversed upon washing the compound from the bath. In an 
earlier part of the experiment (not shown in Figure), edro-
phonium chloride in a dose of 4 mcg/ml had no effect on the 
course of the blockade produced by 800 mcg/ml of the benzyl de-
rivative. 
D. Neuromuscular Paralysis in Chicks 
The intravenous administration of decamethonium iodide in a 
dose of 0.05 mg/kg produced a spastic paralysis which lasted for 
5 to 7 minutes. Following the period of paralysis, the chick 
recovered completely. Tubocurarine chloride similarly adminis-
tered in a dose of 0.5 mg/kg produced a flaccid paralysis. The 
period of paralysis and recovery was more prolonged with tubo-
curarine chloride, lasting about 15 to 20 minutes. 
Due to the limited number of chicks available at the time 
and the initial difficulties encountered in obtaining a success-
ful injection, little more than a qualitative test could be per-
formed on the quaternary compounds selected for screening. In 
all cases, injection of the particular quaternary compound re-
sulted in the production of a flaccid paralysis. Birds which 
had received the methyl (4l8 mg/kg), n-propyl (224 mg/kg), 
n-butyl (161 mg/kg), and benzyl (70 mg/kg) derivatives died with 
out recovering from the paralysis. 
Phenylethyl pilocarpinium iodide in a dose of 60 mg/kg 
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produced a flaccid paralysis with complete recovery within a 
short period of time. The chicks receiving the n-amyl compound 
(94 mg/kg) showed a partial paralysis. These birds were unable 
to stand and squatted on their legs. They were also unable to 
hold up their heads and lowered them to the top of the labora-
tory table. When tapped on their backs, the birds raised their 
heads for a short period before they were again lowered to the 
counter. These animals recovered. A bird who had received a 
25 mg/kg dose of p-methoxybenzyl pilocarpiniurn iodide was in-
jected with neostigmine methylsulfate (8 mg/kg) at the height 
of the paralysis. The paralysis was more than completely antag-
onized. Almost immediately after the injection of neostigmine, 
the block due to the quaternary compound was antagonized. The 
chick got up and began to walk around. Within a minute, the 
bird developed a spastic paralysis and died in the block. 
E. Isolated Guinea pig Ileum 
1. Effect of Quaternary Pilocarpine Compounds on the 
Spasmogenic Action of Acetylcholine - All of the qua-
ternary pilocarpine compounds antagonized the responses of the 
isolated guinea pig ileum to acetylcholine chloride. Some of 
the derivatives, e.g., allyl- and p-methoxybenzyl pilocarpinium 
iodides, were more effective than others in this regard. Allyl 
pilocarpiniurn iodide and p-methoxybenzyl pilocarpinium iodide 
in concentrations as low as 1 mcg/ml reduced the contractions 
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produced by acetylcholine (0.01 mcg/m1) to 85 and 82 per cent 
of predrug control levels. Acetoxyethy1 pi10carpinium bromide 
was one of the most ineffective derivatives in antagonizing the 
contractions of acetylcholine. A concentration of 135 mcg/m1 
was necessary to reduce the effect produced by 0.01 mcg/m1 of 
acetylcholine to 50 per cent of its control value. There did 
not appear to be any great specificity or activity among the 
rest of the quaternary compounds in their ability to antagonize 
spasms induced in the ileal strips by acetylcholine. The pD 
values and standard errors of the median effective concentra-
tion (ED50) obtained for the prevention of acety1cho1ine-
induced contractions of guinea pig ileum by the various quater-
nary pilocarpine compounds are summarized in Table VI. With 
the exception of the acetoxyethy1-, a11y1-, and p-methoxybenzy1 
compounds, the concentrations of all other derivatives which 
produce a 50 per cent reduction in the response to acetylcholine 
lie within a pD range of 4.62=0.19 (phenyl ethyl pi10carpinium 
+ iodide) to 4.17-0.21 (n-propy1 pi10carpinium iodide). This 
represents bath concentrations of 24 to 68 mcg/m1. The quater-
nary compounds which are included in this range are antispas-
modic at about the same level, and neither the character of the 
alkyl groups nor the fact that they may be straight or branched 
chains seemed to influence this antispasmodic property. 
The pD values of the median antispasmodic concentrations 
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for allyl- and p-methoxybenzyl pilocarpinium iodides were 
5.0210.20 and 5.25:0.19 respectively, which represent bath con-
centrations of 9.5 and 5.6 mcg/ml. The increased antispasmodic 
activity of the two derivatives is illustrated by the records 
of a few representative experiments (Fig. 7). In Fig. 7, con-
tractions of the ileum were elicited by the addition of acetyl-
choline in doses of 0.01 mcg/ml bath. (B), (C), (E), (G) are trac-
ings which represent the doses (mcg/ml) of p-methoxybenzyl 
(MBz) , allyl (AI), benzyl (Bz) and n-butyl (Bu) pilocarpinium 
iodides which produced reductions in the height of the acetyl-
choline contraction of 18.0, 15.7, 18.6 and 22.0 per cent re-
spectively from control levels. The magnitude of the antagon-
ism is within the same general area, but there is a 20-fold 
difference in bath concentration, for example, between the 
p-methoxybenzyl derivative and the n-butyl derivative. The same 
relative difference was obtained with higher concentrations of 
the quaternary compounds. Tracings (B), (D), (F), (H) represent 
61.3, 58.1, 60.9 and 70.9 per cent antagonism of acetylcholine-
induced contractions, and the 20-fold dose ratio is again ob-
tained. 
Unlike pilocarpine, which has a stimulatory effect on guin-
ea pig smooth muscle, the quaternary derivatives~ in general, 
have a ~elaxant effect. Although other figures will demonstrate 
this more effectively, the relaxant effect can be seen in Fig. 7 
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Fig. 7 - Antispasmodic activity of several quaternary pilocar-
pine derivatives on the responses of isolated guinea pig 
ileum to acetylcholine, A. Records (A), (e), (E), (G) repre-
sent low doses, and records (B), (D), (F), (H) represent high-
er doses of the quaternary compounds. Bath concentration 
of A was 0.01 mcg/ml. Bath concentrations in mcg/ml for 
p-methoxybenzyl (MBz) , allyl (Al), benzyl (Bz) and n-butyl 
(Bu) pilocarpinium iodides are specified on the records. 
Tissue bathed in Tyrode's solution maintained at 370 • Bath 
was washed at w. Time marker, 10 sec. intervals. 
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(B) and (C). Record (B) illustrates both a change in tone and 
motility of the ileal strip in contact with the p-methoxybenzyl 
derivative, whereas (C) shows a more pronounced effect on motil-
ity. Both effects were more apparent in tissue strips that 
initially displayed greater spontaneous activity. In prepara-
tions where the spontaneous motility was not so great, i.e., (E), 
(F), (G) and (H), the relaxant effect of the quaternary compounds 
was not so pronounced. All the records also illustrate that the 
activity of the quaternary compounds was usually not sustained: 
almost immediately after washing, the tissue regained its 
"normal" tonus, and the next response to the spasmogen was gen-
erally at the same level as the predrug control contraction. 
2. Effect of Quaternary Pilocarpine Compounds on the 
Spasmogenic Action of Histamine - The quaternary pilo-
carpine compounds varied to a greater extent in their ability 
to antagonize histamine-induced contractions of the guinea pig 
ileum than they did in the acetylcholine antagonism experiments. 
As summarized in Table VI, of the fifteen compounds studied, the 
pD values of the ED50's of two, allyl- and n-propyl pilocarpin-
+ + ium iodides, were 4.43-0.15 and 4.26-0.17. This corresponds to 
median antispasmodic bath concentrations of 37.1 and 54.9 mcg/ml. 
The pD values of the ED50's of the methyl- and ethyl- derivative 
were 2.64~0.18 and 2.83~0.09, corresponding to bath concentra-
tions of 2.29 mg and 1.48 mg/ml. 
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Veratryl pilocarpinium iodide was ineffective in antagon-
izing histamine contractions. Addition of the veratryl compound 
to various ileum preparations always produced a stimulatory ef-
fect on the preparation with the doses employed in this test. 
Additional testing of this compound in the histamine experiments 
was suspended. The stimulatory activity of this compound is 
discussed in a subsequent section of this chapter. 
Excluding the quaternary compounds, methyl-, ethyl-, 
n-propyl-, allyl- and veratryl pilocarpinium iodides, which have 
already been discussed, there did not appear to be any out stand-
ing activity among the ten remaining compounds which were in-
cluded in the antihistamine screening test. The concentrations 
of these ten derivatives, which produced a 50 per cent reduction 
in the response of the ileum to histamine, were contained with-
+ in a pD range of 3.68-0.23 for the isopropyl derivative to 
3.08~0.17 for the acetoxyethyl derivative. This represents bath 
concentrations of 208.9 mcg/ml and 831.3 mcg/ml. All of the 
quaternary compounds included in this range possess an anti-
spasmodic effect. There is some suggestion that differences in 
structure may account in part for the 4-fold difference in ac-
tivity, but the magnitude of the difference is not statistically 
significant. 
When the entire series is compared on the basis of the 
ability to antagonize histamine-induced contractions, the 
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quaternary compounds do differ. Methyl- and ethyl pilocarpin-
ium iodides were rather ineffective in antagonizing histamine-
induced contractions in guinea pig ileum and large or exces-
sive concentrations were necessary to demonstrate any anti-
spasmodic activity. Allyl- an4 n-propyl derivatives were more 
active and differed significantly from the two lower members 
at probability levels of less than 0.01. As perhaps might be 
expected, there was no significant difference between isopropyl 
pilocarpinium iodide and the allyl- and n-propyl compounds. 
There was, however, a significant difference (p less than 0.05) 
between the latter two compounds and acetoxyethyl pilocarpinium 
bromide, the deriva~ive which occupied the other extreme of the 
mid-pD range in the series. 
The tracings in Fig. 8 illustrate some of the typical re-
sponses of the guinea pig ileum to histamine (H) in the presence 
and absence of allyl (Al), p-methoxybenzyl (MBz), and benzyl 
(Bz) pilocarpinium iodides. Records (A), (C) and (E) illustrate 
doses (mcg/ml) of the compounds which produced, respectively, 
20.2, 24.2 and 18.8 per cent reductions of histamine-induced 
contractions. Since the percentage reduction is of somewhat 
the same magnitude, the dose required to produce the effect al-
lows a superficial evaluation of the relative effectiveness of 
the three compounds. It is apparent from the figure that at 
this level of antagonism, the allyl compound was about four times 
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Fig. 8 - Antispasmodic activity of several quaternary pilocarpine 
derivatives on the responses of isolated guinea pig ileum to 
histamine, H. Records (A), (C), (E) represent low doses, and 
records (B), (D), (F) represent higher doses of the quaternary 
compounds. (G) is a continuation of record (F). Bath con-
centration of H in mcg/ml was 0.015 in records (A), (B), (C), 
(D) and 0.01 in records (E) and (F). Bath concentration in 
mcg/ml for allyl (AI), p-methoxybenzyl (MBz), and benzyl 
(Bz) pilocarpinium iodides are specified on the recgrds. 
Tissue bathed in Tyrode's solution maintained at 37. Bath 
was washed at w. Time marker, 10 sec intervals. 
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more effective than the benzyl compound and about eight times 
more effective than the p-methoxybenzyl derivative. Of un-
doubtedly greater significance, the records also show the de-
pressant effect that the compounds had on guinea pig smooth 
muscle. The effect persisted for a slightly longer period of 
time than it did in the acetylcholine experiments. This is 
illustrated in (B) of Fig. 8 in which the spontaneous motility 
was still slightly depressed after the allyl compound had been 
washed from the bath and was also apparent by the decreased re-
sponse to the challenge dose of histamine which followed. The 
decreased response to subsequent additions of histamine is per-
haps more clearly shown in (G), which is a continuation of the 
record shown in (F). After the benzyl compound was washed from 
the bath, the responses to histamine continued to be depressed 
from control levels for almost 10 minutes. In a few experiments, 
it was observed that when the tissue was challenged with hista-
mine after exposure to the quaternary pilocarpine derivative, 
the circular muscle responded quite well whereas the longitu-
dinal contraction of the muscle was partially blocked. 
3. Effect of Quaternary Pilocarpine Compounds on the 
Spasmogenic Action of Barium Chloride - The greatest 
variability of their activity as antispasmodic agents was shown 
by the pilocarpinium compounds against the contractions induced 
in isolated guinea pig ileum preparations by barium chloride. 
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Table VI illustrates that the approximate pD values of the qua-
ternary compounds which could reduce the contractions elicited 
by barium chloride to 50 per cent of predrug control levels 
varied from 5.08~0.19 for allyl pilocarpinium iodide to 2.38~0.20 
for sec-butyl pilocarpinium iodide. This represents bath con-
centrations of 8.32 mcg/ml and 4.12 mg/m1 for allyl- and sec-
butyl pilocarpinium iodides respectively. 
In the various isolated tissue experiments, the quaternary 
compounds were administered up to maximum bath concentrations 
of 1000 mcg/ml when necessary to achieve at least a 50 per cent 
reduction in the height of the response of the tissue to the 
spasmogen. In some of the barium antagonism experiments, the 
quaternary compounds were added to the bath in concentrations 
as high as 1800 mcg/ml. The increased levels, however, were 
not always capable of producing a 50 per cent reduction in the 
response of the ileum preparations to barium. In these cases 
the pD values of the median effective concentrations were pre-
dicted from the equation for the regression line which was cal-
culated from the experimental data. The pD values in Table VI 
which are included in the range of 2.96~0.2l to 2.38~0.20 were 
obtained in this way and represent bath concentrations of 1.09 
mg/ml for the isopropyl derivative and 4.12 mg/ml for the sec-
butyl derivative respectively. The magnitude of the values are 
undoubtedly physiologically unsound, and the methyl-, ethyl-, 
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isopropyl-, sec-butyl-, acetoxyethyl- and phenoxy ethyl pilocar-
pinium derivatives should be considered as inactive or ineffec-
tive antispasmodic agents toward barium chloride-induced con-
tractions. Antagonism of barium chloride could not be demon-
strated with either the veratryl or amyl derivatives as a re-
sult of the slight stimulatory effect that these compounds had 
on the tissue preparations. 
Phenylethyl-, p-methoxybenzyl-, n-butyl- and isoamyl pilo-
carpinium iodides possess some antispasmodic activity, but they 
are relatively weak. The pD values of the median effective con-
centrations of these four members ranged from 3.80±O.20 for the 
isoamyl derivative to 3.4l±0.27 for the phenylethyl derivative, 
corresponding to bath concentrations of 157.0 mcg/ml and 387.4 
mcg/ml. The four compounds were antagonists to about the same 
degree. There was no significant difference between the members 
of this group in spite of the fact that two of the derivatives, 
(n-butyl- and isoamyl-) were aliphatic derivatives, whereas the 
other two (phenyl ethyl- and p-methoxybenzyl-) were aromatic in 
nature. It would appear, therefore, that the antagonism was 
nonspecific. 
Allyl-, n-propyl- and benzyl pilocarpinium iodides were the 
most promising members of the series. The activity of these 
three derivatives as antagonists to barium chloride either 
equalled or perhaps slightly exceeded the ability they possessed 
TABLE VI 
pD Values of the ED50 Calculated from Regression Lines for the Antispasmodic 
Activities of the Quaternary Pilocarpine Derivatives Against 
Acetycholine, Histamine and Barium Spasms in 
Excised Guinea Pig Ileum 
Compound Slope Histamine Slope Barium Cl. Slope 
ACh ± S.E. (b) ± S.E. (b) ± S.E. (b) 
Methyl Pilo- 4.61 t 0.18 -1.582 2.64* ± 0.18 -1.577 2.71* ± 0.17 -1.898 
carpinium Iodide 
Ethyl pilo- + 4.38 - 0.13 -0.836 2.83 ± 0.09 -2.914 2.59* ± 0.19 -0.903 
carpinium Iodide 
n-Propyl Pi1o- + 4.17 - 0.21 -1.247 4.26 ± 0.17 -2.467 4.45 ± 0.20 -0.456 
carpinium Iodide 
Isopropyl Pilo- + 4.29 - 0.23 -1.016 3.68 ± 0.23 -1.509 2.96* ± 0.21 -0.830 
carpinium Iodide 
Allyl pi1o- + 5.02 - 0.20 -1.204 4.43 ± 0.15 -3.067 5.08 ± 0.19 -1.257 
carpinium Iodide 
n-Buty1 Pi1o- + 4.25 - 0.23 -1.427 3.09 + - 0.16 -4.386 3.69 ± 0.20 -1.230 
carpinium Iodide 
sec-Butyl Pi1o- + 4.21 - 0.21 -1.174 3.28 ± 0.21 -2.097 2.38* ± 0.20 -0.243 
carpinium Iodide 
n-Amyl Pi10 + 4.50 - 0.21 -1.376 3.51 ± 0.16 -2.487 
carpinium Iodide 
IV 
*Predicted Value ...... 1.0 
Compound 
ACh ± S.E. 
Isoamyl Pi1o- + 4.51 - 0.21 
carpinium Iodide 
Acetoxyethy1 + 3.87 - 0.19 
Pi10carpinium 
Bromide 
Benzyl Pi1o- + 4.60 - 0.23 
carpinium 
Iodide 
Pheny1ethy1 + 4.62 - 0.19 
Pi10carpinium 
Iodide 
Phenoxyethy1 + 4.45 - 0.21 
Pi10carpinium 
Bromide 
p-Methoxybenzy1 + 5.25 - 0.19 
Pi10carpinium 
Iodide 
Veratry1 Pi1o- + 4.30 - 0.21 
carpinium Iodide 
*Predicted Value 
TABLE VI (continued) 
Slope Histamine 
(b) ± S.E. 
-0.923 + 3.44 - 0.23 
-1.160 3.08*± 0.17 
-1.418 + 3.55 - 0.20 
-1.107 + 3.58 - 0.13 
-1.238 + 3.20 - 0.19 
-1.396 + 3.45 - 0.20 
-0.933 
Slope Barium C1. 
(b) ± S.E. 
-0.979 + 3.80 - 0.20 
-2.317 2.94*± 0.05 
-1.160 + 4.11 - 0.13 
-3.189 + 3.41 - 0.27 
-2.480 2.62*± 0.21 
-1.738 + 3.70 - 0.18 
Slope 
~ 
-1.877 
-1.400 
-1.442 
-0.340 
-1.425 
-1.585 
N 
N 
o 
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as antagonists to acetylcholine. Fig. 9 (A) illustrates that 
a bath concentration of the allyl compound as low as 2.5 mcg/ml 
could produce a 28.9 per cent reduction in the response to 30 
mcg/ml barium chloride. When a challenge dose of barium chlo-
ride was administered in the presence of a bath concentration 
of 10 mcg/ml of the allyl compound, a 61.4 per cent reduction 
in the response to 30 mcg/ml of barium chloride was obtained. 
The pD value of the allyl derivative which resulted in a 50 per 
cent antagonism of the response to barium chloride was found to 
+ be 5.08-0.19. This represents a median effective concentration 
of 8.3 mcg/ml. Concentrations of n-propyl- and benzyl pilocar-
pinium iodides which produced a 50 per cent inhibition of bar-
ium chloride-induced contractions were 35.6 mcg/ml and 77.2 
mcg/ml, corresponding to the pD values of 4.45~0.20 and 4.ll~0.13 
listed in Table VI. 
4. Stimulatory Effect of Veratryl Pilocarpinium Iodide -
Unlike practically all of the other quaternary pilocarpine com-
pounds, whenever the veratryl derivative was added to the organ 
bath, a stimulatory effect was evoked in the tissue. Some ileal 
preparations were more sensitive than others and responded with 
more pronounced upward shifts in the baseline, but the effect 
was present in all experiments. The effect appeared to be dose 
dependent, increasing the bath concentration of the quaternary 
usually resulting in greater shifts in the baseline. Elevation 
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Fig. 9 - Antispasmodic activity of several quaternary pilocar-
pine derivatives on the responses of isolated guinea pig 
ileum to barium chloride, Ba. Records (A), (C), (E) represent 
low doses, and records (B), (D), (F) represent higher doses 
of the quaternary compounds. Bath concentrations of barium 
chloride were 30 mcg/ml. Bath concentrations in mcg/ml for 
allyl (AI), benzyl (Bz) and n-butyl (Bu) pilocarpinium io-
dides are specified on the records. Tissue bathed in 
Tyrode's solution maintained at 370 • Bath was washed at w. 
Time marker, 10 sec. intervals. 
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of the baseline was not accompanied by increased motility; on 
the contrary, the motility generally decreased. It would seem 
that addition of the veratryl compound to the organ bath pro-
duced a mild spasm or a contracture of the smooth muscle of the 
ileum. 
Records (A) and (B) of Fig. 10 illustrate responses of the 
guinea pig ileum to doses of 20 and 40 mcg/ml of veratryl pilo-
carpinium iodide. \'lith increased concentration of the veratryl 
compound, there appears to be an increase in the level of the 
spasm. The responses to acetylcholine (0.01 mcg/ml) appeared 
to be antagonized in spite of the spasmogenic activity of the 
veratryl compound. Because the veratryl compound was relatively 
inactive in antagonizing the contractions of histamine and bar-
ium chloride, large doses of the quaternary derivative were 
added to the bath. Addition of the larger doses caused greater 
shifts of the baseline (records (B) and (E». With the subse-
quent addition of the agonist, the recording level of the lever 
system was then exceeded. Therefore, any ability of the vera-
tryl derivative to antagonize the contractions produced by his-
tamine or barium chloride could not be demonstrated. 
Atropine in a bath concentration of 0.01 mcg/ml either com-
pletely (C), or almost completely (F), abolished the stimulant 
effect of the veratryl compound. Tracing (D), recorded 11 min-
utes after atropine had been washed from the bath, demonstrated 
(8 ) 
A I 
A 
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Fig. 10 - Effects of veratryl pilocarpinium iodide (V) on isolated 
guinea pig ileum and on the responses to acetylcholine,A, and 
histamine,H. Bath concentration of acetylcholine and hista-
mine was 0.01 mcg/ml. Bath concentrations in mcg/ml for (V) 
are specified on the records. (A) and (B) stimulatory ef-
fects on ileum and antagonism of acetylcholine by V. Atro-
pine,At (bath concn. 0.01 mcg/ml), administered in record 
(e). (D), 11 min after At. Effects of veratryl compound and 
histamine before (E) and after (F) the additfon of atropine 
(0.01 mcg/ml). Tissue bathed in Tyrode's solution main-
tained at 37 0 • Bath washed at w. Time marker, 10 sec in-
tervals. 
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that as the response of the tissue to acetylcholine was re-
gained, the stimulant effect of the veratryl compound was re-
gained also. 
F. Cardiovascular Responses in Normotensive Dogs 
1. Blood Pressure Changes After Quaternary Pilocarpine 
Compounds - Previous studies (263) on n-butyl pilocar-
pinium iodide demonstrated that, in dogs under pentobarbital 
anesthesia, intravenous injections of doses as small as 1 mg/kg 
of the butyl compound were followed by a transient vasodepres-
sion. More measurable responses were elicited with doses of 4 
and 8 mg/kg. In the present series of experiments, the cardio-
vascular responses to isoamyl pilocarpinium iodide were studied. 
As with the n-butyl derivative, intravenous administration of 
isoamyl pilocarpinium iodide in doses of 4 and 8 mg/kg produced 
a transient vasodepression. More measurable responses were ob-
tained following the injection of doses of 10 mg/kg. This sug-
gests that a dose-effect relationship may exist between the qua-
ternary derivative and the vasodepression which is produced. 
The responses were variable in the dogs that were utilized in 
the tests, but in general, the administration of doses of 10 
mg/kg produced decreases in systolic pressure of 50 to 100 rom Hg 
and decreases in diastolic pressure of about the same magnitude 
in the various dogs. The vasodepression lasted for periods of 
2 to 10 minutes before recovery to predrug control levels. There 
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was a marked slowing of heart rate following administration of 
the drug. In one of the dogs, for example, decreases in heart 
rate of 45 to 63 beats/min. followed doses of 10 mg/kg of iso-
amyl pilocarpinium iodide. The dogs in the experiments were 
sacrificed by repeated injections of the quaternary pilocarpine 
compound at intervals of 2 to 3 minutes. When respiration 
ceased, the heart continued to beat regularly for periods up to 
5 minutes before it stopped. 
2. Effect of Antihistamine on Cardiovascular Responses 
to Histamine and Isoamyl Pilocarpinium Iodide -
Table VII summarizes the effect of the administration of diphen-
hydramine hydrochloride (3 mg/kg) on the vasodepressor and heart 
rate responses to histamine phosphate and isoamyl pilocarpinium 
iodide in the dog. The injection of 5 and 10 mcg/kg of hista-
mine into a dog anesthetized with pentobarbital sodium produced 
vasodepression with 15.8 and 20.0 per cent increases in heart 
rate. The intravenous administration of 10 mg/kg of isoamyl 
pilocarpinium iodide produced 26.7 and 36.5 per cent decreases 
in the systolic and diastolic pressures respectively, and a 5.0 
per cent decrease in heart rate, from control levels. Following 
the administration of diphenhydramine hydrochloride, there was 
pronounced antagonism of both the vasodepressor and heart rate 
effects of histamine phosphate. There was only minimal antago-
nism of the depressor response of the isoamyl derivative after 
TABLL VII 
Effect of Antihistamine on Cardiovascular Responses to Histamine 
and Isoamyl Pilocarpinium Iodide in the Dog 
% Change Heart Rate 
Drug** Dose B.P. from Control Heart (% Change 
(rom Hg) S* D+ Rate from Control) 
Hist. Phosphate 0 187/125 114 
5 meg/kg 150/81 -19.8 -35.2 132 +15.8 
0 180/130 120 
10 mcg/kg 135/75 -25.0 -42.3 144 +20.0 
Isoamyl Pi1o- 0 187/137 120 
carpinium Iodide 
10 mg/kg 137/87 -26.7 -36.5 114 - 5.0 
Hist. Phosphate 0 175/130 120 
10 mcg/kg 118/68 -32.6 -47.7 144 +20.0 
Diphenhydramine 0 168/131 
Hydrochloride 
3 mg/kg 125/85 
175/118 Biphasic response 
* Systolic **Drugs are listed in the sequence of administration 
+ Diastolic N N 
--..J 
** Drug 
Hist. Phosphate 
Isoamyl Pi1o-
carpinium Iodide 
Hist. Phosphate 
* Systolic 
+ Diastolic 
TABLE VII (continued) 
% Change Heart Rate 
Dose B.P. from Control Heart (% Change 
(rom Hg) S* D+ Rate from Control) 
0 187/130 120 
5 mcg/kg 183/112 -2.1 -13.8 126 +5.0 
0 200/135 114 
10 mg/kg 155/93 -22.5 -31.1 108 -5.3 
0 205/137 108 
10 mcg/kg 187/106 -8.8 -22.6 114 +5.6 
**Drugs are listed in the sequence of administration 
~ 
~ 
ex> 
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the antihistamine, with the quaternary compound still producing 
a 22.5 and a 31.1 per cent decrease in the systolic and dias-
tolic pressures. Diphenhydramine hydrochloride had essentially 
no effect on the decrease in heart rate produced by the isoamyl 
compound. 
3. Effect of Atropine Sulfate on Cardiovascular Responses 
to Acetylcholine Chloride, Pilocarpine Hydrochloride 
and Isoamyl Pilocarpinium Iodide - Fig. 11 and Table 
VIII show the results of an experiment in a dog in which the 
effect of atropine on the cardiovascular responses of acetyl-
choline chloride, pilocarpine hydrochloride and isoamyl pilo-
carpinium iodide were compared. Acetylcholine, pilocarpine and 
the isoamyl derivative all produced vasodepression when injected 
into the dog. The quaternary isoamyl derivative, in a dose of 
10 mg/kg, produced a 42.2 per cent decrease in the systolic 
pressure and a 54.7 percent decrease in the diastolic pressure. 
The decrease in systolic and diastolic pressures was of somewhat 
the same magnitude as that produced by 5 mcg/kg of acetylcholine, 
with the peak response of the isoamyl compound occurring slight-
ly later than that of acetylcholine. Unlike either acetylcho-
line or pilocarpine, the quaternary compound produced a brady-
cardia (Fig. 11(C», which amounted to a 22.2 per cent decrease 
from control levels. The other two agents produced increases 
in heart rate at their peak response period. Twenty minutes 
mm Hg 
f200 100 o 
B.P. 
B.P, 
IA) 
(C) 
(0) 
230 
IB) 
PILO, 0.05 mg/kg 
150 
(E) 
mm Hg 186 186 
f~~~ !lhli!!m!!WlWm-.iIillil)llI!lI!milim.@!il!!W~i"I_I'W*'illii.i~_ IU IU hIllIImWu'IUbl'H'II!III'IIIIIIII!bImIl'!!I!II!!!!!!!!!!!!!II!!!!!!l!! lllUUlI I!!!IUIInHUlliIJjIIl!!!!!I!!!!! !!I!!!!III!!!!! IIUUIIIII!l!IIIII.11I1Mi 
o ACh, 5 meg/kg ~ILO, 0.05 mg/kg 
(F) 
B.P. 
mm Hg I~ 
t::: 1I~1I~~~II~ls~oL1A~M~'~10~m~g/~k~gll~~~~~~~~~~~~~12~9~~~~~ 
o 10 20 
TIM E , Ite . LI __ ...JII.......-_--li 
150 
_!!!lllUnUI 'II!III !! '1II0!l!I!!II!!lI!!UIIIIlIlllJljlIUillllW 
Fig. 11 - Effect of atropine sulfate on the cardiovascular re-
sponses to acetylcholine chloride, pilocarpine hydrochlo-
ride and isoamyl pilocarpinium iodide. Dog, 10 kg, pen-
tobarbital sodium anesthesia (30 mg/kg). Blood pressure 
(B.P.) recorded from femoral artery. Heart rate indicated 
by numbers above B. P. tracing (be'ats/min). Responses to 
acetylcholine chloride (ACh) 5 mcg/kg in (A) and (D), pi-
locarpine hydrochloride (PILO) 0.05 mg/kg in (B) and (E), 
isoamyl pilocarpinium iodide (ISOAM) 10 mg/kg in (C) and 
(F). Break in record (C) 9 min. and in (F) 7 min. after 
injection. Atropine sulfate, 5 mg/kg, administered I:M. 
between (C) and (D). 
TABLE VIII 
Effect of Atropine Sulfate on Cardiovascular Responses to 
Acetylcholine Chloride, Pilocarpine Hydrochloride 
and Isoamyl Pilocarpinium Iodide in the Dog 
% Change 
Drug ** Dose B.P. from Control Heart 
Heart Rate 
(% Change 
(mm H9:) s* D+ Rate from Control) 
Acetylcholine 0 160/105 180 
Chloride 
5 mcg/kg 100/50 -37.5 -52.4 198 +10.0 
Pilocarpine 0 160/105 189 
Hydrochloride 
0.05 mg/kg 128/70 -20.0 -33.3 198 + 4.7 
Isoamyl Pilo- 0 180/128 162 
carpinium 
Iodide 10 mg/kg 104/58 -42.2 -54.7 126 -22.2 
Atropine 0 190/130' 162 
Sulfate 
5 mg/kg,IM 185/130 - 2.6 0 168 + 3.7 
Acetylcholine 0 170/115 186 
Chloride 
5 mcg/kg 170/115 0 0 186 0 
*Systolic **Drugs are listed in the sequence of administration I'V 
+Diastolic w I-' 
Drug ** 
Pilocarpine 
Hydrochloride 
Isoamyl Pi1o-
carpiniurn 
Iodide 
*Systo1ic 
+Diasto1ic 
(TABLE VIII (continued) 
% Change Heart Rate 
Dose B.P. from Control Heart (% Change 
(rom H~) S* D+ Rate from Control) 
0 185/130 174 
0.05 mg/kg 185/130 0 0 174 0 
0 190/130 186 
10 mg/kg 100/43 -47.4 -66.9 129 -30.6 
**Drugs are listed in the sequence of administration 
I\) 
w 
I\) 
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after the intramuscular administration of 5 mg/kg of atropine 
sulfate (injected between records (C) and (D) in Fig. 11), in-
jections of the three compounds were repeated. The cardiovas-
cular responses to acetylcholine and pilocarpine were complete-
ly antagonized by atropine, whereas the responses to the iso-
amyl derivative were unaffected by atropine. Inspection of the 
record (tracing (F» or the values of Table VIII would indicate 
that the response was enhanced 1 10 mg/kg of isoamyl pilocarpin-
ium iodide produced 47.4 and 66.9 per cent reductions in sys~ 
tolic and diastolic pressures respectively and a 30.6 per cent 
reduction in heart rate. The increased response which was ob-
tained in the presence of atropine is of interest for further 
study. Before the administration of atropine sulfate, the 
isoamyl compound did not appear to affect the depressor re-
sponse produced by injected acetylcholine. 
4. Effect of Isoamyl Pilocarpinium Iodide on Cardiovas-
cular Responses to Epinephrine, Norepinephrine and 
Bilateral carotid Occlusion -Fig. 12 and Table IX 
show the responses to epinephrine, norepinephrine and bilateral 
carotid occlusion in a dog before and after the intravenous ad-
ministration of 10 mg/kg of isoamyl pilocarpinium iodide. The 
figure and table illustrate just one of a series of responses. 
Injection of the quaternary compound was repeated several more 
times during the course of an experiment, and in the intervals 
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between doses of the isoamyl derivative, challenges with epine-
phrine, norepinephrine and bilateral carotid occlusion were 
made. The responses were not appreciably different from those 
illustrated. Isoamyl pilocarpinium iodide produced a vasode-
pressor response along with a bradycardia. During the peak re-
sponse, the systolic pressure Was reduced to 46.2 per cent and 
the diastolic to 57.1 per cent of control values. There was a 
22.2 per cent change (decrease) in heart rate. There Was no 
evidence of any antagonism, blockade, or reversal of the re-
sponses to carotid occlusion, norepinephrine or epinephrine. 
For example, 2 mcg/kg of epinephrine produced elevations in sys-
tolic and diastolic pressure of 54.5 and 45.4 per cent before 
the administration of the isoamyl derivative and 50.0 and 44.1 
per cent increases in systolic and diastolic pressures, respec-
tively, after administration of the quaternary derivative. Re-
sponses to the other two agents were similarly unaffected. 
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Fig. 12 Effect of isoamyl pilocarpinium iodide on the cardio-
vascular responses to epinephrine, norepinephrine and bi-
lateral carotid occlusion. Dog, 10 kg, pentobarbital so-
dium anesthesia (30 mg/kg). Blood pressure (B.P.) record-
ed from femoral artery. Heart rate indicated by numbers 
above B.P. tracing (beats/min). Responses to epinephrine 
(EPI) 2 mcg/kg in (A) and (E): 20 sec. bilateral carotid 
occlusion (BeO) in (B) and (F), norepinephrine (NOREPI) 
2 mcg/kg in (e) and (G). Breaks in record (D) represent 
intervals 3 min. and 8 min. after injection of isoamyl pi-
locarpinium iodide (ISOAM), 10 mg/kg. · ISOAM administered 
between (e) and (E). 
TABLE IX 
Effect of Isoamyl Pilocarpinium Iodide on Cardiovascular 
Responses to Epinephrine, Norepinephrine and Bilateral 
Carotid Occlusion (BCO) in the Dog 
_~)':l 
% Change Heart Rate 
Drug ** Dose B.P. from Control Heart (% Change 
(mm Hg) s* D+ Rate from Control) 
Epinephrine 0 165/110 192 
2 mcg/kg 255/160 +54.5 +45.4 186 - 3.1 
BCO 0 153/105 174 
20 sec. 205/150 +34.0 +42.8 186 + 6.9 
Norepinephrine 0 150/105 186 
2 mcg/kg 210/150 +40.0 +42.8 168 - 9.7 
Isoamyl Pilo- 0 158/105 162 
carpinium 
Iodide 10 mg/kg 85/45 -46.2 -57.1 126 -22.2 
Epinephrine 0 170/118 174 
2 mcg/kg 255/170 +50.0 +44.1 162 
- 6.3 
*Systo1ic N w 
+Diasto1ic **Drugs are listed in the sequence of administration 0\ 
Drug ** 
BCO 
Norepi-
nephrine 
*Systo1ic 
+Diasto1ic 
TABLE IX (continued) 
% Change 
Dose B.P. from Control Heart 
(mm-.!!9l S* D+ Rate 
0 160/110 150 
20 sec. 207/153 +29.4 +39.1 156 
0 160/110 162 
2 mcg/kg 210/145 +31.2 +31.8 144 
**Drugs are listed in the sequence of administration 
Heart Rate 
(% Change 
from Control) 
+ 4.0 
-11.1 
I\.) 
W 
-...J 
CHAPTER VII 
DISCUSSION - PHARMACOLOGICAL SCREENING 
It has been almost 100 years since Crum Brown and Fraser 
(52,53,54,55) reported upon the effects produced in various al-
kaloids by the formation of their quaternary salts. They 
stated, for example, that in place of the violent contractions 
and muscular rigidity which are produced by strychnine, the 
methiodide salt produced a flaccid paralysis of the muscles 
which closely resembled the action of curare. These investiga-
tors were also the first to observe the muscular paralysis pro-
duced by tetramethylammonium. Just as important, they are to 
be credited with the first attempts at correlating the pharma-
cological effects of a drug with its structure. Research in 
the field of quaternary ammonium compounds has remained active 
ever since. Part of the continuing interest in quaternary am-
monium compounds may be attributed to their versatility. In 
addition to the important curariform and other neuromuscular 
blocking compounds, many quaternary compounds have gained prom-
inence as germicides, parasympathomimetics, anticholinesterases, 
antispasmodic and antisecretory agents, adrenergic blockers, 
ganglionic blockers or hypotensive compounds, antifungal and 
chemotherapeutic agents. As a result of the many facets of 
activity displayed by quaternary ammonium compounds, attempts 
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at structure-activity relationships become complicated. The 
search for patterns of organization and integration, with the 
aim of clarifying the relationships between structural chemical 
elements and biological activity, has commanded the attention 
of many investigators with a variety of backgrounds, training, 
interests and experience. Consequently, the approaches and the 
results of correlating these factors have been almost as varied. 
While the activity of many quaternary ammonium compounds may be 
explained on the basis that the drugs are acting by a physico-
chemical process (77), it is not unusual to find others which 
display marked variation of activity with changes in chemical 
structure. In the latter circumstances, it is assumed that the 
drugs are interacting with specific receptors. However, even 
with agents displaying a specific activity or a structural 
uniqueness, one can usually observe a diversity of responses 
which may vary both qualitatively as well as quantitatively with 
changes in dose, species, specific organ or site. An example 
of this diversity of action was illustrated by Karczmar (137, 
138,156) in studies of the bisquaternary oxamides. In the ser-
ies, methoxyambenonium was shown to be an anticholinesterase 
and a muscle relaxant, as well as an antagonist to both compe-
titive and depolarizing neuromuscular agents. 
Ideally, a knowledge of the relationship between structure 
and action at all the important sites in the body should enable 
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one to predict ~ priori the necessary structural elements that 
are to be incorporated into a drug to produce a desired effect. 
Although there have been instances where this approach has met 
with some success (160), for the most part the synthesis and 
pharmacological screening of drugs have been conducted on an 
empirical basis. On a theoretical basis, beta-erythroidine or 
dihydro-beta-erythroidine could very well be rejected as curari-
mimetic agents because of the absence of a quaternary nitrogen. 
It has been shown (243) that the curarizing potency was very 
markedly reduced when the compounds were converted to their 
methiodides. In similar fashion, Mashkovsky (170) reported that 
the cholinomimetic activity of 3-acetoxyquinuclidine (aceclidine) 
was decreased about 200-foldwhen the compound, a tertiary amine 
resembling acetylcholine in some respects, was converted to its 
quaternary derivative. 
Quaternization of pilocarpine by straight, branched or un-
saturated alkyl groups as well as by aromatic groups resulted 
in the loss of peripheral muscarinic effects which normally are 
produced in mice by the non-quaternary parent compound. Further 
evidence indicated that the quaternary compounds also produced 
a muscular weakness. The acute toxicity in mice following in-
traperitoneal injection increased with increases in chain length 
of the alkyl substituent. In the alkyl series, the most toxic 
compound was the n-amyl derivative, which had an 
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LD50 of 154.7 mg/kg. In a previous toxicity evaluation (263) 
conducted in a similar manner on a different series of alkyl 
derivatives, the hexyl member was found to have an LD50 of 222 
mg/kg. On the basis of the current findings, it appears that 
maximum toxicity in the lower series of normal chain quaternary 
derivatives of pilocarpine was achieved with the n-amyl member. 
The acute toxicity of quaternary derivatives in the unsubsti-
tuted ring series was maximal with the benzyl derivative. In-
creasing the chain length between the unsubstitutedimidazole 
nitrogen and the benzene ring resulted in compounds which were 
not quite as toxic. Introduction of a methoxyl group in the 
para position of the benzene ring (p-methoxybenzyl pilocarpinium 
iodide) produced the most potent compound in the entire series: 
however, the introduction of a second methoxyl group into the 
ring (veratryl pilocarpinium iodide) resulted in a loss of po-
tency. Many factors influence the biological activities of a 
compound, and it would probably be impossible to introduce a 
change in chemical structure which would influence only one of 
these factors without simultaneously affecting others. Cavallito 
and Gray (44) indicated that the lipophilic balance of a cation 
is an important factor in the distribution of quaternary ammo-
nium salts. A high lipophilic balance would facilitate the pas-
sage of the ions through biological membranes and would also 
have a tendency to increase van der Waals bonding. Steric 
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influences are also of importance in bond formation with the 
receptor and may even be emphasized in rigid molecules. Inter-
action of these various factors would be reflected in the bond-
ing ability between drug and receptor and/or other inactive 
sites, and it is not easy to separate the contributions made by 
them. The preparation of the picrate derivatives suggested that 
the quaternary aromatic compounds, especially the methoxy sub-
stituted members, were lipophilic in character. This charac-
teristic of the molecules could, in part, account for the in-
creased potency of the p-methoxy- derivative. The increased 
bulk introduced by the second methoxyl group in the veratryl 
compound might contribute to steric hindrance within the mole-
cule, and this may account for the observed loss of potency. 
Methyl isopilocarpinium iodide was significantly more toxic 
to mice and had a lower EDSO value in the inclined screen test 
than its stereoisomer. This suggests that there might be a 
stereospecific factor involved in the pharmacological activity 
of the quaternary compounds. Additional tests on methyl iso-
pilocarpinium iodide were not performed for lack of drug. Suf-
ficient quantities of isopilocarpine hydrochloride to prepare 
additional members of the series was not available: therefore, 
additional comment on the stereochemical aspects will be re-
served hopefully until another time. 
The preparation of acetoxyethyl pilocarpinium bromide was 
243 
undertaken so that a quaternary derivative of pilocarpine having 
a side chain simulating that present in acetylcholine could be 
prepared and studied. In all of the screening tests, this com-
pound, acetoxyethyl pilocarpinium bromide, was the least active. 
The quaternary compound was somewhat hygroscopic and very solu-
ble in water. This behavior would indicate that the compound 
was more hydrophilic than lipophilic, and it might be expected 
that the polar groups attached to the alkane appendage probably 
contributed to this. These groups might therefore cause molec-
ular hydration which would have not only the effect of increas-
ing the bulk of the quaternary ion, but could very well stabi-
lize it in the solution phase. Cavallito (44) has suggested 
that when an ion becomes self-stabilizing, there would be less 
to be gained energywise from bonding with an external anionic 
group, and this would have an adverse effect on the biological 
activity of the compound. The experimental evidence obtained on 
the acetoxyethyl derivative substantiates this. Because the 
side chain contains an ester group, it would be reasonable to 
expect that cholinesterases as well as other hydrolytic enzymes 
might very well hydrolyze it. Since the compound was so inac-
tive, it might be presumed that the hydrolysis product, if it 
were to be formed, would be inactive also. 
Fig. 13 presents the regression lines of the toxicity data 
(solid lines) and of the inclined screen data (broken lines) for 
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a few representative members of the quaternary pilocarpine 
series. The figure provides further evidence for the statement 
made previously regarding the increasing toxicity of the com-
pounds with increasing length of hydrocarbon chain. This is 
reflected by a shift of the toxicity regression line toward the 
left. The apparent decrease in toxicity which resulted when 
the length of the hydrocarbon chain between the benzene and imi-
dazole rings was increased is shown by a shift of the regression 
line to the right. The inclined screen test, which in this ex-
periment measured the ability of the mice to cling onto a screen 
for maximum periods of 15 minutes in the face of increasing dose 
levels of the quaternary compound, was also a measure of the 
potency or activity of the quaternary compounds. Upon close ob-
servation, it was apparent that the inability of a mouse to re-
main on the screen after receiving an appropriate amount of a 
drug resulted from a muscular weakness beginning in the fore-
paws and progressing to the hind paws. It was presumed that 
central depression was not initially involved, as the moderate-
ly affected mice showed no loss of righting reflex or conscious-
ness and responded to nociceptive stimuli (tail pinch). The in-
clined screen regression lines (Fig. 13) follow a pattern iden-
tical to that described for the toxicity data. With increasing 
chain length in the quaternary compound, there was a shift in 
the response curve to the left. Both toxicity and inclined 
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Fig. 13 - Relationship between muscular weakness and toxicity of 
some quaternary pilocarpine salts in mice. Regression lines 
for toxicity data, solid lines, and for muscular \'leakness, 
broken lines. Ordinate; probits of percentage effect - per 
cent death in toxicity experiments and per cent of mice 
sliding from screen in inclined screen tests. Abscissa; 
dose (mg/kg). Key to quaternary compounds; p-methoxyben~yl 
pilocarpinium iodide,.; phenylethyl pilocarpinium iodide,a; 
sec-butyl pilocarpinium iodide,o; methyl isopilocarpinium 
iodide,6; methyl pilocarpinium iodide,A; acetoxyethyl pilo-
carpinium bromide,O. 
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screen regression lines for each compound had been subjected to 
an analysis of yariance ,to test for the linearity of the regres-
sion and were found to be linear at acceptable levels of signi-
ficance (practically all were included in 0.1 and 1% levels of 
significance). Although there are differences in slope among 
the individual compounds in the series, this may reflect the 
differences in affinity toward the receptors. Van Rossum and 
Ariens {248,249,250} reported that a positive correlation was 
found between the affinity for non-competitive receptors and 
the surface activity. It has also been reported that the affin-
ity increases with the chain length {29,249}. Both of these 
statements may be expressing essentially the same thing in dif-
ferent ways, and it appears that either or both could apply to 
the quaternary pilocarpine compounds. A "t" test for the par-
allelism between the toxicity and inclined screen regression 
lines for each of the 16 compounds studied showed that there was 
no significant difference between their slopes (P greater than 
0.50). The parallelism between the LD50 and the screen ED50 
in this. work strongly suggests that a similar mechanism of ac-
tion is being envoked in each case. It is presumed, therefore, 
that the factors or effects of the quaternary compounds which 
produce the peripheral muscular weakness are the same as those 
which appear to be exerted on the respiratory musculature to 
produce death. 
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Pradhan and De (203) have shown that the ratio of the dose 
of hyatin methiodide which caused respiratory paralysis to that 
dose which caused paralysis of limb muscles in both dogs and 
cats was 1.6 to 2.25: this indicated to them, "a safety margin 
of about 2". Corresponding ratios of 1.25 for d-tubocurarine 
chloride and 2.2 for decamethonium bromide have been reported 
in the literature (214). The range of the safety margins for 
the quaternary pilocarpine compounds, determined in mice as the 
ratio of the LD50/ED50, was 1.20 to 1.76. More than half of the 
values obtained on the pilocarpinium compounds were less than 
1.55. It was interesting that the range was similar to the 
value reported to be characteristic of curarimimetic agents. 
More direct evidence for a skeletal muscle blocking capa-
bility was obtained on the rat phrenic nerve-diaphragm with ben-
zyl pilocarpinium iodide. The quaternary compound produced a 
complete block of the muscle twitch, but had only about l/lOOth 
the activity of d-tubocurarine chloride (66). The block could 
be maintained in the presence of the drug, but could readily be 
reversed when the benzyl compound was washed from the bath. Ac-
cording to Van Rossum and Ariens (248), the biological activity 
of a compound affecting skeletal muscle is determined by both 
the affinity and the intrinsic activity. In general, bis-onium 
compounds have a better affinity on skeletal muscle than mono-
onium compounds. This is also expressed in the suggestion that 
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a bisquaternary ion could form a more stable bond than a mono-
quaternary by the formation of ion-pairs with an anionic site 
(44). Present evidence obtained with the benzyl derivative 
tends to confirm either of these concepts. 
All of the pilocarpinium compounds which were injected into 
chicks produced a flaccid paralysis. It was demonstrated with 
the p-methoxybenzyl derivative that the paralysis could be an-
tagonized by neostigmine. This would suggest that the block 
that was produced could be classified as the competitive-type, 
which is associated with curare and curarimimetic agents. An 
analysis of the structural configurations of the quaternary 
pilocarpine compounds would also tend to substantiate this. 
The cationic head of these quaternary compounds is composed of 
the imidazole and lactone rings of pilocarpine. This bulky, 
rigid structure could be compatible with the concept of a pachy-
curare as suggested by Bovet (35). The concentration of charge 
on the nitrogen atom or the charge density is another important 
factor which contributes to the potency of neuromuscular block-
ing agents (115). The quaternary pilocarpine compounds are 
unique in that the imidazole ring contains two nitrogen atoms 
in a resonating system. It has been previously suggested (205) 
that the charge in the quaternary compounds of imidazole is not 
confined to anyone nitrogen atom, but may reside at one atom 
for part of the time and at the other for the remaining time, 
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or the charge may also be distributed or shared by both nitro-
gen atoms. If the charge were distributed over both atoms, this 
would mean that the charge density at anyone nitrogen may not 
be too great. This could result in a decreased potency in this 
type of a quaternary compound. Zablocka and Esplin (269) have 
recently reported that large doses of pilocarpine (320 - 400 
mg/kg) produced paralysis of neuromuscular transmission in cats. 
The paralysis was enhanced rather than antagonized by atropine 
and could be partially restored by physostigmine. Since their 
findings are difficult to analyze, they will not be related to 
the present work. 
The results of the ophthalmologic investigation showed that 
the miotic activity which could be associated with pilocarpine 
was no longer evident when solutions of the quaternized pilo-
carpine compounds were introduced into the eyes of rabbits. 
In addition, no other apparent chang~s were produced. 
Results of the present investigation showed that isoamyl 
pilocarpinium iodide had a depressant effect on both blood pres-
, 
sure and heart rate in the anesthetized dog. The effect ap-
peared to be dose dependent, in that small doses (4 mg/kg) of 
the pilocarpinium compound produced minimal changes in blood 
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pressure, whereas with larger doses (8 and 10 mg/kg), more mea-
surable responses were obtained. The cardiovascular responses 
were transient, generally returning to predrug control levels 
within 2 to 10 minutes after drug administration. 
The vasodepressor responses to histamine phosphate were 
not affected by the isoamyl compound in the doses administered. 
Diphenhydramine hydrochloride antagonized both the histamine 
and isoamyl pi10carpinium iodide vasodepression, but to quite 
different degrees, i.e., there was pronounced antagonism of the 
histamine response and only a minimal or perhaps insignificant 
antagonism of the isoamyl derivative response. It was concluded 
therefore, that the cardiovascular responses of the isoamyl com-
pound were not the result of a histamine-like mechanism and were 
probably not due to the release of histamine by the quaternary 
compound either. The possible IIhistamine" activity observed by 
·the slightly diminished response of the isoamyl comp9und follow-
ing diphenhydramine hydrochloride was not observed in the ex-
periments with this compound performed on the guinea pig ileum. 
The cardiovascular responses to acetylcholine chloride were af-
fected very little following administration of the isoamyl com-
pound. It would appear that the quaternary compound, while dis-
playing an antispasmodic activity against acetylcholine on the 
guinea pig ileum, did not possess an lIatropine-1ike ll activity 
on the cardiovascular responses to acetylcholine in the dog. 
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Atropine sulfate abolished the vasodepressor responses to ace-
tylcholine chloride and pilocarpine hydrochloride while the vaso-
depression and bradycardia produced by the quaternary compound 
were slightly enhanced. This was perhaps further evidence that 
the muscarinic properties associated with pilocarpine were ab-
sent in this pi10carpinium derivative. It might suggest also 
that the vasodepression induced by the isoamyl compound and that 
induced by pilocarpine were not the result of a single mechan-
ism of action. The bradycardia in the presence of atropine may 
also rule out the possibility that the bradycardia produced by 
iso~ayl pilocarpinium iodide initially resulted from a reflex 
of vagal origin. It has not been established at this time, how-
ever, whether the vasodepression produced by the quaternary com-
pound was a direct effect on vascular smooth muscle, a conse-
quence of the decreased heart rate, or both. Additional studies 
involving the measurement of myocardial contractile force, car-
diac output and perhaps perfusion (e.g., rabbit ear) or flow 
studies would have to be undertaken in the future in order to 
establish this. The inability of the isoamyl compound to affect 
the vasopressor responses to epinephrine, norepinephrine or 
bilateral carotid occlusion would also suggest a lack of sym-
patholytic or ganglionic blocking activity. The results ob-
tained with isoamyl pi10carpinium iodide confirm those previous-
ly observed with the n-butyl member of this series (263). 
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In the review on imidazole and its derivatives, 2-benzyl-
imidazoline, tolazoline hydrochloride, a vasodilator and vaso-
depressor substance, as well as phentolamine, also a hypoten-
sive agent which has slight adrenolytic actions, were mentioned. 
Both tolazoline and phentolamine produce a rapid and marked fall 
in blood pressure. The vasodilation which is produced results 
from a direct action on blood vessels and is not blocked by 
atropine. Unlike the responses obtained with isoamyl pilocar-
pinium iodide, tolazoline and phentolamine are said to increase 
the heart rate by a direct action. Green (92) has reported on 
some of the cardiovascular effects of phenylpyridylamine, a 
substituted allylamine with antihistaminic properties. In doses 
of 10 mg/kg, this substance produced a vasodepressor response 
which was not blocked by atropine or vagotomy. The pharmaco-
logical and structural similarities of the above three compounds 
to the quaternary pilocarpinium compounds seem to provide some 
basis for explaining the action of the latter compounds. Un-
fortunately, when these current dog stUdies were undertaken, 
the benzyl and allyl pilocarpinium iodides had not yet been syn-
thesized, and they possibly could have provided a better basis 
for comparison. 
Results of the experiments on isolated guinea pig ileum 
showed that the quaternary salts of pilocarpine continued to 
display the general depressant activity which they had on other 
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biological test systems. The quaternary compounds antagonized 
the spasms elicited by acetylcholine, histamine and barium 
chloride, the three spasmogenic agents employed in the testing 
procedure. It has been established that acetylcholine contracts 
the guinea pig ileum mainly by direct stimulation of the muscle 
(5,61,75,101)? whereas barium chloride acts both on nervous ele-
ments within the muscle to release acetylcholine and on smooth 
muscle fibers (5,75). The picture is not so clear-cut with his-
tamine. Some investigators report that the action is directly 
on muscle fibers (5,61,75,148), while others claim an indirect 
action on receptors in the plexuses (101,185). 
Most of the quaternary pilocarpine compounds would antag-
onize acetylcholine-induced spasms at bath concentrations lower 
than those required to antagonfze the other spasmogens. Table X 
shows that 13 out of the 15 compounds are more effective in an-
tagonizing acetylcholine than they are at antagonizing either 
histamine or barium. This may indicate that those agents which 
contract the ileum primarily by a direct action on the muscle 
fibers are more vulnerable than those which act on both nervous 
structures and muscle fibers. 
In the review on imidazole and its derivatives, it was men-
tioned that histamine was the best known and perhaps one of the 
mos£ active imidazo1es. Attention was also called to the fact 
that antazo1ine [2-(N-pheny1-N-benzy1aminomethy1)-2-imidazo1ine] 
TABLE X 
Rank of Effectiveness of Each Quaternary Pilocarpine 
Derivative as an Antagonist of Acetylcholine~Ch), 
Barium (Ba), and Histamine (H) Spasms Based on 
the pD Value of the ED50 in Guinea Pig Ileum 
Compound Rank (Decreasing Effectiveness) 
1st 2nd 3rd 
Methyl Pilo- ACh Ba H 
carpinium Iodide 
Ethyl Pilo- ACh H Ba 
carpinium Iodide 
n-propyl Pilo- Ba H ACh 
carpinium Iodide 
Isopropyl pilo- ACh H Ba 
carpinium Iodide 
Allyl pilo Ba ACh H 
carpinium Iodide 
n-Butyl pilo- ACh Ba H 
carpinium Iodide 
sec-Butyl Pilo- ACh H Ba 
carpinium Iodide 
n-Amyl Pilo- ACh H 
carpinium Iodide 
Isoamyl Pilo- ACh Ba H 
carpinium Iodide 
Acetoxyethyl Pilo- ACh H Ba 
carpinium Bromide 
Benzyl pilo- ACh Ba H 
carpinium Iodide 
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Compound 
Pheny1ethy1 Pi1o-
carpinium Iodide 
Phenoxyethy1 Pi1o-
carpinium Bromide 
p-Methoxybenzy1 
Pi10carpinium 
Iodide 
Veratry1 Pi1o-
carpinium Iodide 
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TABLE X (continued) 
Rank (Decreasing Effectiveness) 
1st 2nd 3rd 
ACh H Ba 
ACh H Ba 
ACh Ba H 
ACh 
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has enjoyed some popularity as an antihistamine. Adamson, 
Barrett, Billinghurst and Jones (3) reported on the synthesis 
and stereochemistry of some allylamines. A pharmacological 
evaluation of some of these compounds was made by Green (92). 
The allylamine, triprolidine, and the propylamines, pheniramine 
and chlorpheniramine, displayed antihistaminic activity. The 
antihistamine activity of triprolidine [1-{4 1 -methylphenyl)-1-
{2 1 -pyridyl)-3-pyrrolidino prop-l-ene maleate] was confined to 
the trans-isomer. In addition to the steric specificity, it 
was found that the pyrrolidino group was most effective in the 
allylamines, whereas the dimethyl amino group was most effective 
in the propylamines (2). 
In general, it appears that most of the antihistamines act 
by competition with histamine for the receptors on smooth mus-
cle cells (19). Lee and Jones (161) have analyzed the struc-
tural features necessary for histamine-like properties and have 
suggested that the most important part consists of the side 
chain and amino group of histamine as well as the adjoining con-
jugated =C-N= fragment from the aromatic imidazole nucleus. 
This same unit, with the nitrogen in the amino group in a pro-
tonated form, has been considered to be common to active antag-
onists of histamine. It has been hypothesized that the molecule 
should be planar in this region and that the points of attach-
ment to the receptor appear to involve an onium group, the 
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pyridine nitrogen and also the 3-carbon atom chain. The onium 
center was conceived as the area of ionic bonding with the ter-
minal carbon atom of the chain and the pyridine nitrogen as pro-
viding areas of electrostatic attraction. Substituents on the 
benzene ring and the rest of the molecule containing the pyri-
dine nitrogen could increase the affinity to the receptor by 
contributions from van der Waal's forces (19). 
Results obtained on the antihistamine activity of the pilo-
carpinium compounds showed that allyl- and propyl pilocarpinium 
iodides were the most effective agents. An analysis of their 
chemical structure indicates that they contain those elements 
of structure which might best contribute to a good affinity with 
histamine receptors. In addition to its electronic contribu-
tion, the allyl radical contributes to the planarity of the 
molecule which might be reflected in a closer fit to the recep-
tor surface. The decreased responses to histamine observed in 
some experiments after the quaternary compound was washed from 
the bath would not necessarily indicate desensitization of the 
tissue, but might also indicate more persistent binding of the 
quaternary compound with the tissue. The antagonism of hista-
mine-induced contractions by the other effective members in the 
series appeared to be nonspecific. They were all antagonists 
to about the same degree, and there was no obvious relationship 
between chemical structure and activity. 
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Although there was a greater degree of variability among 
the various members of the quaternary series, the results in 
general showed that the pilocarpinium compounds possessed rather 
poor ability to antagonize the spasms induced in guinea pig 
ileum by barium chloride. If the somewhat nonspecific anti-
spasmodic activity displayed by many of the quaternary compounds 
in the acetylcholine and histamine studies is attributed to in-
teractions with receptors on the surface of smooth muscle cells, 
and if it is assumed further that a similar phenomenon is ob-
tained in the barium studies, then the findings that the qua-
ternary compounds are poor antagonists to barium might be ex-
plained on the basis that substances which are spasmogenic by 
a direct action would be more readily antagonized, while those 
substances which are spasmogenic because they affect intramural 
nervous structures as well as peripheral receptors would be 
poorly antagonized. The quaternary compounds, therefore, might 
block receptors which are directly stimulated by barium chloride, 
but have little or no effect on those receptors which are in-
directly stimulated by barium chloride. The presence of two 
such types of receptors (M and D) for 5-hydroxytryptamine 
(serotonin) in the guinea pig ileum have been reported (61,84). 
On the basis of the experiments described, the mechanism(s) 
by which veratryl pilocarpinium iodide produced its stimulatory 
effect on guinea pig ileum cannot be defined with any degree of 
259 
certainty. Whether the effect is brought about as the result of 
a specific biochemical action or results from a nonspecific 
physicochemical property remains to be determined. 
In conclusion, it can be said that quaternization of pilo-
carpine resulted in the loss of its muscarinic activity and pro-
duced additional changes in its pharmacological profile. 
It was interesting to discover that the most active com-
pounds producing the muscle relaxant effects as well as the 
toxic syndrome in mice were the n-amyl derivative and benzyl and 
p-methoxybenzyl derivatives. Since the n-amyl derivative has a 
5-atom chain and the other two derivatives closely approximate 
this distance, it was tempting to suggest that some of the anti-
spasmodic effects observed in the ileum experiments might be 
directed toward interactions with peripheral cholinergic recep-
tors. Pfeiffer (194) has suggested that compounds which decrease 
or antagonize acetylcholine are similar to acetylcholine in that 
they possess lengths of approximately 7.R. The "prosthetic" 
groups are also similar, but are contained in the center ridge 
of a large umbrella-like molecule. Van Rossum and Ariens (247) 
have shown that a change from parasympathomimetics to parasym-
patholytics is accomplished when groups larger than methyl are 
introduced into the cationic head of the 'mimetic' molecule. 
The three quaternary pilocarpine compounds meet these general 
structural requirements for parasympatholytic activity. The 
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unique qualities and activity of allyl- and propyl pilocarpin-
ium iodides in relation to the suggested structural require-
ments for antihistaminic agents has been mentioned previously 
in this discussion. Therefore, in the midst of all the non-
specificity which has been referred to at other times in this 
discussion, specificity of action appears to exist in some of 
the quaternary compounds, at least in their antihistaminic or 
anti-barium action. 
On the other hand, the nonspecificity and the general bio-
logical depressant activity in the various test preparations 
suggests that the quaternary compounds may be exerting their 
effects via a nonspecific action. The suggestion of a "cutoff 
point" in the toxicity data by the decreased toxicity of hexyl 
pilocarpinium iodide may indicate that limits of solubility 
might have been reached with the n-amyl derivative in the alkyl 
series. The result is that not enough of the next higher homo-
logue (hexyl, in this instance) goes into solution to reach its 
threshold of activity. This nonspecific action suggests that 
the Ferguson principle (77) might be involved in some aspects 
of the activity of the quaternary pilocarpine compounds. To 
propose this as a fact however, it would be necessary to estab-
lish such parameters as solubility, surface tension and perhaps 
the critical micelle concentration of the quaternary compounds. 
CHAPTER VIII 
SUMMARY 
The pharmacological activity of a series of compounds, 
prepared by the quaternization of pilocarpine, was studied by 
means of various screening tests. 
1. Sixteen quaternary pilocarpine and isopilocarpine com-
pounds were included in the series. They were the n-alkyl mem-
bers from methyl pilocarpinium iodide to n-amyl pilocarpinium 
iodide, the branched alkyl derivatives isopropyl, sec-butyl and 
isoamyl pilocarpinium iodides and the unsaturated allyl deriva-
tive. Aralkyl representatives of the series were benzyl, phenyl-
ethyl, p-methoxybenzyl and veratryl pilocarpinium iodides, as 
well as phenoxyethyl pilocarpinium bromide. The remaining two 
members of the series were acetoxyethyl pilocarpinium bromide 
and the quaternary stereoisomer of pilocarpine, methyl isopilo-
carpinium iodide. 
2. Several methods of synthesis and crystallization were 
reported for the series of compounds. yields from the alkyla-
tion reactions varied from 46.4 to 95.0 per cent. In general, 
yields lower than 70 per cent probably reflected losses in puri-
fication. 
. 
3. The melting points of the new compounds were determined, 
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and the melting points of the previously reported quaternary 
derivatives confirmed. The elemental composition of the quater-
nary derivatives Was obtained by microanalysis. 
4. The infrared spectra of the quaternary pilocarpine com-
pounds were determined and are illustrated by reproductions of 
the tracings. Interpretation of the spectra was presented by 
correlating the observed absorption peaks with characteristic 
infrared absorptions known to occur in these regions and by com-
parisons with the infrared spectra of the parent alkaloids. 
5. The picrate salts of the synthesized pilocarpinium de-
rivatives were prepared to serve as an additional means of iden-
tification for the quaternary compounds. Several methods em-
ployed in their preparation have been reported. The melting 
points of the new picrates were determined, and the melting 
points of the previously reported picrates confirmed. N-amyl 
pilocarpinium picrate was the only solid form of that quaternary 
pilocarpine compound which was obtained. The color, crystalline 
appearance and crystallization solvent of the picrates were tabu-
lated in the manner reported by Battersby and Openshaw. 
6. The results of the pharmacological screening tests 
showed that the formation of quaternary compounds of pilocarpine 
resulted in the loss of peripheral muscarinic effects which nor-
mally are associated with the non-quaternary parent compound. 
a. The miotic activity of pilocarpine was no longer 
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evident when solutions of methyl iso- and methyl pi10car-
pinium iodides, as well as the ethyl, n-buty1 and isoamyl 
derivatives, were introduced into the eyes of rabbits. 
b. The blood pressure response in dogs to isoamyl pilo-
carpinium iodide was one of vasodepression only. The re-
sponse was not blocked by atropine sulfate, and was only 
minimally antagonized by diphenhydramine hydrochloride. 
c. The toxic manifestations of the pi10carpinium com-
pounds were different from those seen in either pilocarpine 
or isopi10carpine hydrochloride intoxicated mice. 
d. Most of the quaternary pilocarpine compounds had a 
relaxant effect on the normal base line of isolated guinea 
pig ileum strips, similar to that seen after atropinization. 
7. The inclined screen EDSO's were determined in mice fol-
lowing intraperitoneal injection of the quaternary pilocarpine 
compounds. The development of muscular weakness and the subse-
quent inability of the mice to remain on the screen increased 
with an increasing dose of a particular quaternary and also ap-
peared to increase as the alkyl series was ascended. The effect 
was shown to decrease with increasing chain length in the aral-
kyl series. 
8. The acute LDSO's of the pi10carpinium derivatives fol-
lowing intraperitoneal injection were determined in mice. The 
toxicity increased with increasing chain length in the alkyl 
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series and decreased with increasing chain length in the aralkyl 
series. Isopilocarpine methiodide was significantly more toxic 
to mice than its cis-isomer, pilocarpine methiodide. The slopes 
of the LD50 regression line for a particular quaternary compound 
paralleled the slope of the inclined screen ED50 regression line 
for the same compound. This suggested that the differences in 
the measured end-point were perhaps either quantitative or an 
indication of the relative sensitivity of the muscles, but that 
different mechanisms of action were not involved. 
9. The margin of safety of the quaternary compounds was 
determined in mice as the ratio of the LD50/ED50. The range of 
this margin was 1.20 to 1.76 and suggested that the quaternary 
pilocarpine compounds might be producing their muscular effects 
in a manner similar to that of curare. 
10. The effects of the alkyl quaternary derivatives, methyl, 
n-propyl, n-butyl, n-amyl, and the aromatic quaternary members, 
benzyl, phenyl ethyl and p-methoxybenzyl pilocarpinium iodides, 
were qualitatively investigated after intravenous injection into 
four to five day old chicks. All of the quaternary compounds 
produced a flaccid paralysis. 
11. The benzyl derivatives produced a reduction in muscle 
twitch and a complete paralysis in the isolated rat phrenic 
nerve-diaphragm. The activity of the benzyl compound appeared 
to show about l/lOOth the activity of d-tubocurarine chloride 
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in its blocking capability. 
12. The activity of the quaternary pilocarpine compounds in 
antagonizing the spasms induced by acetylcholine chloride, his-
tamine phosphate and barium chloride has been determined on iso-
lated strips of guinea pig ileum. The allyl and n-propyl deriv-
atives appeared to demonstrate a better ability to antagonize 
histamine-induced contractions than any of the other quaternary 
compounds, while the methyl and ethyl pilocarpinium compounds 
were relatively ineffective antagonists. The rest of the quater-
nary compounds, in general, displayed an antagonism toward his-
tamine, but the activity seemed to be nonspecific. The quater-
nary compounds generally possessed rather poor ability to antag-
onize the contractions elicited in guinea pig ileum by barium 
chloride. On the other hand, antagonism of acetylcholine-induced 
contractions was demonstrated by all of the quaternary compounds. 
Since the antispasmodic activity can be more readily demonstrated 
e 
toward thos~ spasmogens which act in a direct manner, it appeared 
that the quaternary pilocarpine compounds might act as direct 
smooth muscle relaxants. 
13. The general biological depressant activity shown in the 
various test procedures suggests that, with perhaps a few excep-
tions, the quaternary pilocarpine compounds may be exerting their 
effects by a nonspecific action. 
CHAPTER IX 
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TABLE XI 
pD* Values Equivalent to Various 
Dilutions and Concentrations 
pD Dilution Ratio Mcg/M1 Mg % 
(mg/100 m1s) 
2.79 1:625 1600 160 
2;92 1:833 1200 120 
3.00 1:1,000 1000 100 
3.10 1:1,250 800 80 
3.19 1:1,563 640 64 
3.22 1:1,667 600 60 
3.32 1:2,083 480 48 
3.40 1:2,500 400 40 
3.49 1:3,125 320 32 
3.52 1:3,333 300 30 
3.62 1:4,167 240 24 
3.70 1:5,000 200 20 
3.79 1:6,250 160 16 
3.92 1:8,333 120 12 
4.00 1:10,000 100 10 
4.10 1:12,500 80 8 
4.12 1:13,333 75 7.5 
4.22 1:16,667 60 6 
4.30 1:20,000 50 5 
4.40 1:25,000 40 4 
4.60 1:40,000 25 2.5 
4.70 1:50,000 20 2 
5.00 1:100,000 10 1 
5.10 1:125,000 8 0.8 
5.30 1:200,000 5 0.5 
5.40 1:250,000 4 0.4 
5.70 1:500,000 2 0.2 
6.00 1:1,000,000 1 0.1 
* D = Log of reciprocal of the dilution ratio 
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